Machine Learning and latest RayCare innovations on show at ESTRO 37

New features in RayStation 7*New functionality and a wide range of general improvements will be on show. The latest RayStation release that will be demonstrated contains several enhancements to existing functionality that will contribute to improved workflows and planning efficiency, including integration with RayCare, the next-generation oncology information system. Major new functionality includes the addition of robust constraints in multi-criteria optimization (MCO), simulated organ motion for robust optimization and evaluation, multi-atlas-based segmentation and conformal arc planning for photons.  Significant additions on the proton side include support for Hyperscan™ pencil beam scanning technology from Mevion Medical Systems, and support for uniform scanning for proton therapy systems from Mitsubishi Electric. Other proton therapy improvements include snout rotation for passive proton techniques and MLC collimation for PBS and passive techniques.  RayCare: the next-generation oncology information systemRayCare 1 was launched in December 2017 and is already in clinical use at Iridium Cancer Network in Belgium. Iridium will present its first experiences with the system during the RaySearch lunch symposium on Saturday 21 April. Development of upcoming versions of RayCare is going forward rapidly. RaySearch will demonstrate the latest improvements and features, including advanced workflow management tools and integrated planning workflow support for RayStation. RayCare active workflows are highly configurable and the task management features enable an integrated planning experience with RayStation, supporting automation of process steps and communication around planning tasks. Other features on show include the built-in PACS system, which supports automation of imaging workflows, and the control room client for radiation therapy treatment management. Machine Learning demonstrationsThe Machine Learning department at RaySearch is developing solutions for automating workflows and supporting the user in RayStation and RayCare. At ESTRO 37, RaySearch will demonstrate two RayStation applications of machine learning: automated treatment planning and automated organ segmentation. The automated planning application uses machine learning algorithms to generate a set of treatment plans in minutes, based on clinical treatment data from Princess Margaret Cancer Centre and University Medical Centre Groningen. Automated organ segmentation uses deep neural networks to generate a set of 3D organ volumes within seconds. RaySearch will also present the machine learning and analytics framework concept that will enable RayStation and RayCare to become learning systems. Lunch symposium: Advancing Cancer Treatment Through Software InnovationOn Saturday April 21, 13:15 - 14:15, floor P1, room 11, RaySearch will hold a lunch symposium focused on how software is driving innovation in oncology.Moderator: Rik Westendorp, Medical Physicist, Radiotherapiegroep, Deventer, Holland Fight cancer with codeJohan Löf, Founder & CEO, RaySearch Laboratories (publ), Stockholm, Sweden First clinical experience with RayCare 1 in a multi-institutional settingCarole Mercier, Radiation Oncologist, Iridium Cancer Network, Belgium Efficiency improvements with RayStationNick West, Lead Clinical Scientist, The Northern Centre for Cancer Care, Newcastle, UK Questions and conclusion sessionRik Westendorp, Medical Physicist, Radiotherapiegroep, Deventer, Holland       About RayCareRayCare represents the future of OIS technology, developed from the ground up by RaySearch to support the complex logistical challenges of modern, large-scale radiation therapy centers. RayCare will integrate the high-performance radiation therapy algorithms available in RayStation with advanced features for clinical resource optimization, workflow automation and adaptive radiation therapy. About RayStationRayStation integrates all RaySearch’s advanced treatment planning solutions into a flexible treatment planning system. It combines unique features such as multi-criteria optimization tools with full support for 4D adaptive radiation therapy. It also includes functionality such as RaySearch’s market-leading algorithms for IMRT and VMAT optimization and highly accurate dose engines for photon, electron, proton and carbon ion therapy. The system is built on the latest software architecture and features a graphical user interface with state-of-the-art usability. About RaySearchRaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation treatment planning system to clinics all over the world and distributes products through licensing agreements with leading medical technology companies. The company has now launched the next-generation oncology information system, RayCare, which comprises a new product area for RaySearch. RaySearch’s software is used by over 2,600 clinics in more than 65 countries. The company was founded in 2000 as a spin-off from Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since 2003. More information about RaySearch is available at www.raysearchlabs.com * Subject to regulatory clearance in some markets. For further information, please contact:Johan Löf, President and CEO, RaySearch Laboratories AB (publ)Telephone: +46 (0)8-510 530 00johan.lof@raysearchlabs.com

Anna Ullman Sersé appointed Interim Head of Nelly

"We are pleased to appoint Anna Ullman Sersé as the Interim Head of Nelly. Anna has solid experience within retail and has supported Nelly’s strategy development since 2016. This makes her a good fit with Nelly that is one of the strongest Nordic brands in online fashion. I also want to take this opportunity to thank Jan for his time with Qliro Group,” says Marcus Lindqvist, President and CEO of Qliro Group. Anna Ullman Sersé joined as Head of Business Development for Qliro Group 2016 and has since led the strategy development for Nelly and the other business areas. Anna has long experience as a management consultant at Accenture Interactive. As Nordic lead for retail, she worked with most of the largest retailers in Sweden. Anna holds a Master of Law and a Master of Science in Business Administration from Stockholm University. For more information, please visit www.qlirogroup.com, or contact:Niclas Lilja, Head of Investor RelationsTelephone: +46 736 511 363E-mail: ir@qlirogroup.comAbout Qliro Group Qliro Group is a leading Nordic e-commerce group in consumer goods, lifestyle products and related financial services. Qliro Group operates the leading Nordic marketplace CDON.COM, the online fashion brand Nelly.com and Qliro Financial Services that offers financial services to merchants and consumers. In 2017 the Group had sales of SEK 3.4 billion. Qliro Group’s shares are listed on the Nasdaq Stockholm Mid-Cap segment under the ticker symbol QLRO.

Intrum and Intesa Sanpaolo enter into a long term strategic partnership, creating a market leading servicer of non-performing loans in Italy

As communicated yesterday Intrum has submitted a binding offer to Intesa Sanpaolo regarding the establishment of a servicer of non-performing loans (NPLs) in Italy. Intesa Sanpaolo has accepted the offer. Below is a summary of the agreed transaction. The information below is in all material respects the same as presented in the press release yesterday. The co-investor in the SPV is, however, presented with a name - CarVal Investors Highlights · Intrum and Intesa Sanpaolo have agreed to establish a market leading servicer of non-performing loans (NPLs) in the Italian market, involving the two transactions outlined below: 1. Merger of Intesa Sanpaolo’s NPL recovery operations and all of Intrum’s current Italian operations* into a leading servicer of NPLs in Italy (Joint Venture Servicer)- Intrum will own 51% of the Joint Venture Servicer.- The Joint Venture Servicer enters into a 10-year exclusive servicing agreement with Intesa Sanpaolo for the vast majority of the bank’s new NPL inflow during this period.- Intrum will consolidate the Joint Venture Servicer in the financial reporting. 2. Intrum, together with CarVal Investors, will acquire a 51% participation of a NPL portfolio with a Gross Book Value (GBV) of EUR 10.8 billion to be deconsolidated from Intesa Sanpaolo. The portfolio will be held by a securitization Special Purpose Vehicle (SPV). - Intrum will own 80% of the 51% of the holding in the SPV.- CarVal Investors on behalf of its managed and advised funds including Fondaco SGR S.p.A have committed to co-invest for an amount corresponding to the remaining 20% of the 51% holding in the SPV.- The SPV will be financed by non-recourse senior asset backed notes. - Intrum will not consolidate the SPV in the financial reporting.  · The aforementioned transactions reflect an overall valuation of around Euro 3.6 billion for the Joint Venture Servicer and the NPL portfolio. · Intrum’s estimated total net cash investment for its holding in the servicing platform and its interests in the SPV is EUR 670 million. The net investment envisages no further syndication. · Intrum will make an initial payment of EUR 156 M at the end of April 2018. The remainder of the purchase price will be paid at closing, which is expected at year-end 2018.  · The transactions represents a significant reinvestment of proceeds from the remedy units divested in March 2018 and hence a significant contribution to Intrum’s planned M&A and portfolio investments in 2018, in turn supporting Intrum’s ambitions for profitable growth.   · The transactions are subject to authorizations being received from the relevant authorities.  · Italy is one of the largest markets for NPLs in Europe which highlights the importance of this long term strategic partnership.  *** “This innovative transaction is a milestone for Intrum and provides us with long-term access to the large Italian Credit Management Services market. Together with Intesa Sanpaolo we are building a Credit Management Services provider in one of the largest European markets that will draw on our mutual strengths. The joint venture sets a new standard in the market where two experienced industrial players join forces to create a market leader servicer in Italy,” says Mikael Ericson, President and CEO of Intrum. Joint Venture Servicer  Intrum and Intesa Sanpaolo will set up a Joint Venture Servicer into which the bank contributes its NPL servicing platform and Intrum will contribute all its current Italian operations (apart from Cross Factor S.p.A. and the holding company Lindorff Italy S.r.l.). Intrum will own a majority interest of 51% in the joint venture. Intrum will appoint the majority of the board members as well as the CEO. The new company will operate under the Intrum brand and Intrum will consolidate it in the financial reporting. The Intesa Sanpaolo NPL servicing platform currently has around 600 employees and services a portfolio of non-performing loans of approximately EUR 30 billion. The Joint Venture Servicer will continue to service these volumes and also benefit from a 10-year exclusive servicing agreement with Intesa Sanpaolo in relation to the vast majority of Intesa Sanpaolo´s new inflows. The Joint Venture Servicer will offer leading specialist servicing capabilities to banks and other creditors as well as portfolio sale services that will allow banks to de-risk their balance sheets through long term established relationships with one of the market leaders. NPL portfolio Furthermore, Intesa Sanpaolo will divest a portfolio of non-performing loans with a EUR 10.8 billion gross book value, of which the majority are secured loans. Intesa Sanpaolo will retain a 49% interest in the SPV. The SPV will be participated by Intrum, together with one or more co-investors. CarVal Investors, a leading global alternative investment fund manager with approximately USD 10 billion in assets under management, has provided a commitment to co-invest with Intrum for an amount corresponding to 20% of the 51%. Intrum will make an initial payment of EUR 156 million at the end of April 2018. The remainder of the purchase price will be paid at closing. The portfolio acquisition will be part-financed at closing through issuance of asset backed senior notes, the subscription of the notes is guaranteed by a bank consortium with the following key terms: · Legal Maturity: 5.5 years, Senior LTV: 60%, Senior Interest Rate: EURIBOR 1m (floored at zero) + 325bps, Undrawn Interest Rate: 325bps and Upfront Fees: 100bps · The commitments from the bank consortium are subject to conditions, including but not limited to, satisfactory documentation and regulatory approvals *** “Italy is one of the largest markets for non-performing loans in Europe with over EUR 300 billion of non-performing loan exposures on banks’ balance sheets. Through this partnership we gain a larger access to the growth opportunities that the Italian market provides. We see that banks are increasingly looking to outsource parts of their receivables management to sophisticated specialist servicers that are able to recover outstanding debts in a professional and compliant manner, and restore bank’s customer’s credit worthiness in an efficient and respectful way,” says Mikael Ericson. The transaction represents a significant contribution to the group’s planned M&A and portfolio investments in 2018 and will support Intrum’s ambitions for profitable growth. Intrum remains committed to the long-term target of net debt/cash EBITDA of 2.5-3.5 and whilst immediately after the transaction the net debt/cash EBITDA ratio is estimated to approximately 4.5x for the Intrum Group this is a temporary effect and the net debt/cash EBITDA ratio will decrease in the first 12 months as the cash flow from the portfolio is gradually included in the calculation of leverage. Intrum’s expectation is to be in the middle of the target range by 2020. The transaction is expected to be earnings per share accretive in 2019. The overall transaction is expected to close at year-end 2018. The Joint Venture Servicer will be consolidated into the accounts of the Intrum Group as per closing date. The NPL portfolio is to be transferred into the SPV in April 2018, with investors being exposed to the risks and rewards of the portfolios from January 1 2018. Net collections between January 1, 2018 and closing will be deducted from the gross purchase price. The completion of both parts of the transaction is subject to authorizations being received from the relevant authorities. Advisors Mediobanca, financial Goldman Sachs, financial RCC Studio Legale Lex, legal For more information, please contact: Mikael Ericson, CEO & PresidentTel: +46 8 546 102 02 Thomas Moss, acting CFOTel: +46 8 546 102 02Annika Billberg, Chief Brand & Communications OfficerTel: +46 702 67 97 91 About Intesa Sanpaolo Intesa Sanpaolo is an Italian banking group which was formed by the merger of Banca Intesa and Sanpaolo IMI. Intesa Sanpaolo is among the top banking groups in the euro zone, with a market capitalisation of approximately 52 billion euro. Intesa Sanpaolo is the leader in Italy in all business areas (retail, corporate, and wealth management). The Group offers its services to 12.3 million customers through a network of approximately 4,700 branches well distributed throughout the country with market shares no lower than 12% in most Italian regions. Intesa Sanpaolo also has a selected presence in Central Eastern Europe and Middle Eastern and North African areas with approximately 1,100 branches and 7.6 million customers belonging to the Group's subsidiaries operating in commercial banking in 12 countries ---------------------------------------------------------------------- * Apart from Cross Factor S.p.A. and the holding company Lindorff Italy S.r.l. This information was submitted for publication, through the agency of the contact person set out above, at 12.00 CET on 18.04.17.

Saab Delivering Digital Towers to First Airport Without Traditional Tower

Saab Digital Air Traffic Solutions AB has been selected by Scandinavian Mountains Airport to both install and operate digital towers at their airport. This is the first time digital tower services will be put into operation at a new airport. It also marks the first time that Saab will be delivering true digital air navigation service provider capabilities. The contract includes the installation of the Saab R-TWR system at the airport during 2018/19 and initial operations from the digital tower centre in Sundsvall from December 2019 for a period of ten years. The airport will be serving the destinations within the region, including Sälen and Trysil ski resorts, mainly during the winter season, thus enabling the airport to make use of the flexibility of digital tower services from a centralized location. “The Scandinavian Mountains Airport contract embeds many of the drivers behind remote towers, use of a standardised, approved and industrialised technical platform, provision of ATC on demand and the launch of a digital ANS provider. We are proud to support the world’s first true digital tower airport” says Johan Klintberg, CEO of Saab Digital Air Traffic Solutions. The Scandinavian mountain region is an international destination, comprising Sweden and Norway’s biggest alpine destinations, Sälenfjällen and Trysil, along with Idre and Engerdal. This will be another step towards the development of the large developing region in Sweden and Norway by improving infrastructure and creating accessibility to the heart of the region. “Digital Tower technology and services from Saab were the natural choices for us when building our airport,” says Brett Weihart, CEO of Scandinavian Mountains Airport. “It will enable us to future-proof our operations and ensure cost-efficient and flexible service. In addition, we envision the airport becoming a part of a wider digital transition for our customers, and Digital Tower is an aspect of this,” says Brett Weihart. The airport will be begin operations during the 2019/20 winter season. For further information, please contact: Saab Press Centre, +46 (0)734 180 018 presscentre@saabgroup.com www.saabgroup.com  www.saabgroup.com/YouTube  Follow us on twitter: @saab  Saab serves the global market with world-leading products, services and solutions within military defence and civil security. Saab has operations and employees on all continents around the world. Through innovative, collaborative and pragmatic thinking, Saab develops, adopts and improves new technology to meet customers’ changing needs. 

Clinical Laserthermia Systems and Toronto General Hospital Begin Clinical Study for MRI-Guided Laser Ablation Treatment of Prostate Cancer

Framingham, MA – April 17, 2018- Clinical Laserthermia Systems Americas, Inc . (CLS) a subsidiary of CLS AB in Lund, Sweden, today announced the commencement of a clinical study with Toronto General Hospital in Canada investigating MRI-guided, focal laser ablation (FLA) treatments for prostate cancer.  The study has been approved by Health Canada and its results will be published on the National Institute of Health Web site:www.clinicaltrials.gov. Starting in April 2018, twenty-five patients will participate in a 24-month study at the hospital to evaluate the safety and efficacy of CLS’s TRANBERG®|Thermal Therapy System and single-use accessories . The study includes men with early stage prostate cancer that have not already undergone radiation or hormone treatment.  “We are very pleased Toronto General Hospital has chosen our minimally invasive TRANBERG Thermal Therapy System for this important clinical study,” stated Lars-Erik Eriksson, CEO of Clinical Laserthermia Systems AB. “The study will produce important data surrounding the performance and efficacy of the TRANBERG Thermal Therapy System for MRI guided focal laser ablation treatments.”  Unique, Non-Cooled, Diffusing Fiber Technology CLS utilizes unique, non-cooled, diffusing laser fiber technology to optimize heat distribution in tissue while eliminating the need for external cooling. The system also includes features designed to improve workflow and reduce procedure times. The TRANBERG®|Thermal Therapy System has not yet received market clearance for immune stimulating interstitial laser thermotherapy (imILT®) by the Food and Drug Administration (FDA) in the United States of America (USA).  Media Contact TopSpin CommunicationsJoe WaldygoP: 480-363-8774E: joe@topspinpr.com

Axel Johnson International acquires Dock Equipment range from Pommier

Forankra France, part of Axel Johnson International Transport Solutions business group, has acquired the Dock Equipment product range from Pommier SA 1 April through an asset acquisition. The products are mainly aimed for logistics hubs, warehouses, trucks and trailers and include the patented Butdock® product.  “This product range is a strategic addition to our existing dock equipment range and allows us to strengthen our product and service offer across Europe,” says Erik Eklöv, Managing Director of Transport Solutions. “Our own R&D development will also play an important role in developing these products further.” Established in 1945, Pommier is a recognised producer and provider of bodywork components in the market for industrial vehicle equipment. The company and its brands are known for quality and reliability, driven by significant investments in R&D. “By selling this part of the business to a reputable company like Forankra, I know that our customers will be treated with care and seriousness,” says Jean-Patrick Sauvy, CEO of Pommier. The Transport Solutions business group comprises leading European providers of cargo securing solutions and vehicle components. It includes ABKATI, Eigenbrodt, Sternhammar, Trailerkomponenter, TMT. Malinen, Widni, Verne, Forankra group and allsafe, with total sales of EUR 150 million in 2017.   For further information, please contact: Hans Glemstedt, Head of Strategy and M&A, Axel Johnson International, +46 (0)8 453 77 41, hans.glemstedt@axinter.com Erik Eklöv, Managing Director of Transport Solutions, Axel Johnson International,+46 (0)70 202 939, erik.eklov@axinter.com Virginie Guillot, Marketing Manager of ACK Forankra, +33 (0)4 72 45 07 24, virginie.guillot@forankra.fr  

CybAero presents new strategic focus

CybAero is and shall continue to be Sweden's leading company within RPAS (Remotely Piloted Aircraft System), a market that is currently in rapid transformation. Within this framework, CybAero will adapt the business to the current conditions with a clear objective of becoming self-sufficient.The market for unmanned aerial vehicles is in strong growth and in a changing phase. The biggest change is that civil service is growing ever stronger. CybAero has therefore decided to direct more resources to that area and to continue the development of APID One in parallel with this. Civil services CybAero still sees great opportunities in future APID One sales, but by combining this with civil service assignments, it is estimated that we can reach revenues sooner. Many commercial civilian missions require approval from the Swedish Transport Agency and can therefore not be carried out by unauthorized operators. CybAero has a big head start since the company already has these licenses and organization. CybAero is currently performing some civil service missions, and the assessment is that this area is gaining momentum and faces a strong expansion. Already today, the company faces an increasing share of requests for different types of civilian missions. CybAero has a structured aviation organization and will operate within all segments of unmanned aerial vehicles. It also means that the development of APID One can take place at a faster pace, because test flights can be combined with service assignments and also provide revenue to the business. APIDIn the case of APID, CybAero will continue the sales efforts that has begun, but also to actively seek new business opportunities. However, the assessment is that no ADIP will be delivered to the customer in 2018. In addition to developing APID towards a user-friendly and robust aircraft, efforts will focus on adapting helicopters to future EU standards. The civilian, European aviation rules for RPAS are essentially already developed and CybAero's assessment is that the company's helicopters will be adapted to these in time by the year 2021 when the EU law begins to apply.The continued development work and adaptation to future APID certification during 2018 means that we will have an updated product in the form of APID to deliver to customers during 2019.PartnersCybAero has, with the latest financing proposal in collaboration with Alpha Blue Ocean (see PR 28/3/2018) funding for the year to come. In combination with revenue from services, the assessment is that the financial position of the company is sufficient to implement the strategy now established. In order to keep costs down while developing products and services, CybAero will, to a greater extent than before, work to seek co-operation and co-financing in our development processes.Assessment of the futureCybAero's assessment is that a significant part of the company's revenue in the coming years will come from the civil service market. The company's ambition, however, is that the long-term source of income comes from proprietary unmanned airplanes seen from a life-cycle perspective.For more information, please contact:Tommy Magnusson, CEOPhone: +46 (0)13-465 29 00Email: ir@cybaero.seThis information is information that CybAero AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 14:35 CET on 17 april 2018.Web:  www.cybaero.se         Videos: www.youtube.com/cybaeroAbout CybAeroCybAero develops and manufactures Remotely Piloted Aircraft Systems (RPAS) for safer and more effective aerial operations in various environments, including those hazardous in nature. The company has made a great international impact with its APID One helicopter, which can be adapted for both military and civilian applications such as coastal and border surveillance, search and rescue missions, and mapping. CybAero’s head office is located in Mjärdevi Science Park in Linköping, Sweden. The company has been listed on the NASDAQ First North since 2007. FNCA Sweden AB is the company's certified adviser.

Alligator Bioscience presents ATOR-1015 preclinical data at the AACR Annual Meeting 2018 confirming localized tumor activation

Lund, Sweden, 17 April 2018 – Alligator Bioscience (Nasdaq Stockholm: ATORX), a biotechnology company developing antibody-based pharmaceuticals for tumor-directed immunotherapy, today presents preclinical data on the immune activating antibody ATOR-1015 at the American Association of Cancer Research (AACR) Annual Meeting 2018 taking place in Chicago, Illinois. ATOR-1015 is a first-in-class bispecific tumor-directed antibody, targeting CTLA-4 and OX40, designed to selectively activate the immune system in the tumor, without increasing systemic toxicity. The preclinical data demonstrate that ATOR-1015 physically localizes to the tumor and selectively activates the immune system in the tumor area, confirming the intended ATOR-1015 mechanism of action. ATOR-1015 is primarily designed for combination therapy with a PD-1 blocking antibody, and the potential of this approach is supported with preclinical data reporting enhanced anti-tumor effect of ATOR-1015 in combination with an anti-PD-1 antibody, as compared to anti-PD-1 monotherapy. In addition, ATOR-1015 demonstrated superior efficacy compared to mono-targeting CTLA-4 and OX40 antibodies. “The results presented in Chicago confirm that our CTLA-4 bispecific antibody ATOR-1015 selectively activates the immune system in the tumor area. This offers great potential for an improved benefit/risk profile for cancer patients. We are more and more excited about the significant prospects for this unique compound, particularly in combination with PD-1 blockers, and are looking forward to initiate clinical development later in the year”, said Per Norlén CEO of Alligator Bioscience. Alligator is planning to initiate an ATOR-1015 Phase I study during the second half of 2018. A poster with the title “CTLA-4 x OX40 bispecific antibody ATOR-1015 induces anti-tumor effects through tumor-directed immune activation” is showcased today at 8-12 a.m. EDT and is also available on the company web page  www.alligatorbioscience.com .  For further information, please contact:Cecilia Hofvander, Director Investor Relations & CommunicationsPhone +46 46 286 44 95E-mail: cecilia.hofvander@alligatorbioscience.com  The information was submitted for publication, through the agency of the contact person set out above, at 3 p.m. CEST on 17 April 2018. About Alligator BioscienceAlligator Bioscience AB is a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs. Alligator’s growing pipeline includes four lead clinical and pre-clinical drug candidates (ADC-1013, ATOR-1015, ATOR-1017 and ALG.APV-527). ADC-1013 (JNJ-7107) is licensed to Janssen Biotech, Inc., part of J&J, for global development and commercialization. Alligator’s shares are listed on Nasdaq Stockholm (ATORX). The Company is headquartered in Lund, Sweden, and has approximately 50 employees. For more information, please visit www.alligatorbioscience.com .

TMG’S CHANNELZERO APPOINTS DYNAMIC CREATIVE, BENJAMIN CROFT, AS CREATIVE DIRECTOR

TMG agency, ChannelZero today announces the appointment of Ben Croft as the agency’s new Creative Director completing Channelzero’s leading executive team line up (he joins Mikey Taylor, CEO, Franky Callanan, ECD and Belinda Wearne who was appointed General Manager in October 2017). Ben returns to Channelzero, having spent the last three years as Senior Art Director at Studio Woo. He has led teams on high-end accounts including Running Bare, Oxford, Jag, Sheike, Paspaley, GPT, Nikon and Mirvac. Ben has previously worked at Channelzero, as contracted Creative Director and notably worked on VS for Men. Ben returns to further escalate the agency’s profile and caliber of its work for its portfolio of clients, taking brands to new heights in 2018, and beyond. Channelzero’s CEO, Mikey Taylor says of the new appointment: “Ben has continued to master his craft and grow his experience over recent years and we are delighted to have brought him back to Channelzero. His skills in art direction, design, branding and photography will catapult Channelzero to the next level which is our focus for 2018.” Commenting on his appointment, Ben Croft says: “There is something about Channelzero that keeps bringing me back. It’s not like any other agency. It has its own rhythm and unique approach to its people, the work and its clients.” ECD, Franky Callanan says of Croft joining the ranks; “Ben brings a true art and creative finesse to the table. His skill and experience will complement our existing team. I honestly cannot wait to see what’s to come over the following months.” Channelzero is a full-service agency, based in Sydney’s leafy district of St Leonards. The Agency is the Australian offering under the global marketing network, TMG (The Marketing Group plc). Channelzero’s clients include Speedo, Nestle, Sanitarium, Rio Tinto and Sydney Water. 

Brighter is nominated to ”Rising Star” by Swecare.

The trade association Swecare, which works to help Swedish healthcare companies expand internationally, introduces a new price for young fast-growing companies. The "Rising Star" Prize will be awarded for the first time during Swecare's 40th Anniversary April 19th in Stockholm and Brighter is one of the nominated companies. – We are very pleased with the nomination and have achieved a good trend with great awards over the last several weeks, both for the design of Actiste and Brighter as a company, says Brighter's founder and CEO Truls Sjöstedt. Brighter was earlier this year nominated for Sweden's biggest design award, Design-S of Swedish Form, and has also won the design world's most prominent award Red Dot Award – both for Brighter's solution Actiste®. – Daily, we see younger companies who, with small funds, high involvement and without respect for the mere 24 hours of the day, attend meetings, delegation trips, incoming visits and networking meetings. They actively contribute to the development of the business and to expand the common knowledge level by not fearing discussion, sharing their successes and failures, as well as ideas about what they and others in the same situation need to succeed. We are impressed by these fighters, and the "Rising Star" prize will be awarded to one of these outstanding ones during the year, and as we anticipate, this will be a rewarding success in due course, says Swecare's project manager Nima Jokilaakso. Swecare Export Award is awarded by Queen Silvia at Swecare's Annual Meeting in Stockholm on April 19th. For more information, please contact: Truls Sjöstedt, CEO Telefon: +46 709 73 46 00      E-post:  truls.sjostedt@brighter.se Henrik Norström, COO   Telefon: +46 733 40 30 45      E-post: henrik.norstrom@brighter.se About BrighterBrighter is a Swedish-based company that, from a unique IP portfolio, creates smart solutions for one of healthcare’s biggest challenges: changing patient behavior. Chronic diseases such as diabetes are rapidly increasing, and account for an increasing share of healthcare costs globally. Brighter's Business Model and Multi-Sided Market Platform - The Benefit Loop™ - is based on the fact that many special interests create value for each other. By increasing access to valid health data, Brighter creates value for all stakeholders in the care chain: patients and their close associates, healthcare providers, research institutes, the pharmaceutical industry, and society as a whole. www.brighter.se About ActisteBrighter's solution Actiste® handles most of the self-monitoring and treatment of insulin-treated diabetes in a single easy-to-use device. Measurement of glucose levels, insulin injections, automatic logging, and timing of all activities are performed from a single unit. Actiste is connected via an autonomous and secure mobile connection, and information can be automatically shared with selected recipients through The Benefit Loop®, Brighter's open cloud-based service where data is collected, processed and analyzed with patient consent. Validated user-generated data, such as test results, can be automatically transferred electronically to many different constituents. The patient selects when and how data is shared and who will have access to it. Through The Benefit Loop, different services can motivate patients with chronic illnesses to change their behavior, which can save lives, reduce relatives' concerns, and release enormous healthcare resources. www.actiste.com  The Company's shares are listed on NASDAQOMX First North/BRIG . Brighter’s Certified Adviser on Nasdaq OMX First North is Remium Nordic Holding AB +46 (0)8 – 454 32 50, CorporateFinance@remium.com, www.remium.com.

Bergs Timber has signed an agreement to acquire Norvik’s timber operations in the Baltics and the United Kingdom

Bergs Timber AB (publ) (”Bergs Timber” or the “Company”) has today signed an agreement with Bergs Timber’s principal owner, Icelandic Norvik hf (”Norvik”), with respect to the acquisition of a number of companies within the Norvik group with operations in Latvia, Estonia and the United Kingdom (the ”Target Companies” and the “Acquisition”).[1] On 22 January 2018, Bergs Timber and Norvik entered into a letter of intent in respect of the Acquisition, which was made public the same day. Since the press release Bergs Timber has carried out a due diligence of the Target Companies and together with Norvik, carefully evaluated the industrial logic behind the Acquisition. Summary of the Acquisition · Through the Acquisition, Bergs Timber will become a significant participant within the sawmill market, as its sawmill capacity increases from approximately 530,000 m³ per year to approximately 920,000 m³ per year. · The Acquisition will increase Bergs Timber’s product processing and thus has the capacity of limiting Bergs Timber’s sensitivity to fluctuations in the economic cycle. · Through the Target Companies’ concentration to the Baltics, the group’s raw materials base is broadened while risks are spread as part of the production is based on costs in euro. · Potential for synergies exist within areas such as raw material procurement, distribution and sales. Purchase price The purchase price will be made up of 170 million newly issued shares in Bergs Timber as well as a cash payment of SEK 270 million. The newly issued shares in Bergs Timber, which are intended to be issued in their entirety following a resolution at the extraordinary general meeting to be held 14 May (the “Issue in Kind”), will amount to a calculated value of approximately SEK 449 million, based on the volume weighted average share price of approximately SEK 2.64 for Bergs Timber’s share of class B during the ten (10) trading days immediately preceding 17 April 2018. The cash payment will be made with SEK 100 million in connection with the completion of the Acquisition, SEK 100 million on 30 June 2019 as well as SEK 70 million on 30 June 2020. Bergs Timber will pay an interest of 6-month STIBOR plus two percent, however, not at any time less than two percent in total, on the payments made after the completion of the Acquisition. In addition, Norvik is entitled to a performance-based earn-out, which in total may amount up to SEK 40 million and will be paid out for the periods 2018, 2019 and 2020. Conditions for the Acquisition The Acquisition is mainly conditional upon: · that the extraordinary general meeting in Bergs Timber, to be held on 14 May 2018, resolves in accordance with the board of director’s proposal on the Issue in Kind; and · that final approval is obtained from relevant banks in respect of the Acquisition and its financing. The resolution to approve the Issue in Kind on the general meeting will be made in accordance with the so called “LEO”-rules in accordance with the Swedish Companies Act, meaning that a valid decision will require that the proposal in respect of the Issue in Kind is supported by shareholders representing at least nine tenths (9/10) of both the votes and shares represented at the meeting. The proposal on the Issue in Kind is available in the notice to the extraordinary general meeting, which has been made public in connection with this press release and made available on Bergs Timber’s web page www.bergstimber.se. The Target Companies are acquired from Berg Timber’s principal owner Norvik The Target Companies are owned by Bergs Timber’s largest shareholder Norvik, which currently holds 29.52 percent of the outstanding shares and votes in Bergs Timber. If the Acquisition is completed, Norvik is expected to reach a holding in Bergs Timber of 64.68 percent. Norvik has announced its intention to divest parts of its holding arising out of the Issue in Kind, with the long term intention to reduce its total holdings of shares in Bergs Timber to levels below 50 percent. Norvik has entered into a lock-up undertaking regarding its shares in Bergs Timber, which will be in force for two years from and including the date when the Acquisition is completed. The lock-up undertaking entails that Norvik is prohibited to divest its shares in Bergs Timber through a stock exchange. However, Norvik shall not be prohibited to divest its shares in Bergs Timber by way of any bilateral transaction, provided that Norvik’s shareholding after such a transaction amounts to at least 40 percent of the total number of shares in Bergs Timber, calculated on the basis of outstanding shares in Bergs Timber at the time immediately following the completion of the Issue in Kind. In addition, Norvik has entered into an undertaking, provided that the Acquisition is completed, not to vote for its entire holding at general meetings in Bergs Timber. The undertaking entails that Norvik is prohibited from voting for shares representing more than 90 percent of the amount of votes held by other shareholders. Furthermore, the undertaking entails that Norvik is prohibited to in any way pursue that the members of the board of directors in Bergs Timber that are active within or directly and materially related to Norvik at any time constitutes a majority of the members of the board of directors of Bergs Timber. The undertakings shall apply as long as Norvik’s shareholding in Bergs Timber exceeds 45 percent of the total number of shares and votes in the Bergs Timber. The Swedish Securities Council has on customary terms granted Norvik an exemption from the mandatory bid obligation that would otherwise arise when Norvik receives shares from the Issue in Kind. Documents Prior to the general meeting that will resolve on the Acquisition, the shareholders of Bergs Timber will be able to receive a fairness opinion related to the Acquisition and obtained from independent expertise, as well as the prospectus that Bergs Timber is required to issue due to that the shares issued in the Issue in Kind are admitted to trading on Nasdaq Stockholm. The fairness opinion and the board of director’s complete proposals have been made available on Bergs Timber’s web page www.bergstimber.se. The prospectus that Bergs Timber is required to issue due to that the shares issued in the Issue in Kind are admitted to trading on Nasdaq Stockholm is expected to be made public around the turn of the month April/May 2018. Indicative timetable · Notice to the extraordinary general meeting – 17 April 2018 · Fairness opinion and board of director’s complete proposals are made available on Bergs Timber’s web page – 17 April 2018 · Estimated date for the publication of the prospectus – around the turn of the month April/May 2018 · Extraordinary general meeting – 14 May 2018 · Estimated date for the registration of the shares issued in the Issue in Kind and the shares being admitted to trading on Nasdaq Stockholm – end of May 2018 Revised financial targets Subject to completion of the Acquisition, the board of directors of Bergs Timber has adopted revised financial targets for the group. · EBITDA margin shall, over a business cycle, exceed 7 percent, · return on capital employed shall, over the same business cycle, exceed 10 percent, · debt/equity ratio shall be less than 1.0, · the goal of annual growth, over a business cycle, shall be 2 percent organically and 5 - 10 percent including acquisitions, and · dividends shall under normal conditions amount to 25 – 40 percent of the Company’s profit after tax. ”We have now, for a couple of months, had the opportunity to get to know and evaluate Norvik’s timber operations. These companies are well managed and profitable with an engaged staff and quality products. I am convinced that the companies strengthen each other and that the acquisition is good both for our staff and our owners”, says Peter Nilsson, CEO of Bergs Timber. Further information about this press release can be provided by Bergs Timber’s CEO and group president Peter Nilsson (+46 703 15 09 27 or +46 10 19 98 504). This is information that Bergs Timber is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, on 17 April 2018 at 16:30 (CEST). Bergs Timber AB (publ), 556052-2798, Bergs väg 13, SE-570 84 Mörlunda, telephone +46 10 19 98 500. More information about our operations can be found on our web page under the address www.bergstimber.se. ---------------------------------------------------------------------- [1] The companies intended to be acquired are the Latvian companies SIA Vika Wood (Reg. no 40003241801) and BYKO-LAT SIA (Reg. no 40003139), the Estonian companies Aktsiaselts Laesti (Reg. no 11562764) and Aktsiaselts EWP (Reg. no 10250689) and the British company Continental Wood Limited (Reg. no 05518779).

Endomines’ Annual General Meeting postponed – new date is 22 May 2018

Endomines AB, Stock Exchange Release 17 April 2018 at 17:00 CEST The shareholders in Endomines AB (publ) are hereby notified that the Annual General Meeting on 19 April 2018 is cancelled due to administrative issues and that the new date for the Annual General Meeting will be Tuesday 22 May 2018. The agenda for the Annual General Meeting will not change from the agenda that was included in the notice to the original date for the Annual General Meeting. The formal notice to the Annual General Meeting on 22 May 2018 will be made public in a separate press release and will also be published in Swedish in the Official Swedish Gazette (Sw. Post- och Inrikes Tidningar) on 20 April 2018. The notice will also be available on the Company’s webpage. The record date for being entitled to participate at the Annual General Meeting will be Wednesday 16 May 2018. Shareholders must also give notice to the company of their intention to participate at the Annual General Meeting no later than 16 May 2018. Please note that such notice must be given even if the shareholder has given notice of attendance to the now cancelled date for the Annual General Meeting. For further information, please contact: Saila Miettinen-Lähde, CEO, +358 40 548 36 95, saila.miettinen-lahde(at)endomines.com Marcus Ahlström, CFO, +358 50 544 68 14, marcus.ahlstrom(at)Endomines.com The information was submitted for publication, through the agency of the contact persons set out above, at 17:00 CEST on 17 April 2018. About EndominesEndomines is a mining and exploration company with its primary focus on gold. The Company operates a gold mine in Pampalo, has exploration activities along the Karelian Gold Line in Eastern Finland and develops mining operations in Idaho, USA. Endomines aims to improve its long-term growth prospects by increasing its exploration activities and through acquisitions. Endomines aims to acquire deposits that are situated in stable jurisdictions and can be brought to production rapidly with limited investments. The shares trade on Nasdaq Stockholm (ENDO) and Nasdaq Helsinki (ENDOM).

Aspire Global enters an agreement with Aller Media Denmark

Aspire Global has signed an agreement on platform-services with Aller Media Denmark, a company within Aller Group, the leading publisher of magazines and newspapers in the Nordic region. Aller Media Denmark will be launching an iGaming brand during the second quarter and has chosen Aspire Global’s full-service solution to target the Danish market, becoming one of the first media companies in the Nordic to add an iGaming offering to their business. “The agreement with Aller Media Denmark is in line with our strategy to focus on regulated markets by providing large media companies with the opportunity to launch an iGaming brand of their own. Media companies in regulated markets possess the opportunity to generate new income streams, leveraging their established brands and Aller Media A/S has a unique position in the Danish media market. We look forward to the launch”, says company CEO Tsachi Maimon.  Aller Media A/S is one of the leading publisher of magazines and weekly’s in Denmark with a strong online presence. The agreement with Aller Media Denmark is in line with Aspire Global’s long-term strategy to focus on partnerships with large media companies in regulated markets. Recently Aspire Global entered Portugal through a similar partnership with Cofina Media. Aspire Global has been operating under a Danish gaming license for six years. For further information, please contact: Tsachi Maimon, CEO, Tel: +356-797 778 98 or email: tsachi@aspireglobal.comJov Spiero, VP Sales, Tel: +972 54 616 3021 or email: jovs@aspireglobal.com About this information  Aspire global discloses the information provided herein pursuant to the EU Market Abuse Regulation (MAR). The information was submitted for publication by the contact person above at 5:30 pm (CET) on April 17th, 2018.  About Aspire GlobalFounded in 2005, Aspire Global offers a full-service iGaming solution for operators and white labels. The robust, market-leading platform includes a complete suite of services for casino and sportsbook, such as multilingual CRM, payments and risk control, support call center, VIP management and acquisition optimization. Aspire Global also holds licenses in regulated markets including the UK, Denmark, Belgium, Italy and Malta. The company share is listed on Nasdaq First North Premier under ASPIRE. Certified Adviser: FNCA AB, Sweden. Please visit Aspireglobal.com

Notice to Annual General Meeting of Endomines AB (publ)

Endomines AB, stock exchange release 17 April 2018 at 17:30 CET The shareholders of Endomines AB (publ) are hereby invited to the Annual General Meeting to be held on Tuesday 22 May 2018 at 16.00 CET at Konferens Spårvagnshallarna, Birger Jarlsgatan 57 A, 113 56 Stockholm, Sweden. Attendance To be entitled to participate in the Annual General Meeting, shareholders shall have entered into the share register kept by Euroclear Sweden AB on Wednesday 16 May 2018 and given notice of his/her intention to participate at the Annual General Meeting no later than Wednesday 16 May 2018. Notice of attendance shall be made in writing to Endomines AB (publ), Birger Jarlsgatan 41 A, 111 45 Stockholm, Sweden, by telephone +358 50 544 68 14 or by email anmalan@endomines.com. When given notice of participation, the shareholder shall state name, personal identification number or company registration number, address, telephone number, number of shares represented at the Annual General Meeting and proxies and assistants, if any. Proxies If participation is by way of proxy, such document should be submitted to Endomines no later than Wednesday 16 May 2018, in order to facilitate the entry into the meeting. Any proxy must be submitted in original. A proxy form is available at www.endomines.se. Nominee registered shares To be entitled to participate in the Annual General Meeting, shareholders having their shares in the share register kept by Euroclear Sweden AB in the name of a nominee must request to temporarily be registered into the share register in his/her own name. Such registration, so-called voting rights registration, must be completed no later than on Wednesday 16 May 2018, which means that shareholders must notify the nominee well in advance. To be entitled to participate in the Annual General Meeting, shareholders having their shares in the share register kept by Euroclear Finland Oy in the name of a nominee must request to temporarily be registered into the share register in his/her own name and give notice of his/her intention to participate at the Annual General Meeting pursuant to the section “Attendance” above. Registration in the share register must be completed no later than Wednesday 16 May 2018, at 10:00 AM (Finnish time), which means that shareholders must notify the nominee well in advance before such date. Proposed agenda 1.Opening of the meeting 2.Election of Chairman of the meeting 3.Verification of the voting list 4.Approval of the agenda 5.Election of one or two persons to verify the minutes 6.Establishment of whether the meeting has been duly convened 7.Presentation of the Annual Report and the Auditor’s Report as well as the Consolidated Financial Statement and the Group Auditor’s Report 8.Statement by the CEO 9.  Resolutions regarding   ads. adoption of the profit and loss statement and the balance sheet and the consolidated profit and loss statement and consolidated balance sheet adt. appropriation of the company’s result according to the adopted balance sheet adu. discharge from liability for the members of the Board of Directors and the CEO 10. Proposal regarding resolution to amend the Articles of Association11.Statement of the Nomination Committee's work and proposals 12.Resolution regarding remuneration for the Board of Directors and the Auditors 13.Resolution regarding the number of members of the Board of Directors and Deputies 14.Election of the members of the Board of Directors and Chairman of the Board of Directors 15.Election of the Auditor 16.The Board of Directors proposal of resolution regarding Guidelines for remuneration of the Senior Management 17.The Board of Directors proposal of authorisation for the Board of Directors to resolve on issue of new shares, warrants and convertible bonds 18.Closing of the meeting Proposals to the Annual General Meeting Item 2 –Election of Chairman of the meeting The Nomination Committee proposes Christoffer Saidac, Attorney at law, to be elected as Chairman of the meeting. Item 9b – Resolutions regarding appropriation of the company’s result according to the adopted balance sheet The Board of Directors proposes that no dividend is paid for 2017 and that the company’s funds are allocated so that SEK -88,106,747 is carried forward, consisting of share premium reserve of SEK 324,791,076, loss brought forward of SEK 360,369,697 and the loss for the year of SEK 52,528,126. Item 10 – Proposal for resolution to amend the Articles of Association  The Board of Directors considers it more appropriate to elect the company’s auditor for one year at a time, and not four years as stated in the Articles of Association. Accordingly, the Board of Directors proposes that Section 7 of the Articles of Association are amended and worded as follows: “The company shall have one or two auditors with a maximum of equivalent number of deputies, or one registered auditing firm.” Item 12 – Resolution regarding remuneration for the Board of Directors and the Auditors The Nomination Committee proposes that the remuneration for the Chairman of the Board of Directors shall be SEK 350,000 per year (325,000), and SEK 200,000 to each other member of the Board of Directors per year (175,000), no remuneration shall however be paid to a member of the Board of Directors employed by the company, that remuneration for members of the Board of Directors’ work in the Remuneration Committee, Audit Committee and Technology and Security Committee set up by the Board of Directors, shall be an unchanged amount of SEK 25,000 per member of the Board of Directors per year for each such committee, that remuneration to the Chairman of the Audit Committee shall be an unchanged amount of SEK 50,000 per year, and a that a meeting remuneration of SEK 3,000 shall be paid for each physical board meeting and participating board member. The remuneration to the Auditors is proposed to be paid in accordance with approved accounts. Item 13-14 – Resolution regarding the number of members of the Board of Directors and Deputies and election of the members of the Board of Directors and Chairman of the Board of Directors  The Nomination committee proposes that the Board of Directors consist of five members with no deputies and re-election of members of the Board of Directors Michael Mattson, Rauno Pitkänen and Staffan Simberg, and new election of Thomas Hoyer and Ingmar Haga. Furthermore, the Nomination Committee proposes that Ingmar Haga is elected Chairman of the Board of Directors. Ann Zetterberg Littorin has informed the Nomination Committee that she is not available for re-election. Further information of the proposed new members of the Board of Directors is available at www.endomines.com. Item 15 – Election of the Auditor The Nomination Committee proposes, in accordance with the recommendation from the Audit Committee, that the registered accounting company PricewaterhouseCoopers AB be re-elected as the auditor for the period until the end of the Annual General Meeting 2019. Item 16 – The Board of Directors proposal for resolution regarding Guidelines for remuneration of the Senior Management The Board of Directors proposes that the Annual General Meeting resolves on the following guidelines for remuneration of the Senior Management. Senior Management refer to the CEO and the other members of Group Management (the “Management”), as well as members of the Board of Directors, to the extent they receive compensation outside the board assignment. Endomines will apply market-based remuneration levels and terms of employment to recruit and maintain a management with high competence and capacity to achieve set goals, designed to promote the company’s long-term value creation. The remuneration shall motivate the Management to do its utmost to ensure the shareholders’ interests. Remuneration to the Management shall consist of fixed salary, variable remuneration, any performance and share-related incentive programs and other benefits and pensions. The total remuneration shall be market-based and competitive and based on competence, responsibility and performance. The variable remuneration shall be designed with the purpose of promoting the company’s long-term value creation and be based on outcomes in relation to clearly defined goals as well as being maximized in relation to the fixed salary determined. The variable remuneration shall not exceed 40 per cent of the fixed salary for the CEO and for the other members of the Management not exceed 30 per cent of the fixed salary. In case of termination of employment contracts by the company, the notice period shall not exceed twelve months. Severance pay and fixed salary for a member of the Management should in general not exceed an amount corresponding to the fixed salary for twelve months upon termination by the company. Pension benefits shall be determined by fees. Share-related incentive programs within the company shall ensure long-term commitment to the company’s development, an increased community of interests partnership between the program participant and the company’s shareholders and shall be implemented on market terms. Members of the Board of Directors elected by the Annual General Meeting may in special cases receive remuneration for services within their respective areas of competence, which do not constitute board work. For these services a market-based remuneration must be paid, which the Board of Directors must approve. The Board of Directors may waive these guidelines only if there are special reasons for this in a specific case and the reason for the deviation is reported at the next Annual General Meeting. In accordance with the Swedish Corporate Governance Code, the Board of Directors’ Remuneration Committee follows and evaluates the implementation of the Annual General Meeting Guidelines for remuneration to Senior Management. The company’s auditor has, in accordance with Chapter 8, Section 54 of the Swedish Companies Act issued an opinion as to whether the guidelines for remuneration to Senior Management resolved upon on the Annual General Meeting 2017 were adhered to. The evaluation and auditor’s review has resulted in the conclusion that Endomines has followed the guidelines for remuneration resolved by the Annual General Meeting 2017. Item 17 – The Board of Directors proposal for resolutions of authorisation for the Board of Directors to resolve on issue of new shares, warrants and convertible bonds The Board of Directors proposes that the Annual General Meeting authorises the Board of Directors, on one or more occasions during the period until the next Annual General Meeting, with or without deviation from the shareholders’ preferential rights, against cash payment, for payment in kind or by way of set-off, resolve to issue new shares, warrants and/or convertible bonds. Issuance pursuant to such authorisation may not result in the company’s share capital exceeding the maximum allowed share capital in accordance with the company’s Articles of Association at any given time. In respect of shares, the basis for the subscription price shall be the market value of the shares with any customary discount. The reasons for deviation from the shareholders’ preferential rights are to enable directed issues primarily to enable structural transactions, to broaden long-term ownership in Endomines, and to use the opportunity to acquire capital for additional investments on favourable terms to further develop prospecting efforts, thereby promoting Endomines’ ability to create additional value for all shareholders. Miscellaneous Specific majority requirements For a valid resolution of the Annual General Meeting, according to the Board of Directors’ proposal under paragraphs 10 and 17, it is required that the resolution of the proposal is supported by shareholders representing at least two thirds of both the votes cast and the shares represented at the Annual General Meeting. Authorisation The Board of Directors, or a person appointed by the Board of Directors, shall be entitled to make such minor amendments to the Annual General Meetings resolutions which may be required in connection with registration with the Swedish Companies Registration Office and Euroclear Sweden. Number of shares and votes As per the day of this notice, there is a total of 35,147,785 shares in Endomines, each carrying one vote, totalling 35,147,785 votes. Shareholders’ right to request information Upon request by any shareholder and where the Board believes that such may take place without significant harm to the Company, the Board of Directors and CEO should provide information at the Annual General Meeting in respect of any circumstances which may affect the assessment of a matter on the agenda, and any circumstances which may affect the assessment of the company’s or a subsidiary’s financial position and as regards the Company’s relationship to other Group companies and the consolidated accounts. Documents The complete proposals of the Nomination Committee (in Swedish) in accordance with items 2 and 12-15, the Board of Directors’ proposals (in Swedish) in accordance with items 9 b, 10, 16 and 17, as well as Endomines’ Annual Report, the Board of Directors’ presentation of the Remuneration Committees’ evaluation pursuant to the Swedish Code of Corporate Governance and the Auditor’s Report (in Swedish) pursuant to Chapter 8, Section 54 of the Swedish Companies Act will be available at the company and at the company’s website www.endomines.se, no later than three weeks prior to the Annual General Meeting. The Nomination Committee’s statement regarding the proposal for the Board of Directors and information on proposed members of the Board of Directors is available at the company’s website (in Swedish). The documents will be sent by mail to the shareholders who request it and provide their postal address. ____________________________ Stockholm, April 2018 Endomines AB (publ) The Board of Directors  Contact personSaila Miettinen-Lähde, CEO, +358 40 548 36 95, saila.miettinen-lahde@endomines.com The information was submitted for publication, through the agency of the contact persons set out above, at 17:30 CEST on 17 April 2018. About EndominesEndomines is a mining and exploration company with its primary focus on gold. The Company operates a gold mine in Pampalo, has exploration activities along the Karelian Gold Line in Eastern Finland and develops mining operations in Idaho, USA. Endomines aims to improve its long-term growth prospects by increasing its exploration activities and through acquisitions. Endomines aims to acquire deposits that are situated in stable jurisdictions and can be brought to production rapidly with limited investments. The shares trade on Nasdaq Stockholm (ENDO) and Nasdaq Helsinki (ENDOM).

Report from the AGM of ProfilGruppen AB

Around 120 shareholders and guests attended today's Annual General Meeting at Folkets Hus in Åseda. The meeting was chaired by Kåre Wetterberg. CEO summarized the year of 2017CEO Per Thorsell gave a summary of last year’s events and success. A summary of the CEO's speech will be published on the company’s website.  Decisions of the Annual General MeetingThe income statement and balance sheet as well as the consolidated income statement and the consolidated balance sheet for the 2017 financial year were adopted.   DividendFor the 2017 financial year, the Board decided a dividend of SEK 4.50 per share (previous year SEK 3.00 per share). The cut-off date for the dividend will be 19 April 2018. The dividend payment through Euroclear Sweden AB is expected to be made 24 April 2018. Election of the Board and auditorThe following Board members were reelected; Monica Bellgran, Mats Egeholm, Bengt Stillström, Thomas Widstrand and Kåre Wetterberg. Kåre Wetterberg was elected as Chairman. The Company’s auditor, Ernst & Young AB, with Franz Lindström as auditor in charge, was reelected for the coming year. FeesThe Annual General Meeting decided on fees for Board members in accordance with the nomination committees proposals. Hence, fees will be paid as follows: To the Chairman SEK 365,000. To other Board Members elected in the meeting not employed by the company SEK 150,000 each. The remuneration- and audit committees are included in the Board's tasks and no additional fees will be awarded. No fees will be paid to Board Members and deputies elected by the employees. Remuneration for auditors was decided in accordance with approved invoices. Decision on the nomination committee for the AGM 2019The Annual General Meeting approved the proposal from the nomination committee on the procedural issues regarding how the new nomination committee is to be appointed and regarding its duties for the Annual General Meeting 2019. Authorisation for the Board to decide on new issues of sharesThe Annual General Meeting granted the Board authorisation, during the period until the next Annual General Meeting, on one or more occasions, with or without preferential rights for the shareholders, to make decisions regarding new issues of maximum 700,000 shares, corresponding to in total approximately 9.5 percent of the share capital. The decision on new issue may contain conditions stating that the shares issued may be paid by issue in kind, offsetting or otherwise under conditions in accordance to the Swedish Companies Act 13 chapter 5§ first paragraph 6. The Board is authorised also to decide on the other terms of a new issue of shares. For a valid decision of the AGM, assistance from shareholders representening at least two thirds of both the votes cast and the votes represented at the AGM is required. The reason for the authorisation is to enable the company to issue shares as payment for acquisitions of companies or shares of companies and/or assets, which the Board deems to be of value to the ProfilGruppen group's activities, or in order to strengthen the company’s capital position. Guidelines for remuneration for senior executivesThe AGM decided on guidelines for remuneration for senior executives according to the proposal of the Board. Minutes from the AGMVerified minutes from the AGM will be published on the Group’s website. Financial informationThe interim report for the second quarter will be submitted on 17 July 2018, 14.00 CET. Dates for the release of financial information are available on the Group’s website. Åseda, April 17, 2018 Board of ProfilGruppen AB (publ.) Corporate ID no. 556277-8943

Cimco Marine AB (publ) has been approved as issuer on Nasdaq First North Bond Market

Nasdaq Stockholm AB has on 16 April 2018 resolved to approve Cimco as issuer of fixed income instruments on Nasdaq First North. During the approval process, Nasdaq has identified a potential rule violation in respect of Cimco’s disclosure requirements. Nasdaq’s approval is conditional upon that nothing arises during the handling of the possible rule violation that affects the prerequisites for the approval. As announced on 25 January and 7 February 2018, Cimco has issued corporate bonds in the amount of MSEK 80. Cimco has, in accordance with the terms and conditions for the bonds, applied for listing of the bonds on Nasdaq First North. The first day of trading is expected to be 19 April 2018. By reason of the listing, Cimco has prepared a company description. The company description is available on Cimco’s website www.oxe-diesel.com. For further information, please contact: Myron Mahendra, CFO, +46 763-47 59 82, myron.mahendra@oxe-diesel.com Certified Adviser Västra Hamnen Corporate Finance AB is Cimco’s Certified Adviser. Cimco Marine AB (publ) is obligated to make this information public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, on 17 April 2018 at 7:45 pm. Cimco Marine AB (publ) has, after several years of development, constructed the OXE Diesel, the world´s first diesel outboard engine in the high power segment. OXE Diesel has a unique belt driven propulsion system that allows a hydraulic multi-friction gearbox to be mounted. This means that the engine can handle significantly higher loads than a traditional outboard engine. Cimco’s OXE diesel has a horizontally mounted engine as opposed to a traditional outboard with a vertically mounted engine.

Catena Media resolves upon a directed new issue of shares as payment for assets acquired in March 2018

On 28 March 2018, the Company announced that it had acquired assets in BonusSeeker.com, and that USD 1.0 million of the purchase price could be paid in form of newly issued shares in Catena Media.  In light of the foregoing, the board of directors of the Company has, under the authorization in the articles of association of the Company, resolved upon a directed share issue of 63,904 shares to the seller of the assets. The subscription price amounts to SEK 128.21 per share, corresponding to the volume-weighted average price for Catena Media’s share on Nasdaq Stockholm during a period of 30 trading days up to and including 27 March 2018. As previously announced, seventy-five (75%) of the shares will be subject to a lock-up period of 12 months as from the closing date of the transaction.  The rest of the twenty-five (25%) of the shares will not be under any lock-up restrictions.  Through the share issue, the number of ordinary shares in Catena Media increases by 63,904 shares from 54,391,469 shares to 54,455,373 shares and the share capital increases by EUR 95,86 from EUR 81 587 to EUR 81 683.  For further information, please contact:   Henrik Persson Ekdahl, Acting CEO, Catena Media plcPhone: +46 706 914343, E-mail: henrik.persson@catenamedia.com  Åsa Hillsten, Head of IR & Communications, Catena Media plcPhone: +46 700 818117, E-mail: asa.hillsten@catenamedia.com  The information was submitted for publication, through the agency of the contact persons set out above, on April 17, 2018 at 21:30 CET. About Catena Media Catena Media plc is an online performance marketing company that has established a leading position through strong organic growth and acquisitions.  The business was started in 2012 and the group has approximately 282 employees in the US, Australia, Japan, Serbia, UK, Sweden and Malta, where the Head Office is situated. In 2017, revenues reached approximately EUR 67,6 million. The company is listed on Nasdaq Stockholm Mid Cap. Further information is available at www.catenamedia.com 

Correction: Catena Media resolves upon a directed new issue of shares as payment for assets acquired in March 2018

On 28 March 2018, the Company announced that it had acquired assets in BonusSeeker.com, and that USD 1.0 million of the purchase price could be paid in form of newly issued shares in Catena Media.  In light of the foregoing, the board of directors of the Company has, under the authorization in the articles of association of the Company, resolved upon a directed share issue of 63,904 shares to the seller of the assets. The subscription price amounts to SEK 128.21 per share, corresponding to the volume-weighted average price for Catena Media’s share on Nasdaq Stockholm during a period of 30 trading days up to and including 27 March 2018. As previously announced, seventy-five (75%) of the shares will be subject to a lock-up period of 12 months as from the closing date of the transaction.  The rest of the twenty-five (25%) of the shares will not be under any lock-up restrictions.  Through the share issue, the number of ordinary shares in Catena Media increases by 63,904 shares from 54,391,469 shares to 54,455,373 shares and the share capital increases by EUR 95,86 from EUR 81 587 to EUR 81 683.  For further information, please contact:   Henrik Persson Ekdahl, Acting CEO, Catena Media plcPhone: +46 706 914343, E-mail: henrik.persson@catenamedia.com  Åsa Hillsten, Head of IR & Communications, Catena Media plcPhone: +46 700 818117, E-mail: asa.hillsten@catenamedia.com  The information was submitted for publication, through the agency of the contact persons set out above, on April 17, 2018 at 21:30 CET. About Catena Media Catena Media plc is an online performance marketing company that has established a leading position through strong organic growth and acquisitions.  The business was started in 2012 and the group has approximately 282 employees in the US, Australia, Japan, Serbia, UK, Sweden and Malta, where the Head Office is situated. In 2017, revenues reached approximately EUR 67,6 million. The company is listed on Nasdaq Stockholm Mid Cap. Further information is available at www.catenamedia.com 

Sino Agro Food, Inc. Reports Audited FY 2017 Results

Sino Agro Food-Q4 2017 Interim Report Sino Agro Food-Q4 2017 Interim Report April 17, 2018 GUANGZHOU, China-- Sino Agro Food, Inc. (OTCQX: SIAF | OSE: SIAF-ME), a specialized investment company focused on protein food including seafood and cattle announces results for the year ending December 31, 2017. Revenue  Results reflect the carve-out of aquaculture operations announced March 2, 2017. Income from Sino Agro’s interest in the carved-out company, Tri-Way Industries Ltd. is reported as “Income from unconsolidated equity investee.” Revenue from the sale of goods from the former aquaculture business segment is no longer reported. Revenue from the sale of goods decreased year over year (“YoY”) by USD 89.6M, or 33%, to USD 181.2M for the year ended December 31, 2017 year over year (“YoY”). Revenue from consulting and project development decreased by USD 55.2M, or 76%, to USD 17.0M YoY. Prior to the acquisition of aquaculture farms by JFD/Tri-Way, construction and development costs were financed mainly by their respective owners and investors, and partially through the deferred accounts payable to Sino Agro’s wholly owned subsidiary, Capital Award. Beginning with the transfer of assets to JFD/Tri-Way, further infrastructure expansion and development became the sole responsibility of JFD/Tri-Way, and has been limited to available cash flow generated by internal operations. This accounts for the decrease in revenues from the aquaculture operations and Capital Award. Capital Award is the turnkey provider of consulting and project development services for JFD/Tri-Way, who is pursuing several avenues to fund development, including conventional financing of approximately USD 100M. Overview   Adverse conditions impacting performance in the second quarter and third quarters continued in fourth quarter, resulting in a decline in gross profits on a YoY basis for FY 2017 from USD 83.9M to USD 19.6M.   Chief among these factors were continued pricing pressure in the beef and cattle businesses, and delays in the expected time to procure financing which could, among other things, rejuvenate business at Capital Award. It should be noted that based on recent discussions with lenders, Tri-Way remains confident in the approval of its applications for financing, but cannot pinpoint an exact time. During the fourth quarter the Company took several actions to reprioritize its various business operations, focusing on its most prospective areas, while also addressing balance sheet items to support its carve-out and spinoff strategy: ·  While Tri-Way pursues debt financing and to a lesser extent, SIAF also at the subsidiary level, at the corporate level, SIAF has taken steps to reduce obligations. Certain obligations provide security in the form of share equity which is to be returned to SIAF upon repayment, or are in the form of convertible notes. ·  Trade facilities that provide working capital for the distribution business have been reduced from a total of USD 20M to USD 15M. ·  Two additional loans have been paid down by USD 5.7M from USD 10.4M to 4.7M. ·  A promissory note to Euro Capital China AB has been renegotiated. ·  SJAP disposed of its QZH slaughtering and deboning operation, retaining a right, with certain provisions, to reinstate it, if favourable market and regulatory conditions return. ·  SJAP also renegotiated agreements with cooperative farmers to eliminate further losses until market conditions improve and the cattle fattening operation returns to profitability. All of these bullet points are explained in detail in the Company’s recent 10-K filing under the heading of “Subsequent Events.” The Company has adapted to these segment specific conditions by restricting its capital expenditures, reducing general and administrative expenses, and tailoring product mix to products with reasonable, albeit lowered, gross margins.   Other Key Points   ·    As of December 31 2017, the Company had net working capital of USD 168.3M, with a quick ratio of 3.8 – 1, current assets to current liabilities. This comes after reductions in inventories and receivables resulting from operational consolidations, and from reclassifying certain liabilities from long-term to current. ·    As of December 31 2017, the Company’s stockholders’ equity stood at USD 612.4M. ·     FY 2017 income from SIAF’s investment in Tri-Way was USD 12.0M, based on the full year ownership interest of 36.6% applied to Tri-Way’s total 2017 net income of USD 32.8M. The 36.6% figure became effective October 5, 2017 after the one-year anniversary date of Tri-Way’s consolidation, and SIAF’s exercise of its option to convert Tri-Way's $41m in outstanding debt into an additional equity interest of 12.71%; equivalent to 12.71m common shares of Tri-Way, bringing SIAF’s interest to 36.6% and 36.6m common shares. ·     While pleased with the relative performance of Tri-Way, three growth avenues beyond those provided from reinvestment of available cash flow have been identified, if and when additional capital becomes available: · Building out its farm facilities primarily at Aquafarms 4 and 5, which is mainly dependent on long-term financing. SIAF will continue to monitor the progress being made on Tri-Way’s funding efforts and will report any progress to its shareholders as it materializes. · SIAF’s R & D branch has determined an economical way to raise salt water Mexican White Prawns. Tri-Way is proceeding with an experimental farm at Enping’s Aquafarm1, with the intent of proving efficiently scalable production to be built and deployed if and when build out funds become available. · Tri-Way is organizing a Trading Division based in Hong Kong (“HK”) to import frozen seafood and other frozen food products to be sold in China by JFD’s commercial arms (which are special vehicles, or companies being established since mid-2017). Each hold respective specific import/export permits and licenses. Tri-Way’s imports will differentiate from SIAF’s imports, which mainly consist of live seafood and slaughtered/dressed beef. Having the Trading Division established in HK would carry advantages, in addition to providing an anticipated quicker revenue stream. Estimates of performance from this division show considerable leveraged trade sales at a healthy profit margin. · As a private company, Tri-Way has applied for a series of short-term conventional bank loans to provide the necessary seed-capital to assist the Trade Division business get underway. · The Company believes that coupling trade sales with existing and growing wholesale fish sales will demonstrate sufficiently sizeable and growing performance history to create a healthy balance of economic fundamentals in the future. ·     The Company’s intention to distribute 18.3% ownership of Tri-Way Industries Ltd. to SIAF shareholders remains in effect and will be executed based on the considerations and optimal outcome of tax and regulatory issues. In addition, Tri-Way’s advisors have requested that the change in ownership occur at a later date in consideration of qualifiers associated with the conventional lending process and until pre-IPO process.   ·    The Company is moving toward carving out its subsidiaries, with Tri-Way as a model. Depending on performance, these companies intend to pay a dividend to their shareholders, including those receiving shares distributed by SIAF to SIAF shareholders. Of course, as a direct shareholder, SIAF anticipates receiving dividends from these independent companies, as well. · Using funds from investees, SIAF anticipates being able to pay an additional cash dividend at the SIAF corporation level to its shareholders sometime in 2018, with the intent of increasing its dividend payment as the investees develop and provide stronger dividends to the Company. ·  More details regarding distribution of a possible cash dividend in 2018 will be made available in the Company’s Q1 2018 report due in May, allowing the Board additional time to assess both the amount and timing of the dividend based on current activity, still underway. Again, all of these bullet points are explained in detail in the Company’s recent 10-K filing. Financial Comparisons The Company achieved the following results, comparing FY 2017 to FY 2016: +-----------------------------------------+------+------+-----+|(USD M, except per share and margin data)|FY ‘17|FY ‘16|% |+-----------------------------------------+------+------+-----+|Revenue |198.2 |342.9 |(42)%|+-----------------------------------------+------+------+-----+|Gross Profit |19.6 |83.9 |(77)%|+-----------------------------------------+------+------+-----+|Gross Profit Margin |9.9% |24.5% |(56)%|+-----------------------------------------+------+------+-----+|Earnings Per Diluted Share (FD) (USD) – |(.53) |1.93 | ||from continuing and discontinued | | | ||operations | | | |+-----------------------------------------+------+------+-----+ The following table breaks out revenue by business segment, comparing FY 2017 to FY 2016: Revenue (USD M) FY '17 FY '16 %Integrated Cattle Farm (SJAP) 77.2 134.6 (43)%Organic Fertilizer (HSA) 7.2 20.6 (66)%Cattle Farms (MEIJI) 20.4 29.8 (31)%Plantation (JHST) 4.6 13.3 (65)%Seafood & Meat Trading 71.8 72.4 (1)%Sale of Goods Total 181.2 270.8 (33%) Project Development Total 17.0 72.2 (76)%Group total 198.2 342.9 1.5% Integrated Cattle (SJAP) Gross profit for the Integrated Cattle segment in FY 2017 declined to USD .9Min FY 2016. Fertilizer, and bulk and concentrated livestock feed showed gross profits of USD .5M, USD 2.4M USD, and 5.3M respectively, and live cattle sales added USD .7M. However, the total SJAP gross profit of USD 8.95M was offset by a loss of USD 8.0 in the value added processing, QZH’s slaughter and deboning operations. The cattle market has endured depressed pricing for well over 12 months. The Company had already dramatically reduced the sale of live domestic cattle due to unprofitable conditions. Continuing increased competition in the fourth quarter had a materially negative impact on gross margins, filtering through to deboning and packaging, as competitive pricing for final product became increasingly challenged. As reported in November 2017, during the third quarter, gross margin for the deboning of imported beef deteriorated to the unsustainable level of 2.8%, which endured further deterioration to negative margin in the fourth quarter. In addition, the Central Government has instituted new environmental regulations that would require significant additional capital expenditure at SJAP. For these reasons, SJAP management took two major actions. ·    To eliminate any additional losses being incurred through QZH, SJAP decided to discontinue and dispose of QZH operations. If favourable market conditions were to reoccur, the Abattoir license were reinstituted, and Governmental assistance existed in developing a long-range plan, the option remains to consider resuming QZH operations in the future. Thus, as of December 30, 2017 (the “deemed date of disposal”), QZH’s operations were discontinued and SIAF, based on its proportional ownership of QZH through its variable interest entity SJAP, had incurred a net loss on disposal totalling USD 9,365,543. ·    SJAP’s agreements with cooperative farmers had locked in pricing and credit terms. While the agreements worked very well for both parties through 2015 and manageably in 2016, the continued deterioration of wholesale beef prices has made SJAP’s existing commitments to cooperative farmers untenable. With the local government, SJAP settled a release from its arrangements whereby: · The cooperatives accepted a portion of the loss they had incurred in 2017 and the losses they have already incurred preparing for 2018, resulting from SJAP no longer being capable of making do on its commitment to purchase. · SJAP agreed to pay the cooperatives a deeply discounted portion of its commitment/obligation to them at an average price of USD 800/head, about one-third of the out of pocket cost typically paid cooperatives in exchange for release from commitments to purchase. This creates a one-time cost of USD 17.75 million, as compared to the estimated cumulative total loss of USD 46.75 million in 2017/2018 based on SJAP’s lock-in commitment price to buy. Therefore, the estimated amount of out of pocket loss to SJAP is reduced by about USD 30 million. ·  In 2018, SJAP will continue operations for in house cattle rearing and fattening on a smaller scale, also reducing the scale and production of bulk livestock feed, concentrated livestock feed, and fertilizer. These segments should begin a natural growth rate of 5 - 10% while other related activities continue. Processing for value added activities at QZH have been discontinued. Under this arrangement ongoing activities are expected to retain profitability albeit at lower levels than before the pricing pressures occurred, providing a stable business until market conditions return favorably and the local government’s plan to develop Huangyuan District into a prominent cattle and beef trading center can materialize. The rationale, terms, and impact of both actions are explained in great detail in the Company’s 10-K filing, available here: http://sinoagrofood.investorroom.com/sec-filings Organic Fertilizer (HSA) Overall gross profit for HSA decreased by 73% to USD 2.2M. The overall decrease was mainly due to the YoY drop of 31,356 metric tons (“MT “), or 77%, in volume of mixed organic fertilizer sold to 9,042 metric tons (“MT”), as well as the a price decline of USD 7/MT. The significant drop in sales volume was primarily due to a shutdown in production allowing construction work to be completed at the cattle workstation throughout the second half of 2018, and other reasons detailed in the 10-K. It is now anticipated that HSA’s annual target of 40,000 MT for organic mixed fertilizer will be reached somewhere in mid 2019. Cattle Farms (MEIJI) Improved cost efficiency led to a 145% increase in YoY gross profit to nearly USD 3.8M. Even though the number of head sold dropped by 39%, due an 11% increase in price per head, revenue declined significantly less, With a drop in unit costs, gross profits margins improved from 5% in FY 2016 to 18% n FY 2017. Plantation (JHST) As reported in previous quarters business at the HU plantation suffered from a poor quality of flowers due to root diseases caused by years of excessive rain. Nonetheless, the business managed a gross profit of USD 1.3M on sales of USD 4.6M, down from USD 13.3M in 2016. The Company has experimented with a variety of hearty alternative cash crops and distribution avenues. One is processing Immortal Vegetable plants into dried tea to be repackaged and sold through one of China’s best herbal health brand. In March 2018, JHST signed two growing contracts, one a contract for a fruit for processing into a natural aromatic, and the second for 200 acres to produce Passion Fruit for a Juice manufacturer. The Company anticipates that these changes will accelerate the sales results toward 2016 results, with less dependence on fair weather. Seafood and Meat Trading (Corporate) Gross profit declined 9% YoY to USD 8.0M, on a 1% decrease in revenue, stemming largely from the Company’s decision to trade selective products with reliable profit margins. The Company believes that this business segment has excellent growth potential. Historically, it has generated consistent profit margins, averaging 10.5% on a 12.5% product mark-up. FY 2017 Interim Report  For detailed segment operational performance and developments, please take the time to read our latest 10-K filing, or refer to the FY 2017 Interim Report  posted to the Company website at http://sinoagrofood.investorroom.com/download/Sino-Agro-Food_FY-2017-Interim-Report.pdf . Earnings Call Information  The Company will announce the date and time of it earnings conference call in the near future, closer to the anticipated date in the first part of May. Please submit questions by email to info@sinoagrofood.com. These will be organized and answered on the call.

YIT to establish a plot fund together with an investor group

YIT is involved in establishing a fund that invests in residential plots in Finland. YIT’s partners in the fund are Ålandsbanken and pension insurance company Varma. The investing capacity of the fund is EUR 100 million with an equity of EUR 50 million thereof. The equity investors of the fund are YIT (20%), Varma (40%) and Ålandsbanken (40%). The fund is managed by Ålandsbanken. YIT is responsible for finding plots for the fund, and Ålandsbanken as the managing party makes the investments. YIT recognises profit generated by the fund corresponding to its ownership share of the fund. Additionally, YIT constructs self-developed residential buildings on the plots owned by the fund. The residents have a chance to redeem their plot share partly or completely at a preferred moment, which enables YIT to offer more flexibility for the consumer regarding the timing of residential investment. “Ålandsbanken Funds and YIT have established a strong collaboration during the last five years. We are very content that the co-operation is further strengthened with this new fund. We are also taking a significant step by starting co-operation with Varma, which is one of the largest investors in Finland”, says Tom Pettersson, Managing Director at Ålandsbanken Funds Ltd. “The plot fund is a good way to spread Varma’s indirect property investments and it offers us an opportunity for stable and predictable profit with moderate risk. We are happy to operate with our experienced partners as this is our first investment in residential plots in Finland through a fund”, says Ilkka Tomperi, Investment Director, Real Estate at Varma. YIT’s strategic target is to make a significant part of its large, long-term investments with partners. The plot fund is part of the Partnership properties segment established at the beginning of 2018. The segment focuses on financing the initial phases of major development projects and on the ownership and subsequent realisation of plots and the developed projects at a suitable moment. ”The plot fund is a logical step in our strategy that we followed when we established the Partnership properties segment at the beginning of this year. This is a way to grow our investing capacity in a capital-efficient manner together with our partners,” comments Esa Neuvonen, Executive Vice President for YIT’s Partnership properties segment. For further information, please contact:  Hanna Jaakkola, Vice President, Investor Relations, YIT Corporation, tel. +358 40 5666 070, hanna.jaakkola@yit.fi Pasi Huhtakangas, Director, Residential Investment Projects, YIT Corporation, tel. +358 40 565 3907, pasi.huhtakangas@yit.fi YIT CORPORATION Hanna Jaakkola Vice President, Investor Relations Distribution: Nasdaq Helsinki, major media, www.yitgroup.com YIT is the largest Finnish and significant North European construction company. We develop and build apartments, business premises and entire areas. We are also specialised in demanding infrastructure construction and paving.  Together with our customers our 10,000 professionals are creating more functional, more attractive and more sustainable cities and environments. We work in 11 countries: Finland, Russia, Scandinavia, the Baltic States, the Czech Republic, Slovakia and Poland. The new YIT was born when over 100-year-old YIT Corporation and Lemminkäinen Corporation merged on February 1, 2018. Our pro forma revenue for 2017 was over EUR 3.8 billion. YIT Corporation's share is listed on Nasdaq Helsinki Oy. www.yitgroup.com

Interim Report January - March 2018

• Rental income amounted to MSEK 815 (722) for the quarter • Profit from property management excluding the share in profit from part-owned companies amounted to MSEK 371 (312) for the quarter. Profit from property management including the share in profit in part-owned companies totaled MSEK 439 (447) for the quarter, corresponding to SEK 2.61 per ordinary share (2.66). Profit from property management in the preceding year was impacted by a significant increase in value of part-owned properties, recognized in share in profit from joint ventures • Profit after tax for the quarter totaled MSEK 701 (986), corresponding to SEK 4.19 per ordinary share before dilution (6.02). Profit in the preceding year was impacted by a significant increase in value of part-owned properties, recognized in share in profit from joint ventures • The earnings capacity at March 31, 2018 amounted to MSEK 1,946 SIGNIFICANT EVENTS DURING AND AFTER THE QUARTER • In March, Hemfosa became sole owner of the specialist hospital and the local medical center in Gardermoen, Norway, when the property-owning companies that were previously held in a joint venture became wholly owned subsidiaries of Hemfosa • At the end of March, the Hansagården property in Bergen, with a high proportion of tenants in the community services sector, was acquired. The total area amounts to 29,000 sqm and the rental value to MSEK 34. • The process involving an in-depth analysis of the opportunities and structure for a split of the Hemfosa Group into two listed companies is progressing. The aim is to create greater shareholder value through defining a community services-focused property company and a transaction-based property company, which both are poised to capture favorable property transactions. COMMENTS FROM THE CEO Exciting acquisitions and future plans Hemfosa started 2018 at a fast tempo. We acquired community service properties in Norway and developed our cooperation with established players in the community services sector and our other tentants. We are particularly proud that in March we became the long-term sole owner of the ultra-modern and fully leased healthcare and medical properties in Gardermoen near Oslo, that have now been completed and in which the Norwegian Heart and Lung Association (LHL) and other tenants now are moving in. During the quarter, we also took the next steps in the process of evaluating a demerger of Hemfosa into two companies. Hemfosa is reporting favorable and stable profit from property management for the first quarter of the year. A snowy and cold winter led to slightly higher property expenses at the same time as we increased earnings by over MSEK 140 though a growing property portfolio. In total, we took possession of community service properties at a value of approximately SEK 2.7 billion during the quarter. HEALTHCARE PROPERTIES COMPLETED ACCORDING TO PLAN At the end of March, Hemfosa became the sole owner of two healthcare properties in Gardermoen’s new center of excellence for health services and medical care that was recently completed. This is a new build project that we started working with in 2015, in a joint venture together with property developer Aspelin Ramm of which we are both proud and pleased to have completed. When we entered into the project, we knew that project engineering and constructing a large, modern hospital would be a complex assignment. We shared a well-thought out concept and a clear strategy for the development of the entire area together with our partner Aspelin Ramm and the tenant the Norwegian Heart and Lung Association (LHL). The new specialist hospital was completed on schedule, on budget and with no observations in final inspection. As an owner and manager of mainly community service properties, it feels particularly important to contribute toward a society that is sustainable in the long term. Therefore, we are also proud that the specialist hospital, besides setting a high standard for the operations, is one of the most climate and energy-friendly hospitals in Norway. For the long-term finance of the healthcare properties at Gardermoen, Hemfosa has raised a green loan from Swedbank for SEK 1.5 billion, which is clear evidence that the investment fulfills high demands for sustainability while also providing competitive terms and conditions. BUILDING A NETWORK OF PARTNERSHIPS We are continuing to build a network of partnerships in the community services sector and develop well-functioning premises for a growing number of community players. One of them is Emrahus, from which we acquired two additional LSS homes during the quarter. Others are the Swedish Migration Agency, which recently moved into newly renovated premises in Uppsala. Other projects are the planning of properties for a school in Järfälla and a government agency in Norway. We can also see that the need for new functional community service properties is continuing to rise in many areas of our markets. NO NEGATIVE EFFECT OF NEW DEDUCTION RULES In March, the Swedish government presented a proposal on new tax rules referred to the Council on Legislation for consideration, which includes limitation on companies’ right to make tax deduction on interest. We do not believe that this will have any material impact on Hemfosa. Looking at the industry as a whole, we believe that the new rules will lead to slight decrease in the indebtedness of companies. We believe that the property market is rather cautious at the moment, probably affected by the uncertainty in the housing sector. Nevertheless, we see interesting opportunities for Hemfosa in terms of both acquisitions and new build projects in cooperation with property developers and tenants. We are also looking forward to continuing the process of evaluating and planning for a demerger of Hemfosa into two new companies. We are convinced that a transaction-focused company, poised to capture favorable property transactions, and a community services-focused property company with development potential, which in addition to continued property transactions also will strengthen its project development operations, is the right way forward for the market we see before us. Jens Engwall, CEO

Hemfosa appoints Board of Directors and names new subsidiary – Nyfosa AB

The process involving an in-depth analysis of the opportunities and structure for a split of the Hemfosa Group into two listed companies with the aim of creating greater shareholder value is progressing. During the first quarter of 2018, work has been done on forming a subsidiary, Nyfosa, consisting of Hemfosa’s other properties. In the event of a resolution in favor of demerger, the distribution of shares in Nyfosa and a listing is expected to take place in the second half of 2018.         The Board of Directors of Nyfosa   The Board of Directors of Hemfosa Fastigheter has resolved that the Board of Directors of Nyfosa should consist of Bengt Kjell as Chairman of the Board and Jens Engwall, Marie Bucht Toresäter, Lisa Dominguez Flodin, Johan Ericsson, Per Lindblad and Kristina Sawjani as Board members. The Board of Nyfosa intends to take up its duties on May 7, 2018.  Bengt Kjell  Bengt Kjell is currently Chairman of the Board of Hemfosa Fastigheter AB, SSAB and Expassum AB, and also Deputy Chairman of Indutrade AB and Pandox AB. He is also Board member of AB Industrivärden and ICA Gruppen AB, among other companies.   Jens Engwall  Jens Engwall is currently CEO and Board member of Hemfosa Fastigheter AB, and also Board member of Bonnier Fastigheter AB, Quanta Fuel AS and Hemfosa Gård AB, among other companies.   Marie Bucht Toresäter  Marie Bucht Toresäter currently works as CEO of Novi Real Estate AB and has previously held senior positions at companies including NewSec Advice, Skanska ID and NCC Property Development Nordic AB.   Lisa Dominguez Flodin  Lisa Dominguez Flodin currently works as CEO of Cibus Nordic Real Estate and as CFO of Grön Bostad AB. She has previously held senior positions at companies including Oscar Properties AB and Cityhold Property AB and Board assignments for NP3 Fastigheter AB.  Johan Ericsson  Johan Ericsson currently works as CEO of Klockarbäcken Property Investment AB and CEO of Logistea AB, and is Board member of Brinova AB as well as Chairman of the Board and partner of SHH Bostad AB. Prior to that, Johan worked at Catella AB, where he held various senior positions, including President and CEO.   Per Lindblad  Per Lindblad currently works as CEO of Landshypotek Bank and prior to this worked at companies including SEB where he was Head of Real Estate Finance, Large Corporates and Financial Institutions.   Kristina Sawjani  Kristina Sawjani currently works as Senior Investment Manager of Folksam Fastigheter and has previously held senior positions at AFA Fastigheter and Catella Corporate Finance as head of property transactions and project manager, respectively.   Updated financial information  Community service properties* in Hemfosa’s portfolio had a value of MSEK 30,043 on March 31, 2018, corresponding to approximately 67 percent of the total property value. The 329 community service properties had, on the same date, rental income of MSEK 2,205 and net operating income of MSEK 1,673 according to the earnings capacity at March 31, 2018. The properties encompass premises for schools, offices for public authorities and municipalities, the judicial system such as the police and courts, as well as health and care services.  On March 31, 2018, Hemfosa’s other property portfolio comprised 150 commercial properties with office, logistics and warehouse premises, plus a small number of other types of properties, such as retail properties. The value of these properties totaled MSEK 14,894 at the end of the quarter, and the properties had rental income of MSEK 1,183 and net operating income of MSEK 820 according to the earnings capacity at March 31, 2018.  * Hemfosa’s definition of community service properties is properties with, directly or indirectly, publicly financed tenants that account for at least 70 percent of the rental income.  

Official notification of the annual general meeting.

Brighter AB (publ) will hold its Annual General Meeting (AGM) on Wednesday 16th of May 2018, at 11:00, at the offices of Brighter AB, Norgegatan 2 in Kista, Sweden. RIGHT TO PARTICIPATE AND REGISTRATION Those who wish to participate in the Meeting must: ●   Be registered as a shareholder in the shareholder register maintained by Euroclear Sweden AB by Wednesday 9th of May 2018 and,  ●   Inform the company of their intent to participate in the Meeting by Thursday 10th of May 2018 at the latest.  Registration of participation must be made in writing to – preferably – ir@brighter.se, or by mail to Brighter AB (publ), Norgegatan 2, SE-164 32, Kista, Sweden. When registering, please state your name, personal identity number/corporate registration number, address and phone number. Shareholders who are unable to personally attend the Meeting may exercise their rights at the Meeting through representatives who possess a written, signed and dated power of attorney letter in original form. A power-of-attorney form will be provided upon request and will be available on the company’s website, www.brighter.se, as of no later than three weeks prior to the Meeting, until the day before the Meeting. If the power of attorney was issued by a legal person, a copy of the proof of registration or equivalent form of authorisation for the legal person must be enclosed. To facilitate entry to the Meeting, power of attorney forms in original, proof of registration and other forms of authorisation should be submitted to the company at the aforementioned address by Thursday 10th of May 2018 at the latest. To be entitled to participate in the Meeting, shareholders whose shares are held by a trustee must, through their trustee, register the shares in their own name in the shareholder register maintained by Euroclear Sweden AB by Wednesday 9th of May 2018. This registration can be temporary. PROPOSED AGENDA 1.     Opening of the Meeting.2.     Election of the Chairman of the Meeting.3.     Election of keeper of the Minutes.4.     Election of two officers to verify the minutes.5.     Preparation and approval of the list of shareholders entitled to vote at the Meeting.6.     Approval of the agenda.7.     Determination of whether the Meeting has been duly convened.8.     Presentation of the annual report and the auditors’ report for 2017.9.     Resolutions concerning: a)     the adoption of the income statement and balance sheet for 2017. b)     dispositions concerning the company’s profit or loss as shown in the balance sheet adopted by the Meeting. c)     discharge of the Board members and the CEO from personal liability for their administration during 2017. 10.  Determination of the fees to be paid to Board members.11.  Election of the Chairman of the Board, deputy Chairman and other members of the Board, and any deputy members.12.  Resolution concerning the number of auditors and deputy auditors.13.  Determination of the fees to be paid to the auditor.14.  Election of the auditor and any deputy auditors.15.  Resolution to amend the Articles of Association in regard to share capital and number of shares.16.  Resolution concerning the issuance of warrants, as well as the approval of the transfer of warrants to the company’s Board members.17.  Resolution concerning the issuance of warrants, as well as the approval of the transfer of warrants to employees and key members of the company.18.  Resolution concerning the authorization of an issuance.19.  Conclusion of the Meeting. PROPOSALS Resolution on dispositions concerning the company’s profit or loss as shown in the balance sheet adopted by the Meeting (item 9 b) The Board proposes that the funds available to the general meeting (SEK) Retained Earnings                       -109 288 192 Share premium reserve                 171 071 044 Loss for the year                            -22 841 305                                                           38 941 547 Disposed so that in new account,     38 941 547 be carried forward. Determination of the fees to be paid to Board members, election of the Chairman and other members of the Board and any deputy members, resolution concerning the number of auditors and deputy auditor's, determination of the fees to be paid to the auditor, and the election of the auditor and any deputy auditors (items 10-14) The company’s principal shareholder has notified the company’s Board of said shareholder’s intent to propose that the AGM resolve on certain resolutions as follows: Item 10: That each of the Board members be paid a fee of 100 000 sek and that the Chairman of the Board be paid a fee of 200 000 sek. Item 11: That Lars Flening, Afsaneh Ghatan Bauer, Sara Murby Forste and Jan Stålemark to be re-elected to the Board. Barbro Fridén and Catharina Ihre are proposed as new Directors of the Board and Barbro Fridén to be elected as the new Chairman of the Board. Item 12: That there be one auditor with no deputy auditors. Item 13: That the auditor be paid upon the approval of invoices. Item 14: That the auditing firm Öhrlings PricewaterhouseCoopers AB be re-elected auditor. If this resolution passes, Öhrlings PricewaterhouseCoopers AB intends to re-appoint Bo Magnus Lagerberg as the Chief Auditor. Resolution to amend the Articles of Association (item 15) All 1) The share capital is raised from 3,296,905.35 to 13,187,621.40. The number of shares in the company is proposed to be increased from 65,938,107 to 263,752,428. Alt. 2) Increase share capital from 3,315,462.65 to 13,261,850.60 Number of shares in the company is proposed to be increased from 66,309,253 to 265,237,012. Resolution on the issuance of warrants, as well as the approval of the transfer of warrants to the Company’s Board members Series I 2018/2020 (item 16) The shareholder Mr. Sirous Kia proposes that the Annual General Meeting resolve on the issuance of warrants and the approval of the transfer of warrants primarily as follows. 1.     That the Company issue a maximum of 300,000 warrants, where each warrant is to carry an entitlement for the new issuance of one share in the Company, and whereby the Company’s share capital can be increased by no more than SEK 15,000.2.     That the right to subscribe for warrants be granted to the wholly owned subsidiary Brighter One AB (“the Subsidiary”), with deviations from the shareholders’ preferential rights.3.     That warrants be subscribed for through a separate subscription list by May 16, 2018. The Board is entitled to resolve on an extension of the subscription period.4.     That the warrants be issued free of charge.5.     That the Board of the Company instruct the Subsidiary to transfer the warrants to the Board members elected at the 2018 AGM, as well as to any Board members who are elected in the period until the 2019 AGM (“the Board Members”). The right to acquire warrants is contingent on the Board members having signed a contract pertaining to, among other matters, preemptive rights with the Company or the Subsidiary at the time of the acquisition. +-----+-------------------------+------------------------------+|Group|Chairman |A maximum total of 150 000. ||1 | | |+-----+-------------------------+------------------------------+|Group|Other members (apart from|A maximum total of 150 000, of||2 |member Afsaneh Ghatan |which no more than 50,000 per || |Bauer) |person. |+-----+-------------------------+------------------------------+ 6.     The sum paid for the warrants that are transferred from the Subsidiary to the Boardmembers must be at a market rate, which is determined by applying the valuation model of Black & Scholes or other validated valuation model. The warrants up to the number specified in the table above may be acquired by the Board members in Group 1 and Group 2 over (i) a period of one month after the Company's half-yearly financial statements for Q2 2018 have been published, and (ii) during a period beginning the day after the Company's interim report for Q3 2018 has been published an ending 31 December 2018. The warrants that are offered according to the table above may first be acquired by new Board members in a month after the Company's interim report for Q2 2018 has been published, and subsequently for periods of one month following the publication of each of the Company’s subsequent interim reports (i.e. the two annual interim reports, the half-year report and the year-end report), though no later than one month after the publication of the Company’s 2019 Q1 interim report. The warrants that have been offered to the Board members in Group 1 and Group 2 according to the table above, but that have not been acquired by December 31, 2018 at the latest, may be acquired by new Board members over a period of one month after the publication of the Company’s 2018 Q4 interim report. 7.     The program may, upon full participation and full subsequent subscription of shares with the support of the warrants, based on the total number of registered shares and votes at the time of this proposal of 65 938 107, mean a dilution of no more than 1 per cent of the total number of shares and votes in the Company. The dilution effect of the program under this item 16, taking into account full subscription and utilization of all offered warrants pursuant to item 17, that all outstanding subscription options transferred from the Subsidiary today have been utilized and that 248,000 warrants in programs 2014/2017 Series I and 2015/2018 Series I are revoked and in addition, convertible debentures of a total of SEK 10,400,000 are calculated to be 10 percent. At the date of this notice, the Board of Directors has resolved to cancel 248,000 warrants in Program 2014/2017 Series I and 2015/2018 Series I which is expected to be registered with the Swedish Companies Registration Office at the time of the AGM. The reason for the cancellation is to reduce the dilution effect that may arise from all the warrants and convertibles issued in the Company. 8.     The newly subscribed shares first entail the right to a dividend on the record date immediately following the date on which the shares were registered in the shareholder register maintained by Euroclear Sweden AB.9.     The complete terms and conditions for the warrants state, inter alia, that:  a.     For each warrant, the holder bears the right to subscribe for one new share in exchange for a cash payment at a share price corresponding to 300% of the average volume weighted closing price of Brighter's share for the 20 trading days before the 2018 AGM.b.     The share price and the number of shares that can be subscribed for with the backing of a warrant may be subject to adjustments according with the full terms of the warrants.c.     Shares backed by warrants can be subscribed for over (i) a period beginning the day after the Company’s 2021 Q2/half-year interim report has been published and ending on September 30, 2021, and over (ii) a period of one month after the publication of the Company’s 2021 Q3 interim report until December 31, 2021.  10.  It is proposed that the Board or the Board of Directors elects to be authorized to take the minor adjustments to this decision that may be necessary in connection with registration with the Swedish Companies Registration Office and possibly with Euroclear Sweden AB.11.  The Annual General Meeting of the Subsidiary shall also approve the subsequent transfer of warrants as described above. Reasons for the deviation from the shareholders’ preferential rights include the following. Shareholder whom has put forward the proposal, deems that an incentive program for the Board is required for the Company to be able to attract, motivate and retain Board members who possess the desired expertise and experience. Furthermore, it is deemed to be beneficial for the Company and its shareholders if  the Board members have a financial interest in the Company that is comparable with that of its shareholders. Since warrants that are transferred at market value are considered transferable securities and are not linked to the assignment in such a way so as to require the payment of social security fees, it is not believed that any social security expenses will be charged to the Company as a result of the incentive program. The costs will therefore only consist of limited costs for implementation and administration of the program. Accordingly, there is no reason to hedge the program. The dilution is expected to have a marginal effect on the Company’s key ratios. The Company, or the party instructed by the Company, will under certain circumstances, for example, if their assignment ends, be entitled to repurchase warrants from the Board members. A valid resolution pursuant to this item requires approval of shareholders representing at least nine tenths of both the votes cast and the shares represented at the meeting. Resolution on the issuance of warrants, as well as the approval of the transfer of warrants to employees and key members of the Company – Series II 2018/2021 - (item 17) The Board proposes that the meeting resolve on the issuance of warrants and the approval of the transfer of warrants primarily as follows. 1.     That the Company issue a maximum of 800,000 warrants, whereby each warrant is to carry an entitlement for the new issuance of one share in the Company, and whereby the Company’s share capital can be increased by no more than SEK 40,000.2.     That the right to subscribe for warrants be granted to the Subsidiary, with deviations from the shareholders’ preferential rights.3.     That warrants be subscribed for through a separate subscription list by May 16, 2018, at the latest. That the Board be entitled to resolve on an extension of the subscription period.4.     That the warrants be issued free of charge.5.     That the Board of the Company instruct the Subsidiary to transfer the warrants to employees and key members of the Company (“the Participants”) within the following framework. One condition for acquisition is that the Participants be employed by the Company at the time of acquisition and that they have not resigned from or been dismissed by the Company, as an employee or as a consultant, at the stated time. Employees are also defined as individuals who, no later than the date of acquisition, have signed a contract with the Company for impending employment. The right to acquire warrants is contingent on the Participants having signed a contract pertaining to, among other matters, preemptive rights with the Company or the Subsidiary at the time of the acquisition. +-----+-------------------+---------------------------------------+|Group|COO |A maximum total of 300,000 warrants. ||1 | | |+-----+-------------------+---------------------------------------+|Group|Other key members |A maximum total of 250,000 warrants, of||2 |of the Company |which no more than 200,000 per person. || |(this | || |currently relates | || |to approximately 20| || |people) | |+-----+-------------------+---------------------------------------+|Group|New acquisitions |A maximum total of 250,000 warrants, of||3 | |which no more than 200,000 per person. |+-----+-------------------+---------------------------------------+ 6.     The sum paid for the warrants that are transferred from the Subsidiary to the Participants must be at a market rate, which is determined by applying the valuation model of Black & Scholes or other validated valuation model. The warrants up to the number specified in the table above may be acquired by the Participants in Group 1 and Group 2 over (i) a period of one month after the company’s 2018 Q2 interim report has been published, and over (ii) a period beginning the day after the company’s 2018 Q3 interim report has been published and ending on 31 December 2018. The warrants that are offered under section 5 a) above may first be acquired by the Participants in Group 3 over a one-month period after the company’s 2018 Q2 interim report has been published, and subsequently for periods of one month following the publication of each of the company’s subsequent interim reports (meaning the four annual interim reports), though no later than one month after the publication of the company’s 2019 Q1 interim report. 7.     The program may, upon full participation and full subsequent subscription of shares with the support of the warrants, based on the total number of registered shares and votes at the time of this proposal of 65 938 107, mean a dilution of no more than 2 per cent of the total number of shares and votes in the Company. The dilution effect of the program under this item 17, taking into account full subscription and utilization of all offered warrants pursuant to item 16, that all outstanding subscription options transferred from the Subsidiary today have been utilized and that 248,000 warrants in programs 2014/2017 Series I and 2015/2018 Series I are revoked and in addition, convertible debentures of a total of SEK 10,400,000 are calculated to be 10 percent. At the date of this notice, the Board of Directors has resolved to cancel 248,000 warrants in Program 2014/2017 Series I and 2015/2018 Series I which is expected to be registered with the Swedish Companies Registration Office at the time of the AGM. The reason for the cancellation is to reduce the dilution effect that may arise from all the warrants and convertibles issued in the Company. 8.     The newly subscribed shares first entail the right to a dividend on the record date immediately following the date on which the shares were registered in the shareholder register maintained by Euroclear Sweden AB.9.     The complete terms and conditions for the warrants state, inter alia, that:  a.     For each warrant, the holder bears the right to subscribe for one new share in exchange for a cash payment at a share price corresponding to 300% of the average volume weighted closing price of Brighter's share for the 20 trading days before the 2018 AGM.b.     The share price and the number of shares that can be subscribed for with the backing of a warrant may be subject to adjustments according with the full terms of the warrants.c.     Shares backed by warrants can be subscribed for over (i) a period beginning the day after the Company’s 2021 Q2/half-year interim report has been published and ending on September 30, 2021, and over (ii) a period of one month after the publication of the Company’s 2021 Q3 interim report until December 31, 2021.  10.  It is proposed that the Board or the Board of Directors elects to be authorized to take the minor adjustments to this decision that may be necessary in connection with registration with the Swedish Companies Registration Office and possibly with Euroclear Sweden AB.11.  The Annual General Meeting of the Subsidiary shall also approve the subsequent transfer of warrants as described above. The Board may cite the following reasons behind deviations from the shareholders’ preferential rights. The proposal has been prepared by the Remuneration Committee. The Board deems that personal, long-term shareholding among the Participants will lead to greater motivation and an increased sense of inclusion in the Company. The Board also deems that the program is a suitable complement to the Participants’ employment terms and conditions, so competitive terms and conditions are offered to them in order for the Company to be able to attract and retain key members for its operations. Since warrants that are transferred at market value are considered transferable securities and are not linked to the employment or assignment in such a way so as to require the payment of social security fees, it is not believed that any social security expenses will be charged to the Company as a result of the incentive program. The costs will therefore only consist of limited costs for implementation and administration of the program. Accordingly, there is no reason to hedge the program. The dilution is expected to have a marginal effect on the Company’s key ratios. The Company, or the party instructed by the Company, will under certain circumstances, for example, if their employment or assignment ends, be entitled to repurchase warrants from the Participants. A valid resolution pursuant to this item requires approval of shareholders representing at least nine tenths of both the votes cast and the shares represented at the meeting. Resolution concerning the authorization of an issuance (item 18) The Board proposes that the AGM resolve on the matter primarily as follows: The Board is to be authorized to, on one or more occasions prior to the next AGM, resolve on the new issuance of shares, the issuance of warrants, and/or the issuance of convertibles primarily as follows: The issuance is to be able to be conducted with or without deviating from the shareholders’ preferential rights. The authorization is to include the right to resolve on an issuance in exchange for cash payment, offset payment or payment in kind, and in other respects be compatible with the conditions stipulated in chapter 2, section 5, second paragraph 1-3 and 5 in the Swedish Companies Act. The company shall comply with the available guidelines to ensure shareholders' interests in the best way when using the authorization of an issuance. SPECIFIC MAJORITY REQUIREMENTS (item 19) For resolutions on items 16 and 17 to be valid, the resolutions must be approved by shareholders representing at least nine-tenths of both the specified votes and the shares represented at the Meeting. For the resolution on item 18 to be valid, the resolution must be approved by shareholders representing at least two-thirds of both the specified votes and the shares represented at the Meeting. SHAREHOLDERS RIGHT TO ASK QUESTIONS Shareholders are reminded of their right to request information at the AGM from the Board and the CEO under chapter 7, section 32 of the Swedish Companies Act. DOCUMENTATION The financial statements and auditor’s report are available at the company’s offices and on the company’s website, www.brighter.se. The complete resolutions concerning Items 16-18 will be available at the company’s offices and on the company’s website, www.brighter.se no later than two weeks before the Meeting. A copy of all documentation will immediately and without charge be sent to shareholders who so request and who provide their mailing address. Stockholm, April 2018 Brighter AB (publ) Board of Directors For more information, please contact: Truls Sjöstedt, CEO Telefon: +46 709 73 46 00      E-post:  truls.sjostedt@brighter.se Henrik Norström, COO   Telefon: +46 733 40 30 45      E-post: henrik.norstrom@brighter.se About BrighterBrighter is a Swedish-based company that, from a unique IP portfolio, creates smart solutions for one of healthcare’s biggest challenges: changing patient behavior. Chronic diseases such as diabetes are rapidly increasing, and account for an increasing share of healthcare costs globally. Brighter's Business Model and Multi-Sided Market Platform - The Benefit Loop™ - is based on the fact that many special interests create value for each other. By increasing access to valid health data, Brighter creates value for all stakeholders in the care chain: patients and their close associates, healthcare providers, research institutes, the pharmaceutical industry, and society as a whole. www.brighter.se The Company's shares are listed on NASDAQOMX First North/BRIG . Brighter’s Certified Adviser on Nasdaq OMX First North is Remium Nordic Holding AB +46 (0)8 – 454 32 50, CorporateFinance@remium.com, www.remium.com.

BerGenBio: Promising data highlighting selective AXL inhibitor bemcentinib’s potential to improve efficacy of checkpoint inhibitors presented at AACR

The data highlight bemcentinib’s potential to reverse tumour immune suppression and enhance immune checkpoint inhibitor efficacy. The authors show that bemcentinib targets immune suppression mechanisms in the tumour microenvironment that improve immunotherapy in murine tumour models of non-small cell lung (NSCLC), triple negative breast (TNBC) and pancreatic cancer. Bemcentinib treatment reduces myeloid-derived suppressor cells and the altered immune landscape is associated with increased tumour infiltration of T cells (NK and CD8+) and enhanced therapy responses. A validated AXL immunohistochemistry (IHC) method for use on patient samples to identify the presence of AXL on tumour cells and immune cells in the tumour microenvironment was presented. The authors report that across 92 banked tumour biopsies from patients with TNBC or NSCLC 70% were found to stain positive for AXL using this IHC method. The IHC method is now in use to analyse biopsies taken in connection with the company’s phase II combination trials of bemcentinib with KEYTRUDA® in patients with advanced NSCLC or TNBC. Professor James Lorens, BerGenBio Chief Scientific Officer, commented: “These results highlight a clear and important role for AXL in aggressive disease and resistance to immune therapy in particular. They provide continued confidence in the potential of combining bemcentinib with immune checkpoint inhibitors to improve cancer treatment, and support for our Phase II clinical trial programme of bemcentinib combined with the blockbuster immune checkpoint inhibitor KEYTRUDA, interim results from which are expected during 2018.” The poster is available online - www.bergenbio.com/investors/presentations/ -End-  About BerGenBio ASA  BerGenBio ASA is a clinical-stage biopharmaceutical company focused on developing a pipeline of first-in-class AXL kinase inhibitors as a potential cornerstone of combination cancer therapy. The Company is a world leader in understanding the essential role of AXL kinase in mediating cancer spread, immune evasion and drug resistance in multiple aggressive solid and haematological cancers. BerGenBio’s lead product, bemcentinib (BGB324), is a selective, potent and orally bio-available small molecule AXL inhibitor in four Company sponsored Phase II clinical trials in major cancer indications, with read-outs anticipated during 2018. It is the only selective AXL inhibitor in clinical development. The Company sponsored clinical trials are: · Bemcentinib with TARCEVA® (erlotinib) in advanced EGFR mutation driven non-small cell lung cancer (NSCLC) · Bemcentinib with KEYTRUDA in advanced adenocarcinoma of the lung, and · Bemcentinib with KEYTRUDA in triple-negative breast cancer (TNBC). · Bemcentinib as a single agent and combination therapy in acute myeloid leukaemia (AML) / myeloid dysplastic syndrome (MDS) The clinical trials combining bemcentinib with KEYTRUDA in adenocarcinoma of the lung and TNBC are conducted in collaboration with Merck & Co., Inc. (Kenilworth, NJ, USA), through a subsidiary. In addition, a number of investigator-sponsored trials are underway, including a trial to investigate bemcentinib with either MEKINIST® (trametinib) plus TAFINLAR® (dabrafenib) or KEYTRUDA in advanced melanoma, as well as a trial combining bemcentinib with docetaxel in advanced NSCLC. BerGenBio is simultaneously developing a companion diagnostic test to identify patient subpopulations most likely to benefit from treatment with bemcentinib. This will facilitate more efficient registration trials and support a precision medicine based commercialization strategy. The Company is also developing a diversified pre-clinical pipeline of drug candidates, including BGB149, an anti-AXL monoclonal antibody. For further information, please visit: www.bergenbio.com   KEYTRUDA® is a registered trademark of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA, TARCEVA® is a registered trademark of OSI Pharmaceuticals, LLC., marketed by Roche-Genentech. TAFLINAR® is a registered trademark of Novartis International AG and MEKINIST® is a registered trademark of GSK plc. Contacts   Richard GodfreyCEO, BerGenBio ASA+47 917 86 304 Rune Skeie, CFO, BerGenBio ASArune.skeie@bergenbio.com+47 917 86 513 Media Relations in Norway Jan Petter Stiff, Crux Advisorsstiff@crux.no+47 995 13 891 International Media Relations David Dible, Mark Swallow, Marine Perrier, Citigate Dewe Rogersonbergenbio@citigatedewerogerson.com+44 207 638 9571 This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

ChromoGenics notice to Annual General Meeting 2018

NOTICE OF ANNUAL GENERAL MEETING IN CHROMOGENICS AB (PUBL) The shareholders in ChromoGenics AB (publ) reg. no. 556630-1809 (the “Company”) are hereby convened to the annual general meeting on Wednesday May 16, 2018, at 14.00 at the offices of Law firm Lindahl, Vaksalagatan 10, 751 42 Uppsala. Notice etc. Shareholders who wish to participate at the annual general meeting must: -  on Wednesday May 9, 2017, be registered in the share register kept by Euroclear Sweden AB, and -  notify his or her intention to attend the general meeting by mail to Ullforsgatan 15, 752 28 Uppsala, stating “annual general meeting”, by telephone to 018-43 00 430, or by e-mail to info@chromogenics.com, at the latest on Monday May 14, 2018. Such notification shall include the shareholder’s name, personal identification number or corporate registration number (or similar), address and daytime telephone number, number of shares, details on advisors (no more than two), if any, and where applicable, details of representatives or proxies. Nominee-registered shares To be entitled to participate in the general meeting, shareholders whose shares are registered in the name of a nominee must temporarily re-register their shares in their own names in the share register maintained by Euroclear Sweden AB in order to be entitled to attend the general meeting. Such registration must be duly effected in the share register on Wednesday May 9, 2017, and the shareholders must therefore advise their nominees well in advance of such date. Shareholders who have not executed such re-registration will not be entitled to participate in the general meeting. Proxy Shareholders represented by proxy must submit a dated power of attorney. If the power of attorney is executed by a legal person, a certified copy of the certificate of registration or equivalent must be attached. The power of attorney may not be valid for a period longer than five years from its issuance. The original power of attorney and certificate of registration should be submitted to the Company by post at the address mentioned above in due time prior to the general meeting. The Company provides a form of power of attorney at request and it is also available at the Company’s website, www.chromogenics.com. Number of shares and votes As of the date of this notice, there are a total of 42 188 995 shares and votes in the Company.  Proposed agenda 1.         Opening of the general meeting and election of chairman of the general meeting  2.         Preparation and approval of the voting list 3.         Approval of the agenda 4.         Election of one or two persons to verify the minutes 5.         Determination as to whether the meeting has been duly convened 6.         Presentation of the annual report and the auditor’s report 7.         Resolutions on:                      a)         the adoption of the income statement and the balance sheet,                     b)         allocation of the Company’s loss according to the adopted balance sheet, and                      c)         discharge from liability for each of the members of the board of directors and the managing director 8.         Resolution on the number of members of the board of directors, deputy members of the board of directors, auditors, and deputy auditors 9.         Determination of remuneration to the board of directors and the auditor  10.       Election of members of the board of directors, deputy members of the board of directors, if any, and auditor 11.       Resolution on the nomination committee for the next annual general meeting  12.       Resolution to authorize the board of directors to issue new shares, warrants and/or convertible instruments 13.       Closing of the general meeting Proposals to resolutions Item 1 – Election of chairman of the general meeting The Nomination committee, consisting of Bengt Josefsson (Chairman of the Nomination committee), Leif Kristensson, Poul Erik Schou-Pedersen, Clarence Taube and Anders Brännström, proposed that Mattias Prage, Law firm Lindahl, is elected as chairman of the general meeting. Item 6b) – Allocation of the Company’s results according to the adopted balance sheet The board of directors propose that no dividends will be paid for the year 2017 and that the accumulated loss for the year 2017 is carried forward into new account. Item 8 – Resolution on the number of members of the board of directors and deputy members of the board of directors The Nomination committee has proposed that the board of directors until the end of the general meeting shall consist of five (5) directors, without deputy members. Furthermore it is proposed that the Company shall elect a registered accounting firm as its auditor. Item 9 – Determination of remuneration to the board of directors and the auditor The Nomination committee has proposed that remuneration is paid to each board member who is not i) employed by the company, ii) founder or main owner of the company, or iii) appointed by or a connected person to founder or main owner of the company, with SEK 100.000 for ordinary board members, and SEK 150.000 for the chairman. Item 10 – Election of members of the board of directors, chairman of the board of directors and deputy members of the board of directors, if any The Nomination committee has proposed re-election of Anders Brännström as chairman of the board, Claes-Göran Granqvist, Mari Broman and Peter Gustafson as well as election of Christer Simrén as director. Jerker Lundgren has declined re-election since he is appointed the new CEO of the Company. Christer Simrén has long and wide industrial experience, mainly in the packaging industry, as COO for KorsnäsBillerud and previously as CEO and other leading roles in Korsnäs and the Kinnevik Group. Throughout the years, Christer has driven restructuring and sales strategies successfully with significant growth and good margins. Christer has solid experience in board work, both as chairman and member, in a number of industrial companies and management consulting companies. Christer has a PhD, Dr. of Science in Industrial Management and Economics from Chalmers University of Technology and a Msc in Electrical Engineering & Computer Science from Chalmers. Christer also holds a degree in Economics from the School of Economics at the University of Gothenburg. It is proposed that PriceWaterhouseCoopers (PwC) is re-elected as auditor of the Company, with Leonard Daun as chief auditor, until the next year’s annual general meeting. Item 11  – Resolution on the nomination committee for the next annual general meeting The board of directors propose that the general meeting resolve that the Company, in advance of the next general meeting to be held in 2019, shall establish a nomination committee. It is proposed that the chairman shall instruct the three shareholders with the largest holdings of shares/votes in the Company to each appoint a representative that together with the chairman shall constitute the nomination committee. If any of these three shareholders abstain from its/his/her right to appoint a representative the right passes on to the shareholder that, besides those shareholders that have already abstained or appointed a representative, owns the most shares/votes . It is proposed that the nomination committee shall be tasked with the duty to, at the next general meeting to be held in 2019, bring forward propositions on: · election of the board of directors · election of the chairman · remuneration to the board of directors · election of auditor · remuneration to the auditor · chairman at the general meeting Item 12 – Resolution on the authorization of the board of directors to resolve on the issue of new shares/convertibles/warrants The board of directors propose that the shareholders’ meeting authorizes the board of directors, for the time until the next annual general meeting, to issue shares, warrants and/or convertibles. This may be done at one or several occasions and with or without deviation from the shareholders' pre-emption rights and/or an issue in kind, an issue by way of set-off or any other conditions. An issue in accordance with this authorization shall be on market conditions. The board of directors shall be authorized to decide on the terms and conditions regarding issues under this authorization and what persons shall be entitled to subscribe for the shares, warrants and/or convertible instruments. The reason to propose that the board of directors shall be authorized to resolve on an issue with deviation from the shareholders’ pre-emption rights and that the board shall be authorized to decide on an issue in kind or an issue by way of set-off or otherwise on such terms and conditions as referred to above is in connection with acquisitions of companies or businesses, participate in strategic partnerships and to carry-out directed new issues in order to raise capital to the company. The number of shares and/or warrants that could be issued due to this authorization shall not exceed 4 218 900, corresponding to approximately 10 per cent of the current outstanding number of shares. It is proposed that the managing director is authorized to make such minor adjustments to this resolution that may be necessary in connection with the registration with the Swedish Companies Registration Office and Euroclear Sweden AB. A resolution in accordance with the proposal to authorize the board of directors is valid only if supported by shareholders holding at least two-thirds of both the votes cast and the shares represented at the meeting. Information at the Annual General Meeting The board of directors and the president shall, upon request by any shareholder and where the board of directors determines that it can be done without material harm to the Company, provide information of circumstances which may affect the assessment of a matter on the agenda, and circumstances which may affect the assessment of the Company’s financial position. Documentation The annual report and the auditor’s report, the auditor’s report regarding compliance with the guidelines for remuneration to the senior as well as other documents according to the Swedish Companies Act will be held available at the Company’s office with address Ullforsgatan 15, Uppsala, not later than three weeks before the meeting, i.e. not later than April 25, 2018. The documents will also be sent, without charge, to shareholders who so request and inform the Company of their postal address. The documents will also be available and presented at the general meeting. Every care has been taken in the translation of this document. In the event of discrepancies, the Swedish original will supersede the English translation.  Uppsala in April 2018 ChromoGenics AB (publ) The board of directors

Welcome to the Annual General Meeting (AGM) in Opus Group AB (PUBL)

NOTICE OF PARTICIPATION Shareholders wishing to participate in the AGM shall be registered in the Shareholders’ Register held by Euroclear Sweden AB as of Friday May 11, 2018, and have notified the company of their intention to attend by Friday May 11, 2018. Notification of participation at the AGM shall be made through Opus Group’s website, in writing to ”AGM 2018”, Opus Group AB, Att. Helene Carlson, Basargatan 10, 411 10 Göteborg or via e-mail to ir@opus.se. When giving notice of participation, the shareholder shall state his or her name, personal ID/corporate registration number, address and telephone number, and the names of the assistants they wish to invite, if any (maximum two). Shareholders who are represented by proxy shall issue a written, dated, proxy to be enclosed with the notice of participation. A proxy form is available at Opus Group AB’s website. If the proxy form is issued by a legal entity, a verified copy of the said person’s certificate of registration or other proof of authorization shall be enclosed. The proxy must not be more than one year old, unless a longer period of validity is stated in the proxy, which may not be more than five years. Originals of proxy forms and certificates of registration, if any, should reach Opus Group AB (publ) on Friday May 11, 2018, at the latest. TRUSTEE-REGISTERED SHARES Shareholders with shares registered in the name of a trustee must, in order to be entitled to take part in the AGM, temporarily register their shares in their own names. Such temporary registration must be effected at Euroclear Sweden AB by Friday May 11, 2018. To ensure that such registration is completed in time, shareholders are advised to notify their trustees to request temporary registration well before this date. PROPOSED AGENDA 1.         Opening of the AGM. 2.         Election of chairman of the AGM. 3.         Drafting and approval of the voting list. 4.         Approval of the agenda. 5.         Election of two people to approve the minutes together with the chairman. 6.         Review as to whether the AGM has been duly convened. 7.         Presentation of the annual report, auditors’ report and consolidated accounts and consolidated auditors’ report, along with a presentation of the CEO. 8.         Resolution             a) to adopt the income statement and balance sheet and the consolidated income statement and the consolidated balance sheet.             b) to adopt the appropriation of the company’s profits according to the adopted balance sheet.             c) to adopt the indemnification of the board members and the CEO. 9.         Resolution to adopt new articles of association 10.       Resolution to adopt the number of Board members and deputies, auditors, audit deputies to be elected at the AGM. 11.       Determination of remuneration to the Board of Directors and the auditors. 12.       Election of Board chairman, Board members, deputies, auditors, deputy auditors and registered public accounting firms. 13.       Proposal of the instructions for apiteming the members of the nomination committee. 14.       Resolution to adopt guidelines for determining salaries and other remuneration to senior executives. 15.       Resolution to implement an incentive program (Option program 2018) through a directed issue of options with a following right to subscribe for shares (series 2018/2021). 16.       Resolution to authorize the Board to acquire and transfer own shares. 17.       Resolution to authorize the Board to decide on new issues of ordinary shares and/or warrants and/or convertibles. 18.       Other matters. 19.       Closing of the AGM. THE NOMINATION COMMITTEE’S PROPOSALS UNDER ITEM 2, 10, 11, 12 AND 13 The nomination committee, whose members have been apitemed in accordance with the instructions that were decided at the AGM 2017, has composed of chairman Martin Jonasson (representing Andra AP-fonden), Jörgen Hentschel (representing AB Kommandoran), Carl Schneider (representing Lothar Geilen), Jimmy Tillotson (representing RWC) and the Chairman of the board of directors Katarina Bonde, who together represent approximately 47.2 percent of the total number of votes in the company. Election of chairman of the AGM (item 2) The nomination committee proposes the lawyer Anders Strid, at Advokatfirman Vinge, to be apitemed as the Chairman of the AGM. Resolution to adopt the number of Board members and deputies, auditors, deputy auditors to be elected at the Shareholder’s Meeting (item 10) The nomination committee proposes that there be seven ordinary Board members and no deputies. The nomination committee proposes that a registered public accounting firm be apitemed as auditor. Determination of remuneration to the Board of Directors and the auditors (item 11) The nomination committee proposes a remuneration of SEK 500,000 (480,000) to the Chairman of the Board of Directors and SEK 230,000 (220,000) to each non-employed Board members. The nomination committee further proposes that the remuneration paid for work on the audit committee amounts to a total of SEK 220,000 (147,000), whereof SEK 90,000 (85 000) to the Chairman of the audit committee and SEK 65,000 (62 000) to the other members of the audit committee. Auditor fees are proposed to be paid against approved account. Election of board members and auditors (item 12) The Nomination Committee proposes re-election of the following Board members Katarina Bonde, Friedrich Hecker, Anne-Lie Lind, Magnus Greko and Ödgärd Andersson and new election of Håkan Erixon and Jimmy Tillotson. The Nomination Committee proposes re-election of Katarina Bonde as Chairman of the Board. Anders Lönnqvist has declared that he is not at disposal for re-election. The Nomination Committee proposes that the registered public accounting firm KPMG AB shall be elected to act as auditor for a period of one year. KPMG AB has assigned the Authorised Public Accountant Jan Malm as the auditor in charge. Chairman, re-election: Katarina Bonde Born in 1958. Chairman of the Board since 2016. Background: CEO UniSite Software Inc. 2000–2004, CEO Captura International 1997–2000, Managing Director Marketing Dun & Bradstreet Software Inc 1996–1996, VP Sales and Marketing, Timeline Software Inc. 1994–1995, CEO Programator Industri AB 1989–1992. Other board assignments: Founder and Managing Director of the management consultancy company Kubi LLC, Chairman of the board in Propellerhead AB and in Imint Intelligence AB, board member in Micro Systemations AB (publ), Nordax Group AB (publ), Mycronic AB (publ) and Aptilo Networks AB. Education: Master of Science in Technology at KTH Royal Institute of Technology and studies in Business and Economics at the University of Stockholm. Shares in Opus Group AB: 40,000. Stock options in Opus Group AB: 0. Independent of the Company, its management and major shareholders. Members, re-election: Friedrich Hecker Born in 1962. Board member since 2016. Background: CEO and Managing Director ROSEN Swiss AG (Switzerland) 2012–2015, Friedrich Hecker Consulting 2011– 2012, CEO TÜV Rheinland AG (Germany) 2010–2011, COO TÜV Rheinland AG 2009–2010, member of the executive board TÜV Rheinland AG 2009–2011, Executive Vice President Industrial Services and board member SGS SA (Switzerland) 2003–2009, COO and board member SGS SA 2002–2003, Managing Director in TÜV SÜD Bau und Betrieb GmbH (Germany) 2001–2002. Other board assignments: Senior Advisor to COBEPA S.A., member of the board in Underwriters Laboratory (UL) Inc and Vice President of OiER (Organization for International Economic Relations). Education: Dipl.-Kfm. at Ludwig-Maximilian University in Munich, Germany. Shares in Opus Group AB: 0. Stock options in Opus Group AB: 0. Independent of the Company, its management and major shareholders. Anne-Lie Lind Born in 1971. Board member since 2016. Background: Vice President Camfil Power Systems Europe & Middle East 2016- , CEO AkkaFRAKT 2015–2016, Business Unit Director SKF Logistics Services 2011–2015, Business Unit Manager Engineering SKF Sverige AB 2010–2011, Sales Manager ID Sales Nordic, SKF Sverige AB 2006–2010, Production Manager SKF Sverige AB 2004–2006 and Production Manager Tetra Pak Stålvall AB 2002–2004. Other board assignments: Chairman of the board in AkkaFRAKT and board member in Bulten AB (publ). Education: Master of Science in Engineering from Chalmers University of Technology. Executive MBA from University of Gothenburg. Shares in Opus Group AB: 40,000. Stock options in Opus Group AB: 0. Independent of the Company, its management and major shareholders. Ödgärd Andersson Born in 1972. Board member since 2017. Background: Vice President Software and Electronics at Volvo Car Group 2016- , VP Product Development Unit Packet Core Ericsson 2011–2016. Prior to that several different management and director positions within Ericsson Radio & Fiber Network R&D 2000–2011. Designer Ericsson Radio Base Stations 1997–2000. Other board assignments: Member of The Swedish Royal Academy of Engineering Sciences (IVA). Education: Master of Science in Engineering from Chalmers University of Technology. Shares in Opus Group AB: 0. Stock options in Opus Group AB: 0. Independent of the Company, its management and major shareholders. Magnus Greko Born in 1963. Board member since 2017. Background: VP Strategic Business Development Opus Group 2017- , CEO and President Opus Group AB 2006–2017. Active in the industry since 1984. In 1990, co-founded the company that today is Opus Group AB. Other board assignments: Board member of AB Kommandoran, Dalfrid Invest AB and AB Krösamaja. Education: Graduate in engineering from Polhemsgymnasiet in Gothenburg. Shares in Opus Group AB: 21,447,542 shares privately and through AB Kommandoran, which is owned equally by Magnus Greko and Jörgen Hentschel. Stock options in Opus Group AB: 0. Dependent of the Company, its management and major shareholders. Members, new election: Håkan Erixon Born in 1961. Background: Since 2011, active as board member and advisor to a number of companies and institutions, among other positions Chairman Orio AB (former Saab Automobile Parts) 2012-2017, board member Norrporten AB 2015-2016 and member of Nasdaq OMX Stockholm AB Listing Committee 2010-2016. Senior Advisor, Corporate Finance, Swedish Government Offices 2007-2010. 1989-2007, management positions at several international banks, including 15 years at UBS and Merrill Lynch. Other board assignments: Chairman of Capacent Holding AB (publ) and Hemnet Group AB. Board member of Vattenfall AB (publ) and Alfvén & Didrikson Invest AB. Education: B.Sc. (Hons) in International Business Administration and Economics from Gothenburg School of Economics. Shares in Opus Group AB: 0. Stock options in Opus Group AB: 0. Independent of the Company, its management and major shareholders. Jimmy Tillotson Born in 1979. Background: Partner, RWC European Focus Fund (EFF) 2012- . Director Hermes European Focus Fund 2006-2012, Investment Manager JM Finn & Co 2002-2006. More than 15 years of professional experience in equity and active ownership investing. His areas of expertise include corporate governance, strategy & capital allocation, operational excellence, capital structure and interaction with the capital markets. Other board assignments: No other assignments. Education: Masters (Hons) in Economics from University of Edinburgh, United Kingdom. Shares in Opus Group AB: 0. Stock options in Opus Group AB: 0. Independent of the Company and its management and dependent of the Company’s major shareholders. Proposal of the instructions for apiteming the members of the nomination committee (item 12) The nomination committee proposes the AGM to decide on instructions for apiteming the members of the nomination committee. The proposal implies the following in brief. The nomination committee shall consist of not fewer than five and no more than six members, one of whom shall be the Chairman. The other members shall be apitemed by the four largest shareholders in the company on the last business day of the bank in September. If a shareholder abstains from apiteming a member the right to apitem a member shall transfer to the subsequent largest shareholder. The Chairman of the nomination committee shall be the member that at its formation represents the largest shareholder(s), provided the nomination committee does not unanimously resolve to apitem another member, apitemed by a shareholder, chairman of the nomination committee. The Chairman of the board of directors shall not be chairman of the nomination committee. The company shall publish the composition of the nomination committee through a press release and on the company’s website. The majority of the members of the nomination committee are to be independent of the company and its executive management. At least one member of the nomination committee is to be independent of the company’s largest shareholder or any group of shareholders that act in concert in the governance of the company. No compensation shall be paid to the members of the nomination committee. THE BOARD OF DIRECTOR’S PROPOSALS UNDER ITEM 8B, 9, 14, 15, 16 AND 17 Appropriation of the company’s profits (item 8b) The Board proposes that a dividend of SEK 0.05 per share be paid out. The Board proposes the record date for receiving the dividend to be Monday May 21, 2018. If the AGM votes in accordance with the proposal, payment is expected to be made via Euroclear Sweden AB on Wednesday May 24, 2018. Resolution to adopt new articles of association (item 9) The Board proposes the AGM to take a resolution to adopt new articles of association. Except for some minor adjustments following amendments in the legislation the articles of association § 6 should be amended regarding the number of directors in the Board. § 6 Current wording: The board consists of four to six members with maximum five deputies. § 6 Proposed wording: The board consists of five to nine members and no deputies. Resolution to adopt guidelines for determining salaries and other remuneration to senior executives (item 14) The Board proposes the AGM to decide on the following guidelines for determining salaries and other remuneration to senior executives. The remuneration to senior executives within Opus Group shall be competitive. The remuneration shall consist of a fixed and a variable part. The variable part shall consist of salary, pension contributions and other benefits such as car benefit. The variable part consists of bonus. The variable part shall be based on the earnings trend or other predetermined measurable goals. The variable component shall as a rule not exceed 30 percent of the fixed salary. The pension contributions shall be competitive and as a rule, premium-based. The Board shall be entitled to deviate from the guidelines if there are special reasons in individual cases. Resolution to implement an incentive program (Option program 2018) through a directed issue of options with a following right to subscribe for shares (series 2018/2021) (item 15) The Board proposes that the AGM takes a resolution to implement an incentive program (Option program 2018). The Option program entails that the company, at a maximum, issues 6,000,000 options to the wholly-owned subsidiary Opus Services Sweden AB, which shall entitle subscription of a maximum of 6,000,000 shares. Opus Services Sweden AB shall have the rights and the obligations to handle the subscription rights in accordance with Option program 2018. The Option program 2018 shall complement the previously resolved and ongoing option program Option program 2016:1. Opus Services Sweden AB shall offer the senior executives, others in the management and certain other employees, mainly in Sweden, to acquire options at market value, which will be calculated by using the valuation model Black & Scholes. Opus Services Sweden AB shall gratuitously offer options to the senior executives, others in the management and certain other employees in the US. The Option program will include approximately 25 employees within the Opus-group. Opus Services Sweden AB shall have the right to hold options in custody in order to transfer them to new employees within the Opus-group. Subscription of the shares shall be made from July 2021 and until August 15 2021. The subscription price for the shares subscribed for when exercising the options shall correspond to 120 percent of the average share price of the Opus share during the period April 16 – May 17, 2018. The subscription price shall be paid in cash or by offset. The Company shall have the right to, but no obligation, at the request of a participant that is unable to pay the subscription price in cash, at market price acquire the number of options that enables the participant to exercise remaining options to subscribe for shares at which the subscription price shall be paid by offset against the claim relating to the sold options. Upon full exercise of the options a maximum of 6,000,000 new shares will be issued, which together with the ongoing option program Option program 2016:1 will correspond to a dilution of approximately 3.8 percent. The options transferred to employees in Sweden are not expected to give rise to any payroll expenses nor social security costs for the company. The options transferred to the employees in the US will give rise to social security costs if the employee transfer shares subscribed for through exercise of the options within one year from the exercise of the options. In excess of the social charges, the option program will result in additional costs for financial and legal costs amounting to approximately SEK 100 000. The Board invokes the following as to the reason for the deviation from the shareholders’ preferential rights. The Option program contributes to a higher motivation and engagement among the employees and strengthens the ties between the employees and the company. Further, it is the assessment of the board that the Option program 2018 will contribute to the possibilities to recruit and retain competent and experienced employees and is expected to increase the employee’s interest for the business and the earnings trend in the company. Overall it is the Board’s assessment that the Option program 2018 will be useful for both the employees and the company’s shareholders through an increased share value. The Option program has been prepared by the Board in consultation with the management. Decision to authorize the Board to acquire and transfer own shares (item 16) The Board proposes to the AGM to authorize the Board to, prior to the next AGM, take resolution on acquisition of own shares on one or more occasions. Acquisition of own shares may amount to a maximum corresponding to one tenth of the number of shares issued in the company. The repurchase shall be carried out through an acquisition offer directed to all shareholders, or on Nasdaq Stockholm. Repurchase on Nasdaq Stockholm shall be at a price which corresponds to the registered stock exchange price interval (spread) at any given time. Repurchase through an acquisition offer directed to all shareholders can only be done against payment in cash and the acquisition shall be made at a rate corresponding with the registered price interval (spread) at any given time with a maximum divergence of 30 % up. The purpose of the repurchase of own shares is firstly to align the company’s capital structure, give added value to the shareholders and to be able to transfer shares in conjunction with the financing of company acquisitions. The Board also propose that the AGM take resolution to authorize the Board to, prior to the next AGM, decide on transfer of the own shares that the company holds at the time of the transfer decision. Transfer of own shares may be carried out on Nasdaq Stockholm at a price corresponding to the registered price interval (spread) at any given time. Transfer of shares may also be carried out outside Nasdaq Stockholm, with or without deviation from the shareholders’ preferential rights and with or without terms of contribution in kind or right to set-off. Transfer of own shares can accordingly be used as means of payment in relation to company acquisitions on conditions in accordance with the Companies Act’s rules on issue of shares. Such transfer can only be made at a price in cash or value of obtained assets corresponding with the stock market price at the time of the transfer. If the exercise of the authorization to acquire or transfer own shares is combined with the exercise of the authorization to issue new shares and/or warrants and/or convertibles (item 17), with the purpose of financing the acquisition of the entire or part of the same acquired company or the same investment in connection with a new business contracts or a new business area, the number of shares that has been transferred and issued in connection with the acquisition, together can correspond to a maximum of one tenth of the number of shares issued in the company at the time of the authorization to issue new shares and/or warrants and/or convertibles. The possibility to deviate from the shareholders’ preferential rights at a transfer of own shares is motivated by the fact that a transfer of shares on Nasdaq Stockholm, or otherwise with deviation from the shareholders’ preferential rights can be done with a major rapidity, flexibility and more cost efficient than by a transfer to the shareholders. If the company’s own shares are transferred for compensation in any other form than cash in relation to an acquisition, the company cannot provide the shareholders the opportunity to exercise its preferential rights. Decision to authorize the Board to decide on new issues of ordinary shares and/or warrants and/or convertibles (item 17) The Board proposes that the meeting authorizes the Board to take resolution, on one or more occasions prior to the next AGM, with or without preferential right for the shareholders, on an issue of shares and/or warrants and/or convertibles corresponding to a total dilution effect of maximum ten percent of the share capital. The issue can be carried out as a cash-, in kind- or offset issue. The issue can only be carried out at market value. Deviation from the preferential rights for the shareholders shall only be possible in relation to an acquisition of a company or in connection with entering into new business contracts or establishment of new business areas requiring considerable investments. The reason for the deviation from the preferential rights for the shareholders is that the company in connection with (i) an acquisition rapidly may need access to cash or to make a payment in kind with the shares of the company or (ii) entering into new business contracts or establishing new business areas rapidly may require access to cash to cover capital expenditures to cover necessary investments. If the exercise of the authorization to issue new shares and/or warrants and/or convertibles is combined with the exercise of the authorization to acquire or transfer own shares (item 16), with the purpose of financing the acquisition of the entire or part of the same acquired company or with the purpose of the same investment as described above, the number of shares that has been transferred and issued in connection with the acquisition, together can correspond to a maximum of one tenth of the number of shares issued in the company at the time of the authorization to issue new shares and/or warrants and/or convertibles. SPECIAL MAJORITY REQUIREMENT For a decision relating to item 15 to be valid requires the decision must be supported by shareholders with a minimum of nine-tenths of the voting rights and shares represented at the meeting. For a decision relating to items 9, 16 and 17 to be valid requires the decision must be supported by shareholders with a minimum of two-thirds of the voting rights and shares represented at the meeting. NUMBER OF SHARES AND VOTES There are 290 318 246 shares and votes in the company at the time of the notification of the AGM. All shares are ordinary shares. Currently, the company does not own any of the outstanding shares. AVAILABLE DOCUMENTS The annual report, the auditors’ report, the Board’s statement in accordance with chapter 18, § 4, the auditors’ statement in accordance with chapter 8, § 54 of the Swedish Companies Act, the instructions for apiteming the members of the nomination committee and the Boards’ complete proposals for decisions under item 9, 15, 16 and 17 will available for the company’s shareholders as of April 26, 2018 on the company’s office, which address is Basargatan 10, 411 10 Göteborg, Sweden. The documentation will also be available at the company’s website www.opus.se. The above documents will be mailed to shareholders upon request. The nomination committee’s proposals for the 2018 Annual General Meeting is available on the company website www.opus.se. DISCLOSURES AT THE MEETING The Board and CEO shall, at the request of any shareholder at the AGM, and if the Board does not consider it to have a negative impact on the company, provide information about conditions that can affect the assessment of matters on the agenda, conditions that can affect the assessment of the company’s or subsidiaries’ financial situation, or the company’s relationship to other Group companies. Gothenburg in April, 2018 Opus Group AB (publ) The Board This press info is available in Swedish at www.opus.se

Catarina Ihre proposed as a new member of Brighter's Board of Directors.

At Brighter's upcoming annual general shareholders meeting, the Company’s Nomination Committee will propose changes to the Board of Directors, with Catarina Ihre as a new member on the board. Catarina Ihre has worked as an analyst at Deutsche Bank and Nordea and in Investor Relations at Lundin Mining, SSAB and Electrolux. At Electrolux she held the position of VP Investor Relations.  "I look forward to working with Brighter, a visionary company with high ambitions in a very large market. Healthcare must be cheaper, more digital and help patients get higher quality of life. This is what Brighter's first solution Aciste® means for diabetes, one of the world's largest diseases, says Catarina Ihre. Catarina Ihre holds a degree in Economics from Uppsala University. She has worked for 15 years as an analyst and for 11 years as IR manager in three of the 30 companies whose stock is traded most on Nasdaq Stockholm."I am very pleased that Catarina wants to help Brighter to navigate in what I expect to be a very offensive and expansive period. Her deep global experience from both the investor and the corporate side of investor relations will strengthen the board's work on many levels, says Brighter's founder and CEO Truls Sjöstedt. For more information, please contact: Truls Sjöstedt, CEO Telefon: +46 709 73 46 00      E-post:  truls.sjostedt@brighter.se Henrik Norström, COO   Telefon: +46 733 40 30 45      E-post: henrik.norstrom@brighter.se About BrighterBrighter is a Swedish-based company that, from a unique IP portfolio, creates smart solutions for one of healthcare’s biggest challenges: changing patient behavior. Chronic diseases such as diabetes are rapidly increasing, and account for an increasing share of healthcare costs globally. Brighter's Business Model and Multi-Sided Market Platform - The Benefit Loop™ - is based on the fact that many special interests create value for each other. By increasing access to valid health data, Brighter creates value for all stakeholders in the care chain: patients and their close associates, healthcare providers, research institutes, the pharmaceutical industry, and society as a whole. www.brighter.se About ActisteBrighter's solution Actiste® handles most of the self-monitoring and treatment of insulin-treated diabetes in a single easy-to-use device. Measurement of glucose levels, insulin injections, automatic logging, and timing of all activities are performed from a single unit. Actiste is connected via an autonomous and secure mobile connection, and information can be automatically shared with selected recipients through The Benefit Loop®, Brighter's open cloud-based service where data is collected, processed and analyzed with patient consent. Validated user-generated data, such as test results, can be automatically transferred electronically to many different constituents. The patient selects when and how data is shared and who will have access to it. Through The Benefit Loop, different services can motivate patients with chronic illnesses to change their behavior, which can save lives, reduce relatives' concerns, and release enormous healthcare resources. www.actiste.com  The Company's shares are listed on NASDAQOMX First North/BRIG . Brighter’s Certified Adviser on Nasdaq OMX First North is Remium Nordic Holding AB +46 (0)8 – 454 32 50, CorporateFinance@remium.com, www.remium.com.

Notice of Paradox Interactive AB (publ)’s Annual General Meeting 2018

Please note that this is a translation for information purposes only – in case of any discrepancies between this version and the Swedish version, the Swedish version shall prevail. The Annual General Meeting will be held in Swedish only. Notice of attendance Shareholders who wish to attend the AGM shall: ·be entered in the company’s shareholders’ register kept by Euroclear Sweden AB in their own name by May 12, 2018 (Note that since May 12, 2018 is a Saturday the shareholders’ register will reflect the situation on May 11, 2018 and shareholders must therefore be entered in the company’s share register on that date), and ·notify their intention to attend the meeting no later than Monday, May 14, 2018, to the address Paradox Interactive AB, "AGM", Västgötagatan 5, 118 27 Stockholm, or on the company’s website www.paradoxinteractive.com/en/section/our-company/general-meetings/ by clicking the following link https://goo.gl/forms/Y8XnQgJkMlNj2dZS2. The notification should state name, personal / corporate identity number, address, telephone number and shareholding in the company. If a shareholder intends to bring one or two advisors to the AGM such participation should also be specified in the notification. If participation is by proxy, the power of attorney along with other documents of authority must be brought to the meeting and these documents should be submitted to bolagsstamma@paradoxplaza.com or to the address Paradox Interactive AB, ”AGM”, Västgötagatan 5, 118 27 Stockholm in connection with the notification to participate in the meeting. Power of attorney forms for shareholders wishing to attend the meeting by proxy is available on the company website www.paradoxinteractive.com/en/section/our-company/general-meetings/ and are sent to shareholders upon request. Shareholders who have their shares registered with a nominee must, to be entitled to participate at the Annual General Meeting, temporarily register the shares in their own name. Shareholders wishing such re-registration must inform their nominee of this well before May 12, 2018 (Note that since May 12, 2018 is a Saturday the shareholders’ register will reflect the situation on May 11, 2018 and registration therefore needs to be completed no later than that day). Proposed agenda 1. Opening of the AGM2. Election of a chairman for the AGM3. Establishment and approval of voting list4. Approval of the agenda5. Election of one or two person(s) to verify the minutes6. Determination of whether the meeting was duly convened7. Presentation of the annual accounts and auditors’ report as well as the consolidated accounts and the consolidated auditors’ report8. Presentation by the CEO9. Resolution on the adoption of the income statement and the balance sheet, along with the group income statement and the group balance sheet10. Resolution on the allocation of the company’s profits in accordance with the adopted balance sheet11. Resolution on discharge from liability for the members of the Board of Directors and the CEO12. Resolution on amendment of the articles of association13. Determination of the number of members of the Board of Directors14. Determination of remuneration for the members of the Board of Directors and the auditors15. Election of members and chairman of the Board of Directors16. Election of auditors17. Election of the nominating committee for the AGM 201918. Resolution on guidelines for remuneration to senior executives19. Resolution on authorization for the Board of Directors to issue shares20. The Board of Directors’ proposal for a resolution on Warrant Scheme 2018/2021, including (A) adoption of Warrant Scheme 2018/2021, and (B) directed issue of warrants21. Closing of the meeting Proposals for resolutions Election of chairman of the meeting (agenda item 2) The nominating committee, consisting of Per Håkan Börjesson (appointed by Investment AB Spiltan), chairman, Andras Vajlok (Westerinvest AB), Christoffer Häggblom (Lerit Förvaltning AB) and Håkan Sjunnesson, chairman of the Board of Directors, proposes Håkan Sjunnesson as chairman of the meeting. Resolution on the allocation of the company’s profits in accordance with the adopted balance sheet (agenda item 10) The Board proposes a dividend of SEK 1.00 per share. The Board proposes Tuesday, May 22, 2018 as record date. If the meeting approves the proposal, the dividend will be distributed by Euroclear Sweden AB on Friday May 25, 2018. Resolution on amendment of the articles of association (agenda item 12) The Board of Directors proposes that the articles of association is amended to allow for the Board of Directors to consist of no more than eight members instead of, as is the case today, six members and that the term of the chairman of the Board of Directors is not regulated in the articles of association. Consequently the first paragraph of § 6 in the articles of association will be given the following new wording: “The Board of Directors shall consists of no less than three and no more than eight directors with no more than two deputy directors.” A resolution in accordance with the Board’s proposal will only be valid if it is supported by at least two thirds of both the cast votes and the shares represented at the meeting. Election of the Board of Directors etc. (agenda item 13 – 16) The nominating committee proposes ·that the Board of Directors consists of six members and no deputy members, ·election of Josephine Salenstedt and Peter Ingman and re-election of Håkan Sjunnesson, Cecilia Beck-Friis, and Fredrik Wester as members of the Board for the period up to the end of the next AGM. Re-election of Ebba Ljungerud as member of the Board for the period up to and including July 31, 2018. The current member of the board Peter Lindell has declined re-election. Håkan Sjunnesson is proposed to be appointed chairman of the Board of Directors for the period up to and including July 31, 2018. Fredrik Wester is proposed to be appointed chairman and Håkan Sjunnesson is proposed to be appointed deputy chairman for the period starting August 1, 2018 up to the end of the next AGM If Håkan Sjunnesson’s or Fredrik Wester’s assignment should end ahead of time, the Board of Directors will elect a new chairman internally, ·that the remuneration to the Board of Directors shall be increased to SEK 500,000/year for the Chairman and SEK 250,000/year for each of the AGM-elected directors. To Håkan Sjunnesson, who is proposed to be chairman part of the year and deputy chairman part of the year a total remuneration of SEK 500,000 is proposed. To Fredrik Wester, in accordance with his wishes, a total remuneration of net SEK 1 is proposed for each fiscal year, ·re-election of Grant Thornton as auditor for the period up to the end of the AGM 2019, and ·that the remuneration for the auditor be paid in accordance with the approved invoice. Below follows a short presentation of the persons proposed for first time election. Peter Ingman Born: 1968 Education: Master's degree in business administration, Stockholm School of Economics Other ongoing assignments: CEO of ToBePublished AB, owner of Firesoul AB. Angel investor in several growth companies in their early stages such as Zenia, Musqot, NeueLabs, Beatly, Baton Rouge, Arantus and ProSk8. Previous assignments: Board member of Founders Alliance. Founder and CEO of Spray Interactive and Mynewsdesk AB. Shareholding in Paradox Interactive: 0 shares. Independent: Independent in relation to the company and the management. Independent in relation to major shareholders. Josephine Salenstedt Born: 1984 Education: Master's degree in finance, Stockholm School of Economics Other ongoing assignments: Partner at Rite Ventures, board member of Skincity Previous assignments: Extensive experience from investment activities and active ownership in growth companies in the technology sector, such as chairman of Skincity and board member of Nord Software Oy and 24 Media Network AB. Shareholding in Paradox Interactive: 0 shares. Indirectly through Rite Ventures, which holds 9,535,359 shares. Independent: Independent in relation to the company and the management. Not independent in relation to major owners. The nominating committee’s statement regarding its proposal on the Board of Directors and information regarding the proposed members can be found on the company’s website. Resolution on the nominating committee for the AGM 2019 (agenda item 17) The nominating committee proposes that the AGM resolves on the following order for the preparation of election of members of the Board of Directors and auditors. The committee’s task shall be to prepare proposals to the general meeting 2019 regarding Chairman of the Annual General Meeting, number of Board members, remuneration to the Board and the auditor, the composition of the Board, the Chairman of the Board, rules for the nomination committee for the following year, and the election of the auditor. The chairman of the Board of Directors shall be a member of the nominating committee and be responsible for the summoning of the nominating committee. The Chairman of the Board of Directors will contact the three largest shareholders in terms of votes on September 30, 2018. The three largest shareholders will elect one representative each to form the nomination committee along with the Chairman until the next Annual General Meeting has taken place, or until a new nominating committee has been appointed. If any of these shareholders wants to waive their right to elect a representative, their right is transferred to the shareholder who, after these shareholders, has the largest share ownership until the nomination committee is complete. The nomination committee is also allowed to appoint an additional member to represent the small shareholders. If a member leaves the nomination committee before its work is completed a new member shall, if considered necessary, be appointed by the same shareholder who appointed the resigning representative, or, if this shareholder is no longer one of the three largest shareholders, by the new shareholder that belongs to this group. The composition of the nomination committee shall be announced as soon as it is appointed, and no later than six months before the AGM. In case there is a change in the ownership structure after the nomination committee has been composed, such as one or several shareholders that have appointed members to the nomination committee is no longer being one of the three largest shareholders, the nomination committee may be changed in accordance therewith if the nomination committee deems that it is required. Unless special circumstances so requires, no changes should be made to the composition of the nominating committee if only marginal changes to the number of votes has occurred or if changes occur less than three months prior to the AGM. The nominating committee shall appoint a chairman at the first meeting of the term. The nominating committee shall have the right to obtain resources from the company such as for example secretarial assistance, or use of executive search consultants at the expense of the company if it is deemed necessary. Resolution on guidelines for remuneration to senior executives (agenda item 18) The Board proposes that the Annual General Meeting resolves to approve the Board's proposed guidelines for remuneration for senior management as stated below. Senior management means the CEO and other senior management of the company. The CEO and the other members of senior management are paid a market based monthly salary, a bonus of up to three monthly salaries and customary benefits. All members of senior management is part of the joint profit sharing program for all permanent employees as decided by the Board. The establishment of a warrant program starting 2018 is also proposed, see agenda item 20. The fixed salary is in general reviewed on a yearly basis and shall take into account the individual's qualitative performance. Remuneration to the CEO and the other members of senior management shall be market based. Both Paradox and the CEO shall observe a six-month notice period. CEO is entitled to a severance payment amounting to six fixed monthly salaries in case of termination by the company. In relation to the other members of senior management Paradox will observe the period of notice set out in the Employment Protection Act and the employee must observe the same notice period, but in no case less than 3 months. Other senior management is not entitled to any compensation in connection with their employment being terminated. Other senior management have customary terms of employment. The Board is entitled to deviate from the above guidelines if the Board determines that in a certain case there are special reasons to justify it. Resolution on authorization for the Board of Directors to issue shares The Board of Directors proposes that the annual general meeting authorises the Board of Directors to, on one or several occasions, during the period up to the next annual general meeting, with or without deviating from the shareholder’s preferential rights, resolve to issue new shares, convertibles and/or warrants. The increase of the share capital, which entails issuance, conversion or subscription for new shares, may correspond to a dilution of a maximum of 10 percent of the share capital at the time of the first use of the authorisation to issue shares, convertible instruments and/or warrants. The purpose of the authorisation is to, in a fast and efficient way, acquire companies, businesses or parts thereof or broadening the ownership structure of the Company. Payment may be made in cash and/or with a condition to pay in kind or by way of set-off, or other conditions. A resolution in accordance with the Board of Directors’ proposal shall only be valid where supported by not less than two-thirds of both the votes cast and the shares represented at the annual general meeting. The Board of Directors shall have the right to make such minor adjustments in this resolution that may be necessary in connection with the registration of the authorisation with the Swedish Companies Registration Office. The Board of Directors’ proposal for a resolution on Warrant Scheme 2018/2021, including (A) adoption of Warrant Scheme 2018/2021, and (B) directed issue of warrants (item 20) The Board of Directors proposes that the annual meeting resolves to implement an incentive program for the employees of the Company – Warrant Scheme 2018/2021 – as set out below. Adoption of the scheme (item 20(A)) Background and reasons The purpose of Warrant Scheme 2018/2021 is to reward long term commitments of the Company’s employees, to ensure that the Company’s long term value increase is reflected in the remuneration for the participants of the scheme, to contribute to the capability to recruit and retain competent co-workers and to otherwise increase shared incentives between the group’s employees and the Company’s shareholders. The scheme is further expected to motivate the participants to retain their employment with the Company. It is the intention of the Board of Directors to annually propose incentive programs, essentially corresponding to Warrant Scheme 2018/2021. Given the reasons set out above and the main terms and conditions set out below it is the opinion of the Board of Directors that the proposed Warrant Scheme 2018/2021 is reasonable and beneficial for the Company and its shareholders. Main terms and conditions 1.The Warrant Scheme shall include no more than 352,000 warrants. 2.Each warrant entitles the holder to subscribe for one new share in the Company at a subscription price corresponding to 120 per cent of the volume weighted average transaction price (rounded off to the closest öre (SEK 0.01)) for the Company’s share on Nasdaq First North during the 10 trading days preceding the date of publication of the Company’s interim accounts for the first quarter of 2018 (”Subscription Price 1”) and for the second quarter of 2018 (”Subscription Price 2”) respectively. The subscription price and the number of shares which each warrant entitles to subscribe for may be subject to recalculation pursuant to a bonus issue, share split, new issue with preferential rights and similar measures, whereby conventional terms and conditions for recalculation shall be applied. 3.The Warrant Scheme shall comprise full-time employees of the Company and its subsidiaries. 4.Allotment of warrants is made with not more than 352,000 warrants in aggregate, to be distributed in accordance with the following allotment categories: 1.the managing director: not more than 50,000 warrants, 2.other senior executives and key employees: not more than 25,000 warrants per person, and 3.other employees who have been employed for at least a year without interruption at the time of allotment: not more than 10,000 warrants per person. A resolution on allotment is made by the Board of Directors on two occasions during 2018 as soon as possible after the determination of Subscription Price 1 (“Allotment 1”) and Subscription Price 2 (“Allotment 2”) respectively, whereupon Allotment 2 shall comprise a maximum of 80,000 warrants which are allotted only to persons who were not employed in the group at the time of Allotment 1. The allotted amount shall be determined taking into account the overall goals of the Board of Directors for the development of the group. There is no guaranteed lowest allotment. 5.Allotted warrants are offered for subscription for no consideration. Such offer shall be made within 10 banking days from the date the resolution on allotment is made. 6.Allotted and subscribed for warrants may be exercised by the holder from and including 15 June 2021 up to and including 30 June 2021. 7.In the event a holder of warrants terminates his or her employment or is dismissed or terminated from his or her employment with a group company, and wishes to transfer warrants and in certain other cases, the Company or the Company’s assignee is entitled to re-purchase such holder’s warrants at the market price. The right of re-purchase only relates to warrants which cannot be exercised for subscription yet. 8.For participation in Warrant Scheme 2018/2021 it is presumed that such participation is legally possible, and that such participation in the board of director’s opinion is possible at reasonable administrative costs and with reasonable financial resources. Costs The assessment of the Board of Directors is that Warrant Scheme 2018/2021 will lead to costs for the Company in terms of general payroll tax (Sw. arbetsgivaravgifter) with respect to the benefit the participants obtain following the offer to subscribe for warrants for no consideration as well as limited costs with respect to the establishment and utilization of the Warrant Scheme. The costs for general payroll tax is estimated at SEK 1,186,721 before corporation tax, assuming full allotment, subscription for all allotted warrants, an average Subscription Price of SEK 147.24 as well as a theoretical value of each warrant calculated on the basis of, among other things, the risk free interest rate and share price as well as volatility and dividend yield. Dilution and effect on material key ratios Provided a full subscription of all issued warrants with respect to Warrant Scheme 2018/2021 the number of shares in the Company will increase from 105,600,000 to 105,952,000, corresponding to approximately 0.33 per cent of the shares in the Company. The material key ratios for the group’s business are the group’s equity ratio (Sw. soliditet) and net margin (Sw. nettomarginal). At maximal cost for general payroll tax at allotment and at full subscription of all the warrants issued with respect to Warrant Scheme 2018/2021 it is the board of director’s opinion that the effect of Warrant Scheme 2018/2021 on said key ratios is non-existent or marginal. Preparation The proposal for Warrant Scheme 2018/2021 has been prepared by the Board of Directors in consultation with external advisers. The proposal has been unanimously adopted by the Board of Directors. The managing director of the Company has not taken part in the preparation of the proposal. There are currently no other equity related incentive programs in the group. Directed issue of warrants (item 20(B)) The Board of Directors proposes that the annual meeting resolves on a directed issue of not more than 352,000 warrants, whereby the Company’s share capital may be increased by a maximum of SEK 1,760, on the following terms and conditions. 1.The right to subscribe shall, with deviation from the shareholder’s preferential rights, only be granted to the individuals participating in Warrant Scheme 2018/2021 and with the number of warrants set out in accordance with the principles for Warrant Scheme 2018/2021 adopted by the general meeting. 2.Subscription for warrants shall be made on a subscription list not later than on 30 September 2018, provided however that subscription for warrants with a certain subscription price to subscribe for shares may not be carried out prior to such subscription price having been established. The Board of Directors shall be entitled to extend the term for subscription. 3.The warrants are provided for no consideration. The reason for deviation from the shareholder’s preferential rights is that the issue is part of the implementation of Warrant Scheme 2018/2021. The warrants intended to be issued shall enable the Company’s delivery of shares in accordance with the scheme. To the extent the issued warrants – as a result of e.g. lower than the maximum allotment within the framework of Warrant Scheme 2018/2021 – are deemed by the board of director’s not to be sufficient to cover the Company’s commitments with respect to Warrant Scheme 2018/2021, the Board of Directors proposes that the board shall be authorised to as soon as possible cancel unnecessary warrants. Majority requirements for resolution according to item 20 The Board of Directors’ proposal for a directed issue of not more than 352,000 warrants and the Board of Directors’ proposal with respect to Warrant Scheme 2018/2021 is a cohesive proposal, why a resolution in accordance with one of the partial proposals shall be conditional upon a resolution in accordance with the other partial proposal and that Chapter 16 of the Companies Act shall be applied on the cohesive proposal. A valid resolution in accordance with the board of director’s proposal requires that it is supported by shareholders representing at least nine tenths of both the number of votes cast and the shares represented at the meeting. Number of shares and votes At the time of issuing the notice there are 105,600,000 shares, representing a total of 105,600,000 votes in the company. Right to information The shareholders present at the Annual General Meeting has the right to request information regarding the matters on the agenda or the company's financial situation in accordance with Chapter 7 § 32 Companies Act (2005: 551). Handling of information Information collected on you in connection with your notification to attend the general meeting will be stored and archived internally at Paradox Interactive for a period of fem (5) years in such a manner that only a limited group within the company can access the information. The information is saved for the purpose of fulfilling our obligations under applicable rules and in order to be able to establish a voting register in accordance with Chapter 7 § 29 Companies Act. You can at any time get access to the information we have saved on you by contacting: legal@paradoxplaza.com. Records The annual accounts and the auditor's report, power of attorney form, the complete proposals and other documents under the Companies Act will by the latest be available on Friday April 27, 2018 on the company’s website www.paradoxinteractive.com and held available at the company at the above address. The documents will also be sent free of charge to shareholders who so request and state their address.  _______________________________ Stockholm April 2018Paradox Interactive AB (publ)The Board of Directors

Change in number of shares in Camanio Care AB (publ)

Conversion of convertible notes into shares under the Convertible Notes issued within the financing agreement announced on December 6th 2017. The date of conversion was April 17th 2018 and the number of Notes converted was 40. The number of Notes remaining under the first Tranche for future conversion is 270. The number of shares and the number of votes before the conversion was 15 918 391. Through the conversion the number of shares and the number of votes has increased by 275 862. The total number of shares and the total number of votes after the conversion amount to 16 194 253. Conversion price is 1,45 SEK per share and conversion amount is 400 000 SEK. For terms and conditions of the Notes, please visit Camanio Care’s website: http://www.camanio.com/en/invest/ For further information, please contact:Catharina Borgenstierna, CEOTelephone: 0733-93 00 07E-mail: catharina.borgenstierna@camanio.com About Camanio CareCamanio Care is a company operating in the caretech marketplace with robotics, assistive devices and gamification that focus on supporting basic human needs. We provide products and services that improve quality and efficiency in the areas of Active Life, Mealtime Situation and Digital Care with products such as BikeAround™, Giraff and Bestic®. Camanio Care has its headquarters in Stockholm, Sweden, subsidiaries in the USA and distributors in ten European countries and also Australia and China.   Subscribe to our newsletter and/or read more about us, Camanio Care at: www.camanio.com. This information is information that Camanio Care is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact persons set out above, on April 18th, 2018. 

Preparing for commercialisation of Ygalo®

“Oncopeptides has a very exciting and important product candidate in Ygalo® for patients in need. The product could have significant market potential in the US market. I am looking forward to joining the Oncopeptides’ Board and being part of the continued development of the company and in particular the commercial strategy based on my extensive experience in the pharmaceutical industry” said Per Wold-Olsen. “Since joining the Board of Oncopeptides as Chairman in 2010 the company has advanced dramatically and is now progressing with the lead compound Ygalo® in the pivotal phase III study OCEAN. The development has been made possible through the substantial effort and teamwork of an excellent management and Board, together with the support of our committed long-term investors. The company is now at the stage of starting the build-up in the US preparing itself for potential product registration in 2020. I am pleased to be handing the chairmanship over to Per with his extensive US commercial experience for the next stage of the company’s development” said Alan Hulme. Bio: Per Wold-Olsen Per Wold-Olsen is a Norwegian citizen born in 1947. Per joined the pharmaceutical company Merck & Co Inc. (Merck Sharp & Dohme) in 1974. He has served as Managing Director of the Norwegian subsidiary, Vice President of the Scandinavian region and as Senior Vice President of Worldwide Human Health Marketing and President of Europe and the Intercontinental Region of Merck & Co. Inc. US. He was a member of the Management Committee during the year from 1994 to 2006. Per is chairman of the board of directors of GN Store Nord A/S and of MMV (Medicines for Malaria Venture). He also serves as board member of Gilead Sciences, Inc. Per holds a MBA. in Economics and Administration from Handelshøyskolen BI and a MBA. in Management and Marketing from the University of Wisconsin. Bio: Brian Stuglik Brian Stuglik is a US citizen born in 1959. Brian is the founder of Proventus Health Solutions Inc. and has over three decades of extensive experience in US and international pharmaceutical development, product strategy, and commercialization, with over 25 years of experience in the field of oncology. Proventus Health Solutions helps biotech companies integrate development and commercial considerations into a unified approach, leading to a successful launch and commercialization. Prior to Proventus, Brian served as Vice President and Chief Marketing Officer for the Oncology Global Marketing Division at Eli Lilly and Company until 2016. Brian was instrumental in developing the Oncology division of Eli Lilly and Company with the launch of GEMZAR and had subsequent success in developing and launching several other products, including ALIMTA, ERBITUX, and CYRAMZA. In addition, Brian has extensive experience in early drug development, new product planning and business development. Brian earned his Bachelor of Science in Pharmacy from Purdue University and holds memberships of the American Society of Clinical Oncology, the American Association for Cancer Research, and the International Association for the Study of Lung Cancer. Brian also serves on the Board of Directors and Compensation Committee for Verastem, Inc. (NASDAQ: VSTM). For further information, please contact or visit www.oncopeptides.se: Jakob Lindberg, CEO of OncopeptidesCell phone: +46 705 695 471E-mail: jakob.lindberg@oncopeptides.se  Rein Piir, Head of Investor Relations at OncopeptidesCell phone. +46 708 537 292E-mail: rein.piir@oncopeptides.se The information was submitted through the agency of the contact person above for publication at 09.00 CET on April 18th, 2018.  About Oncopeptides Oncopeptides is a research and development stage pharmaceutical company developing drugs for the treatment of cancer. Since the founding of the company, the focus has primarily been on the development of the lead product candidate Ygalo®, an innovative, peptidase-potentiated alkylator intended for effective and focused treatment of hematological cancers, and in particular multiple myeloma. The current clinical study program of Ygalo® is intended to demonstrate better results from treatment with Ygalo® compared to established alternative drugs for patients with late-stage multiple myeloma. Ygalo® could potentially provide physicians with a new treatment option for patients suffering from this serious disease.

NeuroVive’s KL1333 receives FDA Orphan Drug Designation for treatment of mitochondrial diseases

Orphan drug designation (ODD) will give the KL1333 program extra access to regulatory and scientific advice and interactions at the FDA and may enable a focused development program and speedy approval process. ODD opens up for market exclusivity for seven years within US for NeuroVive´s KL1333, when authorised for marketing. “The ODD approval by the US FDA is a validation of the quality of the KL1333 documentation to date and yet an important milestone for NeuroVive and the KL1333 project. The ODD will be beneficial to us in our efforts to rapidly document the effects and safety of KL1333 in genetic mitochondrial diseases and bring this novel treatment opportunity to the market and patients who are in great need of it,” said Erik Kinnman, CEO, NeuroVive. KL1333 has been developed by the South Korean pharmaceutical company Yungjin Pharm and has in pre-clinical models been shown to increase mitochondrial aerobic energy production, while limiting the accumulation of lactate, counteracting the formation of free radicals and lead to other long-term positive effects on energy metabolism such as the formation of new mitochondria. NeuroVive was 2017 granted exclusive rights from Yungjin Pharm to develop and commercialize KL1333 globally, except in Korea and Japan where Yungjin Pharm retains its exclusive rights. The companies will develop KL1333 within their respective territories collaborating closely on an international level to utilize possibilities for synergies. The first clinical phase I study has recently recruited its last healthy volunteer and results are expected by June. NeuroVive plans to start the next clinical phase I multiple ascending dose study in the second half of 2018.           In the EU, Orphan Drug Designation has been obtained for the treatment of the genetic mitochondrial disease: Mitochondrial Myopathy, Encephalopathy, Lactic acidosis and Stroke-like episodes (MELAS). This information is information that NeuroVive Pharmaceutical AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, at 09:15 a.m. CET on 18 April 2018. For more information, please contact: Daniel Schale, Director of Communications, NeuroVive +46 (0)46-275 62 21, ir@neurovive.com NeuroVive Pharmaceutical AB (publ) Medicon Village, SE-223 81 Lund, Sweden Tel: +46 (0)46 275 62 20 (switchboard) info@neurovive.com, www.neurovive.com About KL1333 and the company’s MRCD project portfolio KL1333 is a potent modulator of the cellular levels of NAD+, a central coenzyme in the cell’s energy metabolism. KL1333 has in preclinical models been demonstrated to increase mitochondrial energy output, reduce lactate accumulation, diminish the formation of free radicals, and to have long-term beneficial effects on energy metabolism such as the formation of new mitochondria. It is in clinical development stage intended to document the use for chronic oral treatment in primary genetic mitochondrial disorders such as MELAS, KSS, CPEO, PEO, Pearson and MERRF. Its mode of action is complementary to that of NVP015, which is intended to alleviate acute episodes of energy crises in genetic mitochondrial disorders with dysfunction in respiratory complex I and to NVP025, intended to protect the mitochondria in skeletal muscle from dysfunctional calcium handling and consequential muscle wasting. About NeuroVive  NeuroVive Pharmaceutical AB is a leader in mitochondrial medicine, with one project in clinical phase II development for the prevention of moderate to severe traumatic brain injury (NeuroSTAT®) and one project in clinical phase I (KL1333) for genetic mitochondrial diseases. The R&D portfolio consists of several late stage research programs in areas ranging from genetic mitochondrial disorders to cancer and metabolic diseases such as NASH. The company’s strategy is to advance drugs for rare diseases through clinical development and into the market. The strategy for projects within larger indications outside the core focus area is out-licensing in the preclinical phase. NeuroVive is listed on Nasdaq Stockholm, Sweden (ticker: NVP). The share is also traded on the OTCQX Best Market in the US (OTC: NEVPF).

Invitation to Saab’s Annual Gripen Seminar

The annual Gripen seminar 2018 will be hosted by Jonas Hjelm, head of business area Aeronautics. The seminar will provide a briefing on Gripen and a market outlook from the Saab perspective. Join the seminar in person or online to learn more about why Gripen is known as the smart fighter. Speakers: Jonas Hjelm, head of business area Aeronautics Richard Smith, head of Gripen marketing and sales Mikael Olsson, acting Wing Commander Flying, Gripen test pilot Inga Bergström, sales director Gripen Electronic Warfare Moderator: Ann Wolgers, Press Officer Time: Wednesday, 16 May 2018 at 08.30-10:00 CET (breakfast is served from 8.00). Place: Saab HQ, Olof Palmes gata 17, 5 tr, 111 22 Stockholm. RSVP: To attend in person, please register no later than 14 May 2018 via http://www.cvent.com/d/tgq8j5 Live-stream: The seminar will be live-streamed via http://saab-seminar.creo.se/180516/annual_gripen_seminar_2018 For online participation, registration is not necessary. It will be possible to post questions via the live-stream or twitter using #smartfighter The seminar will be held in English. All presentations, including the online stream, will be published on Saab’s website, saabgroup.com.  For further information, please contact: Saab Press Centre, +46 (0)734 180 018 presscentre@saabgroup.com www.saabgroup.com  www.saabgroup.com/YouTube  Follow us on twitter: @saab  Saab serves the global market with world-leading products, services and solutions within military defence and civil security. Saab has operations and employees on all continents around the world. Through innovative, collaborative and pragmatic thinking, Saab develops, adopts and improves new technology to meet customers’ changing needs. 

Cxense ASA acquires Enreach Solutions OY

Oslo, Norway - 18 April 2018 - Cxense ASA ("Cxense") today announced it has entered into an agreement to acquire the Finnish Data Management Platform (DMP) company Enreach Solutions OY ("Enreach") from Enreach Solutions AB (the "Seller").  The Enreach DMP features audience segmentation and campaign reporting capabilities that are complementary to the Cxense DMP and the Enreach-Cxense technology combination is already deployed and proven in 13 joint customer cases. Enreach and Cxense have worked tightly together in the European market since the companies formed a partnership in the beginning of 2017.  The transaction will enable the companies to capture operational synergies as well as to over time create a more integrated and competitive DMP offering and fuel the Cxense growth capabilities.  The transaction is expected to add EUR 0.177 million (USD 0.22 million) of quarterly revenue, which is a 6% addition to the Cxense Data Management and Personalization revenue segment. The Enterprise Value of EUR 1.875 million* is expected to be adjusted by approximately EUR 1.083 million due to debt held by Enreach Solutions OY. The expected balance, the purchase price, of approximately EUR 0.8 million will settled by issuance of new shares in Cxense at a price of NOK 55 per share (the "Consideration Shares"). The Consideration Shares represent a 1.6% Cxense shareholder dilution.  In addition to the purchase price, the Seller will be entitled to an earn-out of EUR 900,000 if the Cxense share has traded at a volume weighted average higher than NOK 80 for a period of 10 consecutive days within three years after the closing of the transaction and an additional EUR 900,000 if the Cxense share has traded at a volume weighted average higher than NOK 120 for a period of 10 consecutive days within the same period. The earn-out can be settled by Cxense in cash or by Cxense shares (the "Earn-out Shares"), or by a combination of cash and shares, at Cxense’s sole discretion.  The Consideration Shares are subject to a lock-up period, whereby 50% of the Consideration Shares are subject to a lock-up until 30 November 2018 and the remaining 50% are subject to a lock up of 12 months from the date of closing of the transaction. The Earn-out Shares, if any, will be subject to a lock-up period of 6 months from the time of issuance by Cxense.  Consummation of the transaction is subject to customary conditions, including approval of the transaction by the Board of Directors of Cxense. The transaction is expected to be completed during April 2018.  Enreach Solutions was established in 2010 and is led by managing director Kimmo Kiviluoto.The company currently has 10 employees. Enreach Solutions’ current Board of Directors consists of Kimmo Kiviluoto and Brian Jacobs.  The Q1 2018F Enreach EBITDA was EUR -84 thousand. During Q1 and into Q2 Enreach has optimized its organization and cost base and the EBITDA contribution from Enreach in Q2 2018 is expected to be 0.  The following table provides key financial information for Enreach Solutions:  (EUR thousand) Q1 2018F**  FY 2017 Unaudited  FY 2016 Audited  Revenue  274  1,090  1,272  97  292  0  ·  of whichfrom Cxense*** 177  798  1,272  ·  of whichfrom others COGS  123  595  562 OPEX (excl. 235  1,252  1,527 capitalizedOPEX) EBITDA (excl. -84  -757  -817 capitalizedOPEX)  Capitalized 664  770 OPEX**** EBITDA  -93  -47  Cash and cash 5  15 equivalents  Total assets  2,179  2,779 Total equity   203  -252 Total 1,976  3,031 liabilities   *Cxense will acquire 100% of the shares in Enreach from the Seller. The Enterprise Value of EUR 1.875 will, as described above, be adjusted for cash, debt and deviation from a normalized level of net working capital as of closing. The above figures are estimates based on current expectations for cash, debt and working capital level as of closing. Closing of the transaction is expected to happen in the month of April 2018.  19% of the EUR 1.083 million debt has an 18 month payback time and 5% annual interest, while 81% of the loan has a divided 3 and 5 year payback plan and 1% annual interest.  **Forecast made during due diligence. Unaudited and unreconciled.  ***Revenues from Cxense will be eliminated when consolidating Enreach and Cxense. Enreach Revenues from Cxense represents cost in Cxense today and is booked as Cost of Sales.  ****To be decided according to IFRS and Cxense existing principles for capitalization of R&D  In connection with the transaction, Kimmo Kiviluoto and Ville Wettenhovi will enter into new employment agreements with Enreach Solutions and Kimmo will take part in the Cxense leadership team. Other than these agreements, there are no special agreements or arrangements that have been or will be entered into with the directors or executive management of Enreach Solutions or Cxense in connection with the transaction.  Aabø-Evensen & Co Advokatfirma AS (Norway), Merilampi Attorneys Ltd. (Finland) and EY are acting as advisors to Cxense in connection with the transaction.  For further information, please contact:  Jørgen Marius Loeng Chief Financial Officer E-mail: ir@cxense.com Mobile: +47 90 66 00 62 About Cxense:  Cxense helps publishers and marketers across the globe to transform their raw data into their most valuable resource. Cxense's leading Data Management Platform (DMP) with Intelligent Personalization, gives companies unprecedented insight about their individual customers, and enables them to action this insight real-time in all marketing and sales channels. Benefits include increasing digital revenue and user loyalty. Cxense works with brands such as Aeon, Wall Street Journal, Grupo Clarin, NBC Universal, Aller and many more.  Cxense is headquartered in Norway with offices worldwide and the company is listed on the Oslo Stock Exchange with the ticker 'CXENSE.' For more information: www.cxense.com  This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. 

Save the date: Alligator Bioscience to host Capital Markets Day in Stockholm on 29 May 2018

Lund, Sweden, 18 April 2018 – Alligator Bioscience (Nasdaq Stockholm: ATORX), a biotechnology company developing antibody-based pharmaceuticals for tumor-directed immunotherapy, will host a Capital Markets Day in Stockholm on Tuesday 29 May 2018 for investors, analysts and media. The event will provide a detailed update on Alligator’s project pipeline, including a discussion on the future development of immuno-oncology antibodies. The program will start at 2:00 pm CEST, with registration from 1:00 pm CEST and will end with networking at 5:00 pm CEST. The event will take place at GT30, room Turbinen, Grev Turegatan 30 in Stockholm. The event will be conducted in English and there will be a simultaneous live conference call and webcast for those unable to attend in person. The webcast, with presentation slides, will be available to view on Alligator’s website www.alligatorbioscience.com  and a recording will be made available shortly after the event. If you wish to register for the event, please send an email to anmalan@alligatorbioscience.com with the subject “CMD 29 May”. For further information, please contact:Cecilia Hofvander, Director Investor Relations & CommunicationsPhone +46 46 286 44 95E-mail: cecilia.hofvander@alligatorbioscience.com  The information was submitted for publication, through the agency of the contact person set out above, at 2:30 p.m. CEST on 18 April 2018. About Alligator BioscienceAlligator Bioscience AB is a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs. Alligator’s growing pipeline includes four lead clinical and pre-clinical drug candidates (ADC-1013, ATOR-1015, ATOR-1017 and ALG.APV-527). ADC-1013 (JNJ-7107) is licensed to Janssen Biotech, Inc., part of J&J, for global development and commercialization. Alligator’s shares are listed on Nasdaq Stockholm (ATORX). The Company is headquartered in Lund, Sweden, and has approximately 50 employees. For more information, please visit www.alligatorbioscience.com .

Lithuanian Competition Authority blocks Rimi Baltic´s acquisition of UAB Palink (IKI)

In October 2017 the Lithuanian Competition Authority gave clearance to Rimi Baltic´s acquisition of UAB Palink, which runs the IKI retail chain, under the condition that 17 specifi[c IKI and Rimi stores be sold prior to completion of the transaction. The authority has now rejected the store divestment proposals. This means that Rimi Baltic will not be able to complete the offer for UAB Palink.  The authority rejects the proposals because they are uncertain of the buyers’ competitiveness and their long term commitment to each store.   -        We are surprised and disappointed by the decision. We have thoroughly scanned the market for every possible buyer. We have filed several different options to the Lithuanian Competition Authority, with four different buyers. These were all pre-approved by a Trustee, that was appointed by the Competition Authority specifically to evaluate the buyers and the agreements, says Per Strömberg, CEO of ICA Gruppen. -        Lithuania continues to be an important market to ICA Gruppen, and we will now go back to our earlier focus on organic growth, says Per Strömberg.   It was in December 2016 that ICA Gruppen, through its subsidiary Rimi Baltic, signed the agreement to acquire UAB Palink, which runs the IKI retail chain with 232 stores in Lithuania. This information is such that ICA Gruppen AB is obligated to make public pursuant to the EU Market Abuse Regulation and the Swedish Securities Market Act. The information was submitted for publication at time14.45 on Wednesday, April 18th2018. For more informationICA Gruppen press service, Telephone number: +46 10 422 52 52 

Presentation of Gränges’ interim report for January-March 2018

Gränges’ interim report for the period January-March 2018 will be published at 07.30 CEST on Thursday, 26 April 2018. Investors, analysts and media are invited to a webcasted conference call on Thursday 26 April 2018, at 10.00 CEST. CEO Johan Menckel and CFO Oskar Hellström will present the report. The webcast will be available on www.granges.com/investors. To participate in the conference call, please call +46 8 51999355 (Sweden), +44 203 1940550 (United Kingdom) or +1 8552692605 (United States). Call a few minutes before the conference call begins. A presentation will be available on the Company’s web site before the webcast begins.  For further information, please contact:Pernilla Grennfelt, SVP Communications & Investor Relations pernilla.grennfelt@granges.com, tel: +46 702 90 99 55 About GrängesGränges is a leading global supplier of rolled aluminium products for heat exchanger applications and other niche markets. In materials for brazed heat exchangers Gränges is the global leader with a market share of approximately 20 per cent. The company develops, produces and markets advanced materials that enhance efficiency in the customer manufacturing process and the performance of the final products; brazed heat exchangers. The company’s geographical markets are Europe, Asia and the Americas. Its production facilities are located in Sweden, China and the United States, and have a combined annual capacity of 420,000 metric tonnes. Gränges has some 1,600 employees and net sales of more than SEK 11 billion. The share is listed on Nasdaq Stockholm. More information on Gränges is available at granges.com. 

Instalco acquires Dala Kylmecano

Dala Kylmecano has been active since 1969 and is based in Borlänge, Sweden with approximately 20 employees. The company sells and carries out installations of heat pumps for residential buildings and offers cooling installations for all types of construction projects. In addition, the company has a unit active in dishwashing equipment and installation of medical technology equipment. For the 2016/17 financial year, net sales amounted to approximately SEK 30 million. “With Dala Kylmecano, we strengthen our operations in northern Sweden and increase our expertise in heat pumps and cooling. The company will be a great add-on to our heating and plumbing companies around the city of Borlänge, where we see good possibilities for collaboration and growing the cooling business”, says Johan Larsson, Business Area Manager North at Instalco. The company is owned by four employees who will remain in their respective roles. “Dala Kylmecano has a long history and strong local ties to Borlänge and the Dalarna region, and we are excited to take the next step in our development together with Instalco. To become part of a greater whole gives us further opportunities to grow and we look forward to collaborating with the other companies in the group”, says Christina Sonesson, CEO of Dala Kylmecano. Instalco acquires 100% of Dala Kylmecano, with immediate completion. For more informationAdrian Westman, Head of Investor Relationsphone +46 73 509 04 00, e-mail adrian.westman@instalco.se  Instalco is one of the leading installation companies in the Nordic region, active in the areas of heating, plumbing, electricity, cooling and industrial solutions. We work closely with customers, offering all the advantages of a local company, along with efficient collaboration and leadership. The operations are conducted through approximately 40 leading and highly specialised local companies, with the support of a small central organisation. Instalco is listed at Nasdaq Stockholm under the ticker INSTAL. For further information, visit www.instalco.se.

Evolution Gaming: Interim report January-March 2018

First quarter of 2018 (Q1 2017) · Operating revenues increased by 30% to EUR 51.6 MEUR (39.7) · EBITDA increased by 29% to EUR 22.0 million (17.0), corresponding to a margin of 42.6% (42.9) · Profit for the period amounted to EUR 16.5 million (12.7) · Earnings per share amounted to EUR 0.46 (0.35) Events during the first quarter of 2018 · Investments in studios and game innovation · New production hub in Georgia completed · Continued high demand for Live Casino in Europe and globally Comments from CEO Martin Carlesund:Overall, the first quarter of 2018 has been characterised by growth and profitability in line with our expectations, considering the ongoing investments in both new studios and games. We noted a clearly stronger performance at the end of the period, with good growth and earnings, compared with the beginning of the period. Revenues in the quarter amounted to EUR 51.6 million, corresponding to a 30 percent increase compared with the first quarter of 2017. EBITDA amounted to EUR 22.0 million, with a margin of 43 percent. For the full-year, we expect profitability to be in line with the level achieved in 2017, with some fluctuation, both up and down, from quarter to quarter. During the quarter, we have continued our efforts in product innovation and providing an unparalleled end user experience, in combination with cost-efficient operational excellence, in order to further increase our lead over our competitors. Among other activities, we have launched Lightning Roulette and RNG Roulette. During its beta test period, Lightning Roulette has been widely appreciated by end users, and we have good expectations for its development as it is launched by an increasing number of operators during the year. In addition, we have started to roll out the RNG product, for which we also have high expectations for the long-term, despite the niche comprising a smaller share of the market. During ICE in February, we launched a total of seven new products that strengthen our leading position in the market. In parallel with the strengthening of our product offering, we have worked intensively with the completion of our third European production hub in Tbilisi, Georgia. We went live with the first tables in the beginning of April. The new Live Casino studio is the most advanced we have built to date, offering state-of-the-art technology as well as extended possibilities for our customers to optimise their client offerings through dedicated solutions. The studio has the capacity to accommodate our growth for the next two to three years. I am very proud of how quickly and efficiently the organisation has delivered on this project. I would also like to highlight our new studio in Canada, which is also our first studio outside of Europe. Launched in February, it serves customers of the British Columbia Lottery Corporation with ten tables and five games. The studio is the first licensed Live Casino facility in the regulated Canadian market. We have seen a strong start for our offering, even though the target market of British Columbia comprises a relatively small part of Canada. In terms of the general market development, we observe continued high demand for Live Casino both on the European level as well as globally. We are seeing a notably higher interest in the Asian markets among European licensed operators, which is positive and will become another growth driver going forward. As a B2B provider, our geographic exposure is primarily driven by which markets our customers choose to address, resulting in a high degree of geographical diversification. The United Kingdom is currently our largest market. The size of the market is mostly determined by a combination of population size and how different operators address the market. We rigorously ensure that all operators we add are properly licensed and comply with the requirements of each regulator. In conclusion, we have experienced a good start to the second quarter with increasing activity among our customers, and preparations ahead of the FIFA World Cup 2018 are in full swing. We have a very intensive period ahead of us with many tables to be delivered and go live. With extended studio capacity and new and upcoming game launches, we are increasing our lead over our competitors. It is our assessment that we have further increased market share over the last 12 months, and we see good conditions for continuing to strengthen our market leadership. Presentation for investors, analysts and mediaCEO Martin Carlesund and CFO Jacob Kaplan will present the report and answer questions on Thursday, 19 April 2018 at 09:00 a.m. CET via a telephone conference. The presentation will be in English and can also be followed online. Number for participation by telephone: +46 8 566 42 662. Follow the presentation at https://tv.streamfabriken.com/evolution-gaming-group-q1-2018. For further information, please contact CFO Jacob Kaplan, +46 708 62 33 94, ir@evolutiongaming.com. This information is such that Evolution Gaming Group AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, under the agency of the contact person set out above, on 19 April 2018, at 7.30 am CET.

BASWARE INTERIM REPORT JANUARY 1 – MARCH 31, 2018 (IFRS)

Basware Corporation, stock exchange release, April 19, 2018, 8.45am BASWARE INTERIM REPORT JANUARY 1 – MARCH 31, 2018 (IFRS) Divestments accelerate cloud transitionJanuary-March 2018: · Net sales EUR 35 969 thousand (EUR 36 810 thousand): decrease of 2.3 percent, organic growth at constant currencies 5.3 percent · Organic cloud revenue growth at constant currencies 18.4 percent, amounting to 59.3 percent (51.4 %) of net sales · Adjusted EBITDA EUR 12 thousand (EUR -1 593 thousand) · Adjusted operating profit/loss EUR -2 618 thousand (EUR -4 185 thousand) · Adjusted earnings per share (diluted) EUR -0.60 (-0.31) · Operating profit/loss EUR 12 495 thousand (EUR -5 084 thousand) · Earnings per share (diluted) EUR 0.45 (-0.37) Basware is the global leader in providing networked source-to-pay, e-invoicing and value-added services. Basware’s key strategic priority for the strategy period 2017-2020 is cloud revenue growth. The company continues to strengthen its leading market position in order to grow cloud revenue. For 2018 Basware expects the following on an organic basis at constant currencies: · Cloud revenues to be between EUR 90 and 95 million · Total costs excluding amortization, depreciation and adjustments to be slightly above 2017 levels  Basware has adopted IFRS 15 Revenue from Contracts with Customers as of January 1, 2018 (mandatory application), with full retrospective application. In connection with the IFRS 15 application, the Group has also made certain changes to revenue allocation between Cloud and Non-cloud. Comparatives for 2017 presented in the interim report have been updated to include IFRS 15 restatements and revenue reallocations. GROUP KEY FIGURES 1-3/  1-3/  Change,   1-12/ EUR thousand  2018  2017  %  2017 Net sales  35 969  36 810  -2.3 %  149 167 Cloud revenue  21 343  18 917  12.8 %  80 332 ARR order intake  2 742  2 506  9.4 %  11 246  EBITDA  15 125  -2 491  599 Adjusted EBITDA  12  -1 593  3 294 Operating 12 495  -5 084  -9 509 profit/loss Adjusted operating -2 618  -4 185  37.5 %  -6 814 profit/loss  Profit/loss before 11 741  -6 077  -12 276 tax Profit/loss for the 6 416  -6 371  -11 524 period  Cash and cash 54 183  32 281  67.8 %  20 683 equivalents  Earnings   per share Diluted, EUR  0.45  -0.37  -0.80 Adjusted earnings per -0.60  -0.31  -93.7 %  -0.61 share, diluted, EUR  CEO Vesa Tykkyläinen:As both a shareholder and the CEO of Basware, I am pleased with the progress we made in the first quarter towards executing Basware’s cloud transformation strategy. We completed the divestment of two non-core businesses whilst at the same time continuing to win new customers and transform existing customers to our cloud solutions, and to release innovative new solutions to our customers. Basware’s strategic priority is to grow our cloud business. In the first quarter, Basware’s cloud revenues accounted for 59% of total revenues, up from 51% in the first quarter of 2017. In February we announced the sale of two predominantly non-cloud Finland based businesses, Financial Performance Solutions and Banking. The divestments are important because they enable us to fully focus our attention on our global cloud based strategy. We continued to win great new customers including Healthe Care and Access Information. In addition we continued to transform existing customers including Scania, Fiskars and Sopra Steria to our cloud solutions. Our subscription order intake growth rate was however lower than anticipated this quarter, driven by longer than expected deal closing cycles, particularly in the US and the UK. The first quarter is always seasonally slower for order intake than other quarters. Driving revenue growth through partner sales is an area of focus for Basware and in the first quarter we saw an increase in the proportion of order intake from partners. New partnerships announced in the quarter included an agreement that makes Basware’s network available to Salesforce, and an agreement with cloud ERP provider QAD. Basware is an industry leader in the field of networked source-to-pay solutions and we continued to deliver innovative new data-based solutions for our customers. In the first quarter we announced #Superfinance, our approach to strengthening the abilities of today’s procurement and finance professionals to utilize big data, predictive analytics and artificial intelligence. Other new innovations included an enhanced supplier dashboard, which enables buyer customers to use advanced analytics to further reduce costs and increase value of their supplier base, and a partnership with Dun & Bradstreet to enrich supplier data. In the first quarter two new members joined Basware’s Board of Directors and bring with them a wealth of relevant experience. Daryl Rolley, based in the US, comes to Basware from a broad leadership and sales background, including 8 years at Ariba. Asko Schrey, based in Finland, brings significant leadership and investing experience from the technology and finance sectors. The underlying performance of Basware was solid this quarter, with good organic revenue growth rates after the impact of foreign exchange movements and the announced divestments was accounted for. We continued to execute what we said we would do, and with our clear cloud strategy, I am confident for Basware’s future. FUTURE OUTLOOKOperating environment and market outlook All organisations need to manage their purchasing processes from procurement through to handling invoices and paying them. Currently many organisations only have unsophisticated or partial tools to manage these processes and as a result many are faced with unmanaged spending, inefficient manual and paper-based processes and poor visibility of cashflows. Basware offers a uniquely complete solution for these challenges that is differentiated by the Basware Network, the largest e-invoicing network in the world, and enables customers to manage 100 percent of their spending and make their purchasing processes completely paperless. Basware expects the demand for networked purchase-to-pay services to continue to grow. The total potential market for networked purchase-to-pay services is estimated to be worth EUR 15 billion in annual revenues in Europe and North America. Outlook for 2018 Basware is the global leader in providing networked source-to-pay, e-invoicing and value-added services. Basware’s key strategic priority for the strategy period 2017-2020 is cloud revenue growth. The company continues to strengthen its leading market position in order to grow cloud revenue. Themes affecting cloud revenues in 2018: · SaaS revenues anticipated to continue to grow strongly on an organic basis · Transaction services revenue growth anticipated to accelerate as growth initiatives take effect · Other cloud revenues continue to be impacted by UK public sector revenues · Cloud revenues have a higher proportion of US dollar and Sterling and so are disproportionately affected by foreign exchange movements  Themes affecting non-cloud revenues in 2018: · Maintenance and licence revenues will continue to decline as Basware transitions existing customers to cloud services · Consulting revenues are also affected by the cloud transition and more standardised implementations · Non-cloud revenues are disproportionately affected by the divestments completed in February 2018  For 2018 Basware expects the following on an organic basis at constant currencies: · Cloud revenues to be between EUR 90 and 95 million · Total costs excluding amortization, depreciation and adjustments to be slightly above 2017 levels  Constant currencies means that the effects of any changes in currencies are eliminated by calculating the figures for the period using 2017 exchange rates. Organic means that the figures are adjusted to remove the effects of any acquisitions or disposals within the past 12 months. Espoo, Finland, Wednesday, April 18, 2018 BASWARE CORPORATION Board of Directors Vesa Tykkyläinen, CEO, Basware Corporation For more information, please contact: Niclas Rosenlew, CFO, Basware CorporationTel. +358 50 480 2160, niclas.rosenlew@basware.comDistribution: Nasdaq HelsinkiKey mediainvestors.basware.com Basware interim report Q1 2018 

Swedish crowdfunding platform FundedByMe will attract foreign investors for Polish startups

One of the fastest-growing crowdfunding giants, FundedByMe sets up their newest branch in Poland. The platform had successfully collected more than €50 million for some 470 companies from 25 different countries. The launch of the Polish office was announced on 17 April at Google Campus in Warsaw marking the fifth time that FundedByMe has expanded to an international location. In Poland, it is the first foreign platform that offers capital through equity crowdfunding from an expanding network of more than 110.000 investors. "Within the first year, we want to show the most innovative startups with great potential, which are ready to expand globally. We want to build a bridge between the experienced Swedish investment market and Polish startups and investors." says Maciej Gajewski, CEO and co-founder of FundedByMe Poland, whose previous credits include project management at the MIT Enterprise Forum Startup Accelerator. FundedByMe aims at startups from Poland that generate revenues and are seeking to raise up to €1 million in Sweden and other countries. FundedByMe founders have high hopes for the Polish market due to the quality of technology startups and a startup-friendly ecosystem. "We believe in cross-border investments helping innovative startups expand across all borders more easily. Polish entrepreneurs have a reputation of being diligent, meticulous and executive." explains Lovisa Strömsholm, who is responsible for Investor Relations and International Growth at the company. Based in Stockholm, she has so far been responsible for coordinating and launching the crowdfunding concept of FundedByMe to new markets in Europe and Asia. The launch event in Warsaw featured high-profile presentations of Ronald Domelid, Swedish entrepreneur and co-founder of Stonefactory.se, the largest online retailer in its category, as well as Alicja Domelid, founder of Ecoliving and Naturalbox, which raised over €200.000 through FundedByMe. Moreover, three Polish startups that gained international attention showcased their products. Karol Górnowicz, CEO Skriware, a 3D printing startup from Warsaw, presented their newest fully integrated educational ecosystem consisting of robots, e-learning platform and easy-to-use 3D printers. Furthermore, Marcin Maliszewski, co-founder of Blinkee.city, an electric scooter sharing startup, announced their newest battery stations which are going to be deployed around the cities, providing battery recharge and checking the current battery level. In addition, Jakub Olek, co-founder of Hyper Poland, a startup developing the new mode of transportation - Hyperloop that allows people to travel near the speed of sound, mentioned their work on the most innovative logistics solutions. According to Erik Friberg, the Swedish Trade and Invest Council Business Sweden, Sweden is second after the Silicon Valley in terms of global innovation and opportunities for startups. The branch in Poland has been set up in cooperation with local partners through a new joint venture. FundedByMe is one of the only full-service crowdfunding platforms offering capital through equity crowdfunding. The platform has strategically grown into attractive markets in Europe and Asia. Furthermore, it grabbed the top spot in the Alternative Finance category in the First Round of the European Fintech Awards 2017. The public and a panel of judges have chosen FundedByMe as one of most promising European FinTech companies. For more information visit: www.fundedbyme.com. For further information please contact: Maciej Gajewski maciej@fundedbyme.com

Nordic Entertainment Group leadership team appointed

· Appointments follow announcement of proposed split of MTG and listing of Nordic Entertainment Group · Reflects ambition to develop and invest in Nordic Entertainment Group’s fully integrated broadcasting, digital communication and content production capabilities Following the announcement of the process to initiate a split of MTG  into two companies, MTG and Nordic Entertainment Group, the Nordic Entertainment Group leadership team has now been established. All Group leadership team members will report in to Anders Jensen, the President and CEO of Nordic Entertainment Group. Nordic Entertainment Group will comprise MTG’s current Nordic Entertainment and MTG Studios business segments, as well as Splay Networks. This unique entertainment ecosystem includes the Viasat pay-TV operations, the Viaplay and Viafree streaming services, MTG’s free-TV channels and radio stations, 30 production companies and Splay’s social video and influencer networks. Anders Jensen, currently MTG Executive Vice President and CEO of Nordic Entertainment and future President and CEO of Nordic Entertainment Group: “These talented and committed leaders have the skills, experience and attitude required to realise our high ambitions for Nordic Entertainment Group. We are ensuring continuity in our country organisations and central functions, while driving even clearer commercial alignment across the business with the new Group Chief Commercial Officer role. This Group is a one of its kind in the media space and we are setting the organisation right in order to be able to deliver the most engaging experiences for all of our stakeholders.” The Group leadership team for Nordic Entertainment Group will be as follows, effective 1 July 2018: · Kim Poder, EVP, Group Chief Commercial Officer (CCO), CEO Denmark. As Group CCO, Kim Poder will be responsible for driving Nordic Entertainment Group’s commercial strategy and execution. Kim Poder  is currently CEO of MTG Denmark. · Matthew Hooper, EVP, Group Head of Corporate Affairs (including responsibility for Investor Relations), CEO UK. As CEO UK with immediate effect, Matthew Hooper will be responsible for the management of MTG’s and subsequently Nordic Entertainment Group’s UK based operations. Matthew Hooper  is currently MTG EVP and Group Head of Corporate Communications. · Gabriel Catrina, EVP, Group Chief Strategy Officer and Head of M&A. Gabriel Catrina  is currently MTG Chief Strategy Officer. · Jakob Mejlhede, EVP, Group Head of Content. Jakob Mejlhede  is currently MTG EVP and Head of Programming and Content Development. · Morten Aass, SVP, CEO Norway. Morten Aass  is currently CEO of MTG Norway. · Mathias Norrback, SVP, CEO Finland. Mathias Norrback  is currently CEO of Viasat Finland. · Morten Mogensen will continue in his current role of CEO  of nice entertainment group. · Alexander Bastin, SVP, Head of Viaplay and Viafree. Alexander Bastin is currently MTG SVP and Head of Viaplay and Viafree. · Susan Gustafsson, SVP, Group General Counsel. Susan Gustafsson is currently MTG Group General Counsel. · Kaj af Kleen, SVP, Group Chief Technology and Product Officer. As Group Chief Technology and Product Officer, Kaj af Kleen will be responsible for driving the Group’s continued leadership in product, design, data and technology across all platforms. Kaj af Kleen is currently MTG SVP and Head of Technology for Viaplay and Viafree. · Kim Mikkelsen, SVP, Group Head of Sport. Kim Mikkelsen is currently MTG Denmark Head of Sport. Peter Nørrelund, currently MTG EVP and CEO of MTG Sport, will be an advisor to the President and CEO of Nordic Entertainment Group, focusing on the company’s sports rights portfolio. Peter Nørrelund will also continue as MTG EVP after the company split. · Jennie Jacobs, SVP, Group and UK Head of Human Resources. Jennie Jacobs is currently MTG UK Head of Human Resources. As previously announced , Filippa Wallestam has been appointed MTG SVP and CEO of Sweden and the future SVP and CEO of Nordic Entertainment Group Sweden. The recruitment of the Chief Financial Officer for Nordic Entertainment Group, as well as for certain leadership positions for the remaining MTG, is ongoing. The Board of Directors of Nordic Entertainment Group will also be announced in due course. About the split of MTG On 23 March 2018 it was announced that the Board of Directors of MTG has decided to initiate a process to split MTG into two companies – Modern Times Group MTG AB and Nordic Entertainment Group – by distributing all the shares in Nordic Entertainment Group to MTG’s shareholders, and listing these shares on Nasdaq Stockholm. The Board intends to propose the distribution and listing of the shares at an Extraordinary General Meeting of its shareholders during the second half of 2018. The Board’s final proposal will be subject to the previously announced combination of MTG’s Nordic Entertainment and MTG Studios businesses with TDC Group not being completed. More information about the split can be found here . **** NOTES TO EDITORS MTG (Modern Times Group MTG AB (publ)) is a leading international digital entertainment group and we are shaping the future of entertainment by connecting consumers with the content that they love in as many ways as possible. Our brands span TV, radio and next generation entertainment experiences in esports, digital video content and online gaming. Born in Sweden, our shares are listed on Nasdaq Stockholm (‘MTGA’ and ‘MTGB’). Contact us:press@mtg.com (or Tobias Gyhlénius, Head of Public Relations; +46 73 699 27 09)investors@mtg.com (or Stefan Lycke, Head of Investor Relations; +46 73 699 27 14) Download high-resolution photos: Flickr Follow us:mtg.com  / Facebook  / Twitter  / LinkedIn  / Instagram  / YouTube 

Tobii’s Business Unit President Oscar Werner to become CEO of CLX Communications

Oscar Werner will move on from his position as President of the business unit Tobii Tech after eight years at Tobii, as he has accepted the opportunity to become CEO of CLX Communications AB, a Swedish publicly listed company.  “Oscar has been a key driver to Tobii’s success, both as president of Tobii Dynavox and of Tobii Tech,” said Henrik Eskilsson, CEO of Tobii. “I feel proud that Tobii is producing CEOs of publicly listed companies – it’s a testimony to our depth of talent and strong company culture. I would like to thank Oscar for his many and passionate years at Tobii and wish him all the best of luck in his future role.” “In the past year, Tobii has announced collaborations with global technology leaders including Microsoft, Qualcomm and Dell. We are also seeing very large demand for our technology in VR and AR and are working with major OEMs to make eye tracking foundational to the next generation devices. Tobii has significant momentum right now, which makes my decision bittersweet,” said Oscar Werner. “I am very proud to have been a part of Tobii for nearly a decade and I would like to thank all of my amazing colleagues for your enthusiasm and commitment. I am absolutely convinced that Tobii is ready for mass markets and that very exciting times are ahead of us.” Oscar Werner joined Tobii in 2010 as President of Tobii Dynavox. He assumed his current role as President of Tobii Tech in 2014. Oscar Werner will remain as Business Unit President of Tobii Tech until August 2018, and Tobii has initiated the search for his replacement. In the interim, Henrik Eskilsson will step in and serve as President of Tobii Tech, in parallel with his role as CEO. This information is information that Tobii AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, on April 19, 2018, at 8:20 a.m. CET. 

Precise BioMatch™ Mobile deployed in Huawei Honor 10, integrated with under-glass sensor

”We are pleased to provide Precise BioMatch Mobile to Huawei Honor 10 and supporting Qualcomm Technologies with the first commercial implementation of their new generation ultrasonic fingerprint solutions”, said Torgny Hellström, Executive Chairman of the Board of Directors at Precise Biometrics. “The design of mobile phones in the higher price segments is increasingly moving towards displays that cover the entire front side. This is an important first step in commercializing our products for under display fingerprint solutions”, said Torgny Hellström. For this deployment, Precise BioMatch Mobile has been integrated with Qualcomm Fingerprint Sensor under Glass. Honor 10 was launched today and is Huawei’s latest phone in the Honor series. For more information and availability, visit https://consumer.huawei.com/en/. Qualcomm Fingerprint Sensors were designed to support sleeker handset designs for mobile phones, while being able to scan through up to 800um of cover glass, a common thickness for displays. As well, they offer the added value of enhanced mobile security authentication. For further information about Precise BioMatch Mobile, please visit https://precisebiometrics.com/products/fingerprint-recognition-software/smartphone-tablet/ This information is information that Precise Biometrics AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, at 9.30 CEST on April 19, 2018.  FOR FURTHER INFORMATION, PLEASE CONTACTTorgny Hellström, Chairman of the BoardTelephone: +46 733 45 13 00E-mail: torgny.hellstrom@precisebiometrics.com (hakan.persson@precisebiometrics.com) ABOUT PRECISE BIOMETRICSPrecise Biometrics is a market-leading supplier of solutions for convenient and secure authentication of people’s identity. We develop and sell fingerprint software that provide the market’s best user experience and security. Our solutions are used hundreds of millions of times every day by people all over the world and are marketed together with strong business partners. For more information, please visit https://precisebiometrics.com Follow us on LinkedIn  and Twitter . Qualcomm is a trademark of Qualcomm Incorporated, registered in the United States and other countries. Qualcomm Fingerprint Sensors are products of Qualcomm Technologies, Inc. and/or its subsidiaries.

Invitation – Presentation of Sobi’s Q1 2018 results

On 26 April, at 08:00 CET, Swedish Orphan Biovitrum AB (publ)  (Sobi™) will publish its report for the first quarter 2018. Financial analysts and media are invited to participate in a telephone conference, which will include a presentation of the results, on the same day at 14:00 CET. The event will be hosted by Sobi’s CEO and President, Guido Oelkers, and the presentation will be held in English. The presentation can be followed live, or afterwards on www.sobi.com. Slides used in the presentation will be made available on Sobi’s website prior to the telephone conference. To participate in the telephone conference, please call: SE: +46 8 566 42 662 UK: +44 203 008 98 01 US: +1 855 831 5945Click here to go to the live webcast .  After the live event the webcast will be available on-demand via the same URL. --- About Sobi™Sobi™ is an international speciality healthcare company dedicated to rare diseases. Our vision is to be recognised as a global leader in providing innovative treatments that transform life for individuals with rare diseases. The product portfolio is primarily focused on treatments in Haemophilia and Specialty Care. Partnering in the development and commercialisation of products in specialty care is a key element of our strategy. Sobi has pioneered in biotechnology with world-class capabilities in protein biochemistry and biologics manufacturing. In 2017, Sobi had total revenues of SEK 6.5 billion and approximately 850 employees. The share (STO:SOBI) is listed on Nasdaq Stockholm. More information is available at www.sobi.com. For more information please contact  Media relations Investor relationsLinda Holmström, Senior Jörgen Winroth, ViceCommunications Manager President, Head of Investor Relations+46 708 734 095 +1 347 224 0819, +1 212 579 0506                    linda.holmstrom@sobi.com  jorgen.winroth@sobi.com

Tieto förvärvar svenska säkerhetsföretaget NSEC AB – stärker sin förmåga inom cybersäkerhet

Det nordiska tjänste- och mjukvaruföretaget Tieto har tecknat avtal om att förvärva NSEC AB, ett svenskt säkerhetstjänsteföretag med cirka 30 medarbetare och huvudkontor i Stockholm. Förvärvet utökar Tietos kapacitet inom outsourcade IT-säkerhetsrelaterade tjänster och produkter och stärker bolagets position inom området på den nordiska marknaden. I takt med den allt snabbare digitaliseringen och behovet av mer flexibla affärsmodeller har IT-säkerhet blivit allt viktigare, med krav på ett grundmurat förtroende mellan partners, kunder och slutkonsumenter. Med förvärvet av NSEC AB ökar Tieto sin kapacitet att hjälpa kunder att frigöra sin digitaliseringspotential på ett säkert sätt. En viktig komponent är förmågan att kunna erbjuda ett Security Operations Center med placering i Sverige, en nyckelfaktor för många kunder inom offentlig sektor och som nu blir tillgängligt för alla Tietos kunder. - Vi är en ledande nordisk IT-säkerhetspartner, med målet att förenkla våra kunders digitala tjänster genom flexibla och transparenta cybersäkerhetsmiljöer för olika branscher. Med sina erfarna och kompetenta säkerhetsspecialister är NSEC en pålitlig partner med stabila kundrelationer inom både privat och offentlig sektor. Med denna affär kan vi vidareutveckla Tietos säkerhetserbjudande och tjänsteportfölj i Sverige, säger Markus Melin, chef för Security Services på Tieto. - Det är en spännande möjlighet för samtliga inblandade. Den ökande medvetenheten om säkerhet som en möjliggörare för affärer, den snabbt föränderliga hotbilden samt nya dataskyddsbestämmelser medför att en leverantör ständigt måste ligga i framkant av utvecklingen. Med NSEC kommer Tieto att knyta till sig kompetens dedikerad till ändamålet sedan före millennieskiftet och vi är stolta över att utmärka oss som ledare inom svensk cybersäkerhet. Tieto och NSEC kompletterar varandra på ett unikt sätt, vilket ger våra kunder en efterfrågad blandning av global skala och lokal expertis, säger Kent Magnusson, VD, NSEC. NSEC AB är väl erkänd som aktör på den svenska säkerhetsmarknaden. Förvärvet är ett steg i Tietos strategi att bygga och stärka sin position på den nordiska marknaden, med särskilt fokus på Sverige. För mer information, kontakta: Kia Haring, global kommunikationschef, Tieto, kia.haring (at) tieto.com, +358 40 765 3700 Timo Ahomäki, strategichef, Tieto Security Services, timo.ahomaki (at) tieto.com, +358 40 515 8887 Kent Magnusson, CEO, NSEC AB, kent.magnusson (at) nsec.se, 073 342 96 85 Tieto vill omsätta möjligheterna i den datadrivna världen till livslångt värde för människor, företag och samhället i stort. Vi har som mål att vara förstahandsvalet för kunder som vill förnya sina affärsverksamheter. Vi kombinerar vår mjukvara och våra tjänster med ett starkt driv för innovationssamarbeten och ekosystem. www.tieto.se NSEC AB grundades 1999 och är specialist på IT- och informationssäkerhet. Vårt mål är att hjälpa våra kunder uppnå optimal säkerhet på digitala system och tillgångar, utan att behöva genomföra förändringar som minskar tillgängligheten i daglig användning. Idag är vi marknadsledande inom området och erbjuder kompletta IT-säkerhetslösningar. Vi utför uppdrag i Sverige och i Norden. Våra kunder är några av de mest intressanta företag och organisationer i Sverige. www.nsec.se

Cimco Marine AB have completed a preliminary study of a 3.0-liter turbodiesel engine

– The outcome of the preliminary study is deemed positive and we will shortly move into the next phase, which involves the development of a prototype for practical tests in marine environments, says Cecilia Anderberg, CEO of Cimco Marine.   The preliminary study has been carried out in close collaboration with an expert group from Semcon with extensive experience in marine product marketing.– At Semcon, we have an experienced and competent partner that complements our engineering and development team. Semcon has a long tradition of extensive expertise in engine development for marine applications. The cooperation has worked well, and we’re pleased with the outcome of the preliminary study, says Cecilia Anderberg.   The engine used for the preliminary study is BMW's prestigious 3.0-liter twin turbo diesel engine, that will be modified and adapted for marine professional use.– We have identified what actions are required to enter the next phase. Evaluation and experience from Cimco's existing diesel engine has been a key factor to why the preliminary study was positive and to why we choose to move forward, says Henrik Einarsson, Technical Leading Engineer at Semcon.   A larger and stronger engine is more durable and has a longer life span. Cimco already produces the strongest marine outboard diesel engine on the market today.– Our estimation is that there is a need and demand for even stronger engines among our existing and potential customers, says Cecilia Anderberg.   For further information, please contact:Cecilia Anderberg, CEO Cimco MarineAB, +46 763-10 22 50, cecilia.anderberg@oxe-diesel.comAndreas Blomdahl, Chairman of the Board of Cimco Marine AB, +46 706-28 01 30, andreas.blomdahl@oxe-diesel.comMyron Mahendra, CFO Cimco Marine AB, +46 763-47 59 82, myron.mahendra@oxe-diesel.comLars Sjögrell, Head of Public Relations, Cimco Marine AB, +46 702 69 53 00, lars.sjogrell@perspective.se Certified AdviserVästra Hamnen Corporate Finance AB is Cimco’s Certified Adviser.   Cimco Marine AB (publ) is obligated to make this information public pursuant to the EU Market Abuse Regulation.The information was submitted for publication, through the agency of the contact person set out above, on 19 April 2018 at 11:45 CEST.   Cimco Marine AB (publ) has, after several years of development, constructed the OXE Diesel, the world ́s first diesel outboard engine in the high power segment. OXE Diesel has a unique belt driven propulsion system that allows a hydraulic multi-friction gearbox to be mounted. This means that the engine can handle significantly higher loads than a traditional outboard engine. Cimco’s OXE diesel has a horizontally mounted engine as opposed to a traditional outboard with a vertically mounted engine.   Semcon is an international technology company that develops products based on human needs and behaviors. Semcon works primarily with companies in the automotive, energy and life science industries. Semcon has over 2,000 employees representing a wide range of expert knowledge worldwide. In 2017, the Group had a turnover of 1.8 billion SEK.

Inhalation Sciences appoints Lena Heffler as new CEO

Inhalation Sciences (ISAB) develops instruments that accelerate and facilitate the development of inhaled drugs and lung research. The company’s products are currently in the early commercialization phase. Lena Heffler has been appointed to strengthen the company’s focus on sales and marketing. Lena will succeed present CEO Fredrik Sjövall, who will be proposed as the new Chairman of the Board by the company’s main owner at the next Annual General Meeting on 23 May. Lena will take up her new position on May 7. With an MSc in Biochemistry from Uppsala University and a Licentiate Degree in Clinical Immunology from Karolinska Institutet, Lena Heffler has worked with sales in the life sciences industry for more than 15 years. Her former clients include Agilent, Aerocrine and Addtech. Otto Skolling, Chairman of the Board: "Lena has a strong, clear background in commercialization in life sciences. Commitment, energy and a strong focus on sales were all important cornerstones in the recruitment of our new CEO. We’re confident Lena has all the qualities needed to take Inhalation Sciences to the next level.” Lena Heffler, CEO: "Inhalation Sciences is a company with a unique and very exciting technology platform that has the potential to make a huge difference to inhalation researchers the world over. Right now the company is in an exciting phase, with many customer dialogues ongoing and a commercial breakthrough within reach. I have 15 years of experience selling and marketing products and technologies in the life sciences field. I’m looking forward to transferring those skills to the ongoing job of making PreciseInhale the standard instrument in the world's inhalation labs, and Inhalation Sciences a successful, profitable company."

Nordic Waterproofing has signed an agreement to acquire Veg Tech, a leading supplier of green roofs and multifunctional vegetation systems

Veg Tech was founded in 1987 in Vislanda, Sweden, and has for 30 years helped their customers to create greener and more natural surroundings. The company grows, develops and supplies buildings and cities with multifunctional vegetation systems that contribute to naturally delay the infiltration of rain water, improve water quality and favors and improves biodiversity. The company offers green solutions that create vibrant and sustainable cities for roofs, courtyards & roof gardens, water and soil environments, green facades, etc., and is today a leading supplier to construction companies, property owners and the public sector. Customers throughout the Nordics are provided with a wide range of high-quality plant products such as green roofs and facades, green courtyards and purification of water. The company's production of plants are conducted at four sites in Sweden; two in Vislanda, one in Ljungby, and one in Lagan. Sales offices are located in Stockholm, Gothenburg, Helsingborg, Copenhagen and Oslo. “We are very pleased that we get the opportunity to carry through this acquisition. Veg Tech's solid position in vegetation technology and green roofs is a perfect complement to our existing offering of high quality waterproofing solutions”, says Martin Ellis, President and CEO of Nordic Waterproofing. “Through the acquisition of Veg Tech, Nordic Waterproofing demonstrates and enhances its commitment towards sustainable and environmentally efficient solutions for the building industry”.  "Veg Tech has for many years invested in production capacity and this is a natural step to increase the speed of the development of the company as a market leader within vegetation technology and sustainable construction", says Bengt-Erik Karlberg, CEO of Veg Tech. "We are pleased to get a strong owner with a long-term focus and good understanding of our business, and we see great potential for synergies, primarily in marketing and market expansion but also in product development", Bengt-Erik Karlberg continues. Nordic Waterproofing Holding A/S’s Swedish subsidiary, Nordic Waterproofing Group AB, has signed an agreement to acquire 83 percent of the shares in Veg Tech AB for SEK 129 per share, corresponding to a consideration of SEK 153 m. The acquisition is conditioned upon due diligence, and sellers are the company’s founders, CEO and external investors. The acquisition will be financed by a new bank loan through an extension of Nordic Waterproofing’s current credit facilities. Furthermore, Nordic Waterproofing has committed itself to submit a bid to the minority shareholders to acquire the remaining shares for the same price per share, following the closing of the acquisition of the majority shares. Acquisition-related costs amount to approximately SEK 2 m in the form of consulting fees in connection with the acquisition process, and will affect the income statement during the second quarter of 2018. The acquisition is expected to have a positive effect on Nordic Waterproofing's earnings per share in 2018. This information is such that Nordic Waterproofing Holding A/S is obliged to make it public pursuant to the EU Market Abuse Regulation. The information submitted for publication, through the contact person set out below, on 19 April 2018, at 1.30 p.m. CET.

Elekta and RTsafe sign agreement to distribute personalized stereotactic quality assurance solutions

STOCKHOLM, April 19, 2018 – Elekta (EKTA-B.ST) announced today that it has signed a memorandum of understanding with RTsafe  to distribute innovative, 3D printed pseudo in-vivo phantoms and remote dosimetry services. The agreement with RTsafe will provide cancer centers an elegant quality assurance (QA) solution by elevating confidence in the end-to-end accuracy of stereotactic systems and create wider access to advanced stereotactic treatments for millions of patients. “Worldwide demand for stereotactic treatments are increasing, especially among the 20 to 40 percent of cancer patients who will develop brain metastases. That could be as many as four million individuals needing stereotactic radiosurgery (SRS) per year globally,” said Maurits Wolleswinkel, Head of Portfolio and Chief Strategy Officer at Elekta. “This collaboration aligns well with Elekta’s ongoing mission to simplify the delivery of very complex therapeutic treatment techniques through our leading flagship system Versa HD™  with High definition dynamic radiosurgery (HDRS).” It has been established that SRS provides clear clinical benefits over whole brain radiation therapy* and less conformal modalities. High-dose, stereotactic treatments (SRT/SRS/SBRT) are potent alternatives to surgery for patients with cranial or extra-cranial cancers. However, using these therapies as a routine treatment method has been limited by clinicians’ desire for maximum end-to-end accuracy and confidence to quantify and account for systematic inaccuracies. Together, these can ensure optimal patient safety and treatment effectiveness. RTsafe features the Pseudo-Patients™ line of phantoms that enable radiotherapy departments to obtain accurate end-to-end measurements for stereotactic commissioning. It does this by using a true 3D representation – phantoms using real patient CT data – instead of a single point source measurement. This is particularly important for high-dose, highly focused stereotactic techniques that demand extreme geometric and dosimetric accuracy in all phases of the treatment workflow; from imaging, treatment planning to patient set up, image guidance and treatment delivery. “This agreement is an endorsement of our standing collaboration with Elekta. We have shown how advanced, end-to-end QA procedures play a critical role in the treatment efficiency of HDRS with Versa HD and Monaco® ,” said Dr. Evangelos Pappas, founder and CEO of RTsafe. “Elekta has a versatile, linac-based stereotactic platform powered by HDRS. The trust that Elekta has placed in our RTsafe Quality Assurance approach is a testament to the innovation, determination and dedication of our team. We look forward to implementing this new collaboration with Elekta as we work towards our common goal of safer, more effective stereotactic radiotherapy and radiosurgery treatments for patients globally.”  RTsafe and Elekta recently coordinated a six-center consortium to measure end-to-end accuracy of Elekta’s Versa HD High definition radiosurgery solutions. To view the webinar, click here . Learn more about RTsafe at www.rt-safe.com. * Radiosurgery alone is associated with favorable outcomes for brain metastases from small-cell lung cancer , Robin, Tyler P. et al., Lung Cancer , Volume 120 , 88 - 90 # # # For further information, please contact:Tobias Bülow, Director Financial Communications, Elekta ABTel: +46 722 215 017, e-mail: tobias.bulow@elekta.comTime zone: CET: Central European Time Michelle Joiner, Director, Global Media RelationsTel: +1 770 670 2447, e-mail: michelle.joiner@elekta.comTime zone: ET: Eastern Time About ElektaElekta is proud to be the leading innovator of equipment and software used to improve, prolong and save the lives of people with cancer and brain disorders. Our advanced, effective solutions are created in collaboration with customers, and more than 6,000 hospitals worldwide rely on Elekta technology. Our treatment solutions and oncology informatics portfolios are designed to enhance the delivery of radiation therapy, radiosurgery and brachytherapy, and to drive cost efficiency in clinical workflows. Elekta employs 3,600 people around the world. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm. www.elekta.com

Resolutions at Sweco AB’s annual general meeting and resolution on repurchase and transfer of treasury shares

The Annual General Meeting in Sweco AB on 19 April 2018 passed resolutions on the following: Board of Directors and dividend The annual general meeting resolved, as proposed by the nomination committee, that the Board of Directors shall comprise of eight Directors elected by the general meeting and that no Deputy Directors shall be appointed. The annual general meeting re-elected Gunnel Duveblad, Elaine Grunewald, Johan Hjertonsson, Eva Lindqvist, Johan Nordström, and Christine Wolff and elected Åsa Bergman and Alf Göransson. Johan Nordström was re-elected as the Chairman of the Board of Directors. It was decided to appoint one registered audit firm as auditor and to re-appoint the current auditors, PriceWaterhouseCoopers AB with Michael Bengtsson as chief auditor, up until the conclusion of the annual general meeting 2019. The annual general meeting resolved on fees to the Board of Directors, the Audit Committee, the Remuneration Committee and the auditors in accordance with the proposal of the Nomination Committee. The annual general meeting further resolved on principles for salary and other remuneration to senior executives in accordance with the proposal of the Board of Directors. The annual general meeting resolved, in accordance with the proposal of the Board of Directors, that the shareholders shall receive a dividend of SEK 5.00 per share. The record date is 23 April 2018 and payment is expected to be made on 26 April 2018. The annual general meeting adopted the presented income statements and balance sheets and granted the members of the Board of Directors and the Managing Director discharge from liability for the financial year 2017. The 2018 Share Bonus Scheme The annual general meeting resolved, as proposed by the Board of Directors, to implement the 2018 Share Bonus Scheme. The share bonus scheme covers employees in Sweden on the principally same conditions that applied under 2015 - 2017 Share Bonus Scheme and means that shares are allotted instead of cash bonus. The resolution comprised resolutions on the implementation of the 2018 Share Bonus Scheme as such, as well as several resolutions as a direct result thereof. The scheme includes up to 2,000,000 Class B shares in Sweco (of which not more than 1,500,000 shares for delivery to the participants and not more than 500,000 shares to cover social security contribution costs). The general meeting further resolved to authorize the Board of Directors to transfer up to 1,500,000 Class B treasury shares to employees within the scope of the 2018 Share Bonus Scheme and to sell up to 500,000 Class B shares to secure payment of social security contributions. Sales of Class B shares may be made over Nasdaq Stockholm at a price within the relevant at the time registered price, by which is meant the span between the highest registered purchase price and the lowest registered sales price. Sales of shares may also be made outside Nasdaq Stockholm to a bank or other financial institution, in deviation from the existing shareholders’ pre-emption rights. Such sale may be made at a price corresponding to the registered price range at the stock exchange, with such deviation on market terms that the Board of Directors finds reasonable. The number of shares to which the employee is entitled, corresponds to the earned bonus for the financial year 2018 divided by a base share price, corresponding to the average purchase price weighted by volume for the Class B share during the period 19 March 2018 – 30 March 2018, less the amount corresponding to the dividend per share resolved by the annual general meeting for 2017. The base share price shall be re-calculated in generally accepted manners if events have transpired that affect the share price, such as splits, bonus issues, cancellation and similar during the term of the scheme. The bonus per employee is based on the operational results per employee of the included business units. The maximum bonus per employee is three monthly salaries. Allocation to the employees – which in principle presupposes that the employment has not expired or been terminated – of shares will be made without consideration during the first six months of 2019. The 2018 Share Savings Scheme Further, the annual general meeting resolved, as proposed by the Board of Directors, to implement the 2018 Share Savings Scheme, comprising up to 176,400 Class B shares in Sweco (whereof up to 140,000 shares for allocation to the participants and up to 36,400 shares to cover costs related to social security contributions), on the following main conditions. Up to 100 senior executives and other key personnel will be offered to participate in the 2018 Share Savings Scheme. The 2018 Share Savings Scheme principally corresponds to the share savings scheme decided by the annual general meetings of 2011-2017. Participation in the 2018 Share Savings Scheme requires the participants to acquire Class B shares in Sweco (“Savings Shares”) with their own funds at market rates through Nasdaq Stockholm up to an amount corresponding to 5 to 10 percent of each participant’s fixed annual salary for 2018. If a participant retains ownership to the Savings Shares until the fourth business day following the announcement of the results for the financial year 2021, the participant remains employed on the same, equivalent or higher position in the Sweco group and if the absolute total yield for the Class B share in Sweco is positive during the Retention Period, then each Savings Share entitles the participant to without consideration receive one Class B share in Sweco (“Matching Share”). Provided that certain performance criteria regarding the total yield of the Sweco share set by the Board of Directors are met – the participant is also entitled to receive an additional one to four Class B shares in Sweco (“Performance Shares”). To enable the implementation of the 2018 Share Savings Scheme, the annual general meeting resolved to approve the transfer, without consideration, of up to 140,000 Class B shares to the participants of the 2018 Share Savings Scheme in the period during which they are entitled to receive Matching and Performance Shares. Authorization for the Board of Directors to resolve on acquisitions of treasury shares To enable Sweco to deliver shares under the proposed 2018 Share Bonus Scheme and the 2018 Share Savings Scheme and to cover thereto related costs for social security contributions, as well as enable Sweco to use treasury shares as consideration in, or otherwise finance, potential future company or business acquisitions the 2018 Annual General Meeting resolved to authorize the Board of Directors to resolve on acquisitions of Sweco Class B treasury shares. Up to 2,000,000 Class B shares may be required to ensure Sweco’s obligations under the proposed 2018 Share Bonus Scheme. In order to implement the proposed 2018 Share Savings Scheme, a maximum of 176,400 Class B shares are required. The authorization may be used on one or several occasions up until the next Annual General Meeting. The number of acquired Sweco Class B shares may, together with Sweco shares otherwise acquired and held by Sweco, at any given time not exceed ten (10) percent of all issued shares in Sweco. Acquisitions shall be made over Nasdaq Stockholm. Acquisitions may be made at a price within the relevant registered price range on Nasdaq Stockholm, meaning the spread between the highest purchase price and the lowest selling price prevailing from time to time. Authorization for the Board of Directors to resolve on transfers of treasury shares for the purposes of company or business acquisitions  The 2018 Annual General Meeting also authorized the Board of Directors to resolve on the transfer of Sweco Class B treasury shares for the purposes of company or business acquisitions. The authorization may be used on one or several occasions up until the next Annual General Meeting. Transfers may be undertaken of up to all Sweco Class B shares held by Sweco at the time of the Board of Directors’ resolution, provided, however, that transfers of treasury shares required for the purposes of delivering shares under Sweco’s Share Bonus Schemes and Share Savings Schemes and covering thereto related costs for social security contributions may not be made under this authorization. Transfers may, in deviation from the shareholders’ pre-emptive rights, be carried out outside a regulated market in conjunction with company or business acquisitions. The compensation for transferred shares shall be determined in close proximity to the share price at the time of the transfer, and shall be paid in cash, in kind or by set-off of claims against Sweco. The Board of Directors shall be entitled to determine the other terms and conditions of the transfer, applying the provisions of the Swedish Companies Act. The rationale for the deviation the shareholders’ pre-emptive rights when transferring treasury shares is to enable the financing of company and business acquisitions in a cost-efficient manner. Sale of treasury shares to secure payment of social security contributions related to the 2017 Share Bonus Scheme The annual general meeting resolved to renew the authorization for the Board of Directors to sell Class B treasury shares over Nasdaq Stockholm to secure payment of social security contributions within the scope of the 2017 Share Bonus Scheme, however not more than 500,000 shares. Sales of Class B shares may be made over Nasdaq Stockholm at a price within the relevant registered price range, meaning the spread between the highest purchase price and the lowest selling price prevailing from time to time. Sales of shares may also be made outside Nasdaq Stockholm to a bank or financial institution, in deviation from the existing shareholders’ pre-emption rights. Such sales may be made at a price corresponding to the at the time registered price range at the stock exchange, with such deviation on market terms that the Board of Directors finds reasonable. The authorization may be used on one or more occasions, however no later than prior to the 2019 annual general meeting. Sale of treasury shares within the scope of the 2015 Share Savings Scheme The annual general meeting resolved to authorize the Board of Directors, to resolve on the transfer of Class B treasury shares within the scope of the 2015 Share Savings Scheme. Sales of Series B shares may be made over Nasdaq Stockholm at a price within the relevant registered price range, meaning the spread between the highest purchase price and the lowest selling price prevailing from time to time. The authorization may be used at one or several occasions, however not longer than until the annual general meeting in 2019 and comprise the number of Class B shares required to cover social security contributions under the 2015 Share Savings Scheme, however not more than 10,335 shares. Sale of shares in subsidiary Mecaplan The annual general meeting approved the sale of all of Sweco’s shares in the indirectly owned Finnish subsidiary Sweco Mecaplan Oy, corresponding to 54 percent of all outstanding shares in Mecaplan, to the managing director for an aggregate consideration of EUR 486,000 on market oriented terms. Board resolutions on the repurchase and sale of treasury shares The Board of Directors decided at the statutory board meeting, as authorized by the annual general meeting, to repurchase up to twelve million (12,000,000) Class B treasury shares to deliver under the 2018 Share Bonus Scheme, the 2018 Share Savings Scheme, to cover thereto related costs for social security contributions, and to enable Sweco to use treasury shares as consideration in, or otherwise finance, potential future company or business acquisitions. Acquisitions shall be made over Nasdaq Stockholm. Acquisitions may be made at a price within the relevant registered price range on Nasdaq Stockholm, meaning the spread between the highest purchase price and the lowest selling price prevailing from time to time.  The Board of Directors decided at the statutory board meeting, as authorized by the annual general meeting, to sell not more than 500,000 Class B treasury shares to cover the related costs for social security contributions for the 2018 Share Bonus Scheme. The Board of Directors also decided, as authorized by the annual general meeting, to sell not more than 10,335 Class B shares to cover social security contribution costs for the 2015 Share Savings Scheme. The Board of Directors also decided, as authorized by the annual general meeting, to sell not more than 500,000 Class B shares to secure payments to cover social security contributions for the 2017 Share Bonus Scheme. Sales of Class B shares may be made over Nasdaq Stockholm at a price within the relevant at the time registered price, by which is meant the span between the highest registered purchase price and the lowest registered sales price. Sales of shares may also be made outside Nasdaq Stockholm to a bank or other financial institution, in deviation from the existing shareholders’ pre-emption rights. Such sale may be made at a price corresponding to the registered price range at the stock exchange, with such deviation on market terms that the Board of Directors finds reasonable. Repurchase and sales of Class B treasury shares will be made from 11 May 2018 up until the next annual general meeting, having regard to the restrictions set out by law. Sweco currently holds 3,048,560 treasury shares of which 2,548,560 are Class B shares and 500,000 Class C shares, all together corresponding to 2.5 per cent of the total outstanding number of shares and 1.4 per cent of the votes in the company.

IK sells specialist tourism group Touristry to TGH

Founded in Stockholm in 2011, Touristry quickly gained market share from the incumbent market dominating player. Originally launched as a new brand of “hop on, hop off” buses, Touristry transformed the Nordic tourism sector by unveiling a fleet of modern bright red vehicles equipped with free Wi-Fi and multilingual audio guides. In 2014, the Company further expanded by adding hop-on, hop off sightseeing boats to its offering in Stockholm. Touristry offers an array of tourism services to approximately 2 million customers a year.  In addition to helping cement Touristry’s market leading position in the Nordic region, IK enabled the company to expand into Germany via two add-on acquisitions. Touristy now boasts a presence across Northern European tourist destination cities, including Stockholm, Copenhagen, Helsinki, Tallinn, Riga, and Berlin. Commenting on the sale, Kristian Carlsson Kemppinen, Partner at IK Investment Partners and advisor to the IK Small Cap I Fund said: “Touristry has been a success story and we have greatly enjoyed working with its entrepreneurial team. It has been a pleasure seeing the business grow to new heights. IK remains very interested in supporting management teams and investing in growing and innovative companies across Europe, and helping them to become market leaders like Touristry.”  Micha Gottfarb, founder of Touristry and CEO, commented: “Since our very first meeting, the business relationship with IK has been underpinned by mutual trust and a shared vision. With IK’s help we were able to transform Touristry into a truly international business, with the scale and functionality to grow and sustain our market share. I look forward to building on our success in this next chapter for the company together with our new partner, TGH.” Dirk Lubbers, CEO of TGH, said: “In Touristry we identified a company which had all the ingredients of a great business: innovation, a unique concept, and a product that was widely loved by the market. We look forward to working with Micha and his team to expand Touristry even further and ensure that the European tourism market continues to benefit from the great customer experience Touristry is able to provide. After our very successful expansion in Amsterdam we are thrilled to be able to realise a powerful urban tourism concept abroad. And as a result of our first foreign acquisition, I am proud to announce our new name; Tourism Group International.”

Telia Company Interim report January-March 2018

First quarter summary · Net sales in local currencies, excluding acquisitions and disposals, increased 0.2 percent. In reported currency, net sales rose 3.2 percent to SEK 19,852 million (19,227). Service revenues in local currencies, excluding acquisitions and disposals, decreased 0.9 percent. · Adjusted EBITDA rose 4.2 percent in local currencies, excluding acquisitions and disposals. In reported currency, adjusted EBITDA rose 7.4 percent to SEK 6,495 million (6,049) due to organic growth, positive net impact from acquisitions and disposals and foreign exchange rate impact. The adjusted EBITDA margin improved to 32.7 percent (31.5). · Adjusted operating income fell 3.2 percent to SEK 3,588 million (3,706). · Total net income fell to SEK -600 million (7,054) mainly due to the disposals of Azercell and Geocell (resulting in capital losses and lower net income contribution), and an impairment charge related to Ucell. The devaluation in Uzbekistan in the third quarter of 2017 had also a negative impact in the first quarter of 2018, while the first quarter of 2017 included a positive effect from the adjustment of the provision regarding the Uzbekistan investigations. These also affected Total net income attributable to the owners of the parent that fell to SEK -710 million (6,894). · Free cash flow in continuing and discontinued operations rose to SEK 4,383 million (4,087). Operational free cash flow in continuing operations increased to SEK 4,256 million (3,937). · The Board of Directors has decided to initiate a share buyback program. The ambition is to buy back shares for an annual amount of SEK 5 billion over the coming three year period. The reason is to return excess cash to shareholders and is a continued effort to optimize the capital structure of the company. · Outlook for 2018 is revised. Comments by Johan Dennelind, President & CEO “Dear shareholders and Telia followers, I am pleased to report that the start of 2018 has been encouraging with strong operational free cash flow generation of SEK 4.3 billion and a 7 percent reported EBITDA growth versus last year. Together with the recent Turkcell dividend decision and Spotify divestment, this is strengthening our balance sheet even further. The Board of Directors has decided to utilize its repurchase mandate given at the recent annual general meeting with the aim to buy back shares equivalent to SEK 5 billion per annum over the coming three year period i.e. in total SEK 15 billion. The rationale is to return excess cash to shareholders and to optimize the capital structure of the company. Combining this with the ordinary dividend policy we believe that we will be offering an attractive total return to our shareholders. In addition, we will still have room to execute disciplined value creative M&A within our Nordic and Baltic strategy. The financial performance in the first quarter of 2018 is strong with further cash flow growth, driven by EBITDA, working capital and cash CAPEX reductions. The service revenue development in Sweden improved, mainly from the mobile consumer segment and a slower deterioration in the enterprise segment. In Finland, service revenues saw a continuous positive contribution from mobile, especially the enterprise segment that has turned the corner. During the summer, our Helsinki data center will open adding further services to our customers and we will start to see the effects of the recently acquired ice hockey rights early autumn. In Norway, the Phonero customers have been successfully migrated and we are leveraging on the synergies, in the quarter approximately SEK 100 million, resulting in a double-digit EBITDA growth. The development in the Baltics continues to be encouraging and a reshaped mobile portfolio in Denmark shows early positive signs. On the 2018 ambition to reduce costs we have completed savings of around SEK 0.2 billion during the first quarter, equivalent to around 20 percent of the total program ambition. This is well in line with our plans and the target of SEK 1.1 billion in net cost reduction for 2018 stands firm. The reshaping of Telia Company continues with further, responsible I want to add, disposals of our Eurasian assets Azercell and Geocell. We have also divested our holding in Spotify, which generated a return of 2.4 times the original investment. We have together with our co-owners in Turkcell Holding agreed on a Turkcell dividend that will bring around SEK 0.9 billion to Telia Company during 2018. In addition, we now also have a seat at the Turkcell board, which is a step forward in restoring ordinary corporate governance. In our annual and sustainability report, we have published our responsible business goals, the progress of the work we do to address the UN Sustainability Development Goals and describe Younite, our employee engagement program. Looking at the remainder of 2018 we have a lot to look forward to and deliver upon. We continue to execute the transformation in Sweden and other markets, which is still holding back our full potential of our customer experience and efficiency agenda. We are tracking our plans and not faltering from our dedication to complete the transformation journey. This journey will be completed to deliver a future proof digital leader – a New Generation Telco. We are also reiterating our EBITDA guidance whilst we slightly change our cash flow guidance, where we now see that we will be above last year’s level (previously “around”).” Johan Dennelind, President and CEO This information is information that Telia Company AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 07.00 CET on April 20, 2018. For more information, please contact our press office +46 771 77 58 30, visit our Newsroom  or follow us on Twitter @Teliacompany  . Forward-Looking StatementsStatements made in the press release relating to future status or circumstances, including future performance and other trend projections are forward-looking statements. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. There can be no assurance that actual results will not differ materially from those expressed or implied by these forward-looking statements due to many factors, many of which are outside the control of Telia Company.  We’re Telia Company, the New Generation Telco. Our approximately 20,000 talented colleagues serve millions of customers every day in one of the world’s most connected regions. With a strong connectivity base, we’re the hub in the digital ecosystem, empowering people, companies and societies to stay in touch with everything that matters 24/7/365 - on their terms. Headquartered in Stockholm, the heart of innovation and technology, we’re set to change the industry and bring the world even closer for our customers. Read more at www.teliacompany.com.

Vattenfall aims for leadership in EV charging infrastructure

"We are continuously developing in order to meet requirements of the new energy landscape and the needs of our customers. Electric vehicles are increasingly popular, thus increasing the need for easy charging solutions. This is the key driver for us and our partners and with the new unit we are putting force behind our ambition to build one of Northwest Europe’s biggest charging networks," says Magnus Hall, Vattenfall's CEO. Vattenfall currently operates EV charging networks in Sweden, Germany and the Netherlands. Vattenfall will now gradually extend the offering for convenient home, business and public charging solutions to new markets, such as the UK, France and Norway. "From now on we expect our charging network to double in size every year in order meet a sharp increase in electric vehicle growth. We aim for a turnover of SEK 1 billion within five years," says Tomas Björnsson, Head of Vattenfall's E-mobility business unit. The new business unit employs some 60 people today and is growing rapidly. In a bid to further promote the usage of electrical vehicles, Vattenfall is currently implementing a program to electrify its fleet of 3,500 vehicles. Those will be replaced with EV:s or hybrid-cars by 2022. Vattenfall's strategy is to be fossil free within one generation. Under the current investment plan, SEK 3 billion has been allocated for the development of new businesses, including charging infrastructure and battery storage. FactsVattenfall currently operates 8.800 charging points in Sweden, the Netherlands and Germany. The InCharge charging network was launched in Sweden in November 2016. It is developed together with cities, businesses, municipalities and local power companies. Read more at www.goincharge.com For further information, please contact:Vattenfall’s Press Office, telephone: +46 (0)8 739 50 10, email: press@vattenfall.com

Ericsson reports first quarter results 2018

First quarter highlights (In 2017, certain items affecting comparability had a significant negative impact on the results.)  · Reported sales decreased by -9% YoY. Sales, adjusted for currency, decreased by -2% YoY with lower revenues in market areas North East Asia as well as in South East Asia, Oceania and India. The other market areas showed growth. · Gross margin was 34.2% (15.7%) 1). Gross margin excluding restructuring charges improved YoY, to 35.9% (18.7%) 1), supported by cost reductions and the continued ramp-up of Ericsson Radio System (ERS). · Operating income (loss) was SEK -0.3 (-11.3) b. Operating income (loss) excluding restructuring charges was SEK 0.9 (-9.5) b. · Networks operating margin excluding restructuring charges was 13.5% (12.8%) 1) with strong gross margin and increased investments in R&D. · Digital Services gross margin excluding restructuring charges improved YoY, to 41.4% (-25.5%) 1), driven by improved services margins as a result of cost reductions. Operating income (loss) excluding restructuring charges was SEK -2.0 (-8.8) b. · Managed Services operating margin excluding restructuring charges was 1.9% (-28.7%) 1) as a result of cost reductions and customer contract reviews. · Cash flow from operating activities was SEK 1.6 (-1.5) b. and free cash flow was SEK 0.3 (-3.2) b. Net cash increased YoY to SEK 35.6 (28.3) b. 1) Write-down of assets as well as provisions and adjustments related to certain customer projects had a significant negative impact on the 2017 results. In addition, a restate of 2016 and 2017 numbers has been made following IFRS 15 introduction. +--------------------------+-----+------+------+------+------+|SEK b. |Q1 |Q1 |YoY |Q4 |QoQ || |2018 |2017 |change|2017 |change|+--------------------------+-----+------+------+------+------+|Net sales |43.4 |47.8 |-9% |57.9 |-25% |+--------------------------+-----+------+------+------+------+|Sales growth adj. for |- |- |-2% |- |-24% ||comparable units and | | | | | ||currency | | | | | |+--------------------------+-----+------+------+------+------+|Gross margin |34.2%|15.7% |- |21.6% |- |+--------------------------+-----+------+------+------+------+|Operating income (loss) |-0.3 |-11.3 |- |-19.3 |- |+--------------------------+-----+------+------+------+------+|Operating margin |-0.7%|-23.6%|- |-33.3%|- |+--------------------------+-----+------+------+------+------+|Net income (loss) |-0.7 |-10.0 |- |-18.5 |- |+--------------------------+-----+------+------+------+------+|EPS diluted, SEK |-0.25|-3.08 |- |-5.63 |- |+--------------------------+-----+------+------+------+------+|EPS (non-IFRS), SEK 1) |0.11 |-2.19 |- |-1.09 |- |+--------------------------+-----+------+------+------+------+|Cash flow from operating |1.6 |-1.5 |- |11.2 |-86% ||activities | | | | | |+--------------------------+-----+------+------+------+------+|Free cash flow 2) |0.3 |-3.2 |- |10.1 |-97% |+--------------------------+-----+------+------+------+------+|Net cash, end of period |35.6 |28.3 |26% |34.7 |3% |+--------------------------+-----+------+------+------+------+|Gross margin excluding |35.9%|18.7% |- |25.1% |- ||restructuring charges | | | | | |+--------------------------+-----+------+------+------+------+|Operating income (loss) |0.9 |-9.5 |- |-16.9 |- ||excluding restructuring | | | | | ||charges | | | | | |+--------------------------+-----+------+------+------+------+|Operating margin excluding|2.0% |-19.9%|- |-29.1%|- ||restructuring charges | | | | | |+--------------------------+-----+------+------+------+------+ 1) EPS diluted, excl. amortizations and write-downs of acquired intangible assets, and excluding restructuring charges. When a company reports a loss, the number of shares used for calculating earnings diluted per share shall be the same as for basic calculation.2) Free cash flow: Cash flow from operating activities less net capital expenditures and other investments, see APMs at the end of the report. Non-IFRS financial measures are reconciled to the most directly reconcilable line items in the financial statements at the end of this report. Comments from Börje Ekholm, President and CEO of Ericsson (NASDAQ:ERIC) We have continued to execute on our focused business strategy creating solutions that help our customers improve their business. Our efforts to improve efficiency in service delivery and common costs are starting to pay off. The gross margin1) improved to 36% (19%) in the quarter, tracking well towards our Group target of 37-39% by 2020. A cornerstone in our strategy is to invest in R&D for both technology leadership and cost leadership, which will allow us to generate higher gross margins. We continue to increase our R&D investments in Networks to lead in 5G. In Digital Services we continue to increase investments into our new cloud-native portfolio as well as changing our ways of working for better R&D efficiency. In Managed Services we continue to focus on machine intelligence, automation and analytics to further enhance user experience, improve efficiency and better manage the increasingly complex networks of tomorrow. In Networks we have seen the portfolio becoming more competitive in the last three quarters of 2017, resulting in market share gains, as reported by external sources. In Networks the gross margin1) improved to 40% (35%). In Digital Services, the gross margin 1) improved to 41% (-25%), supported by cost reductions mainly in service delivery. However, operating income in Digital Services remains challenging. In Managed Services the gross margin1) improved to 9% (-7%) supported by efficiency gains in service delivery and customer contract reviews, resulting in a positive operating income1). In segment Emerging Business and Other, we are gradually increasing investments in growth areas such as IoT and Unified Delivery Network (UDN). While the combined operating income of Media Solutions and Red Bee Media improved YoY, these businesses showed a loss2) of SEK -0.5 b. in the quarter. We expect to close the announced Media Solutions divestment by the end of the third quarter. In the quarter we reduced the total workforce by more than 3,000. Since the reduction activities were launched in July last year, we have reduced the total workforce by almost 18,000. To date, the annual run-rate effect of cost savings is approximately SEK 8.5 b., compared with the target of SEK 10 b. for mid-2018. The run-rate reduction does not yet fully impact the quarterly results. Free cash flow improved to SEK 0.3 (-3.2) b. – another step forward in improving our financial resilience. Net cash was SEK 35.6 (28.3)b. The improvements in the quarter are encouraging. However, more work remains to be done. We have confidence in the strategic direction laid out and remain fully committed to our long-term targets. Looking ahead, we expect the rapidly increasing focus on 5G to continue, with initial business discussions focusing on enhanced mobile broadband. We continue to work closely with customers to define the optimal business models to enable them to tap into new revenue streams and capture the full value of 5G. 1) Excluding restructuring charges2) Excluding restructuring charges and corporate allocations Planning assumptions going forward Market related                                                           · The Radio Access Network (RAN) equipment market is estimated to decline by -2% for full-year 2018 with 2% CAGR (2018-2022). In 2018, the Chinese market is expected to decline due to reduced LTE investments, while there is positive momentum in North America. Currency exposure               · Rule of thumb: A weakening by 10% of USD to SEK would have a negative impact of approximately -5% on net sales and approximately -1 percentage point on operating margin (based on 2017 full-year currency exposure). For historical rates, see www.ericsson.com/en/investors Ericsson related · 5-year average sales seasonality between Q1 and Q2 is +9% · Focusing the business and addressing low-performing operations are expected to reduce full-year sales by up to SEK 10 b. in 2019 compared with 2016. · The current revenue baseline of the IPR licensing contract portfolio is approximately SEK 7 b. on an annual basis. · The plan is to implement cost savings with an annual run-rate effect of at least SEK 10 b. by mid-2018, compared with the Q2 2017 annual run rate. · Operating expenses typically vary between quarters due to seasonality. · Restructuring charges for full-year 2018 are estimated to be SEK 5-7 b and slightly higher in Q2 vs Q1. · Actual and estimated net impact from amortization and capitalization of development expenses and from recognition and deferral of hardware costs:  +-------------+-------+---------+-------+-------+---------+---------+|SEK b.  |Q1 2018|Q2 2018 |Q2 2017|FY 2017|FY 2018 |FY 2019 || |Actual |Estimate |Actual |Actual |Estimate |Estimate |+-------------+-------+---------+-------+-------+---------+---------+|Cost of sales|-0.3 |-0.2 |-0.4 |-2.6 |-1 | |+-------------+-------+---------+-------+-------+---------+---------+|R&D expenses |-0.4 |-0.4 |0.1 |-0.3 |-2 | |+-------------+-------+---------+-------+-------+---------+---------+|Total impact |-0.7 |-0.6 |-0.3 |-2.9 |-3 |-1 to -2 |+-------------+-------+---------+-------+-------+---------+---------+ · The divestment of Media Solutions is expected to be closed by the end of Q3 2018. Results will be reported as share of earnings according to the equity method. Ericsson’s holding will be 49% of the shares. Media Solutions sales were SEK 3.2 b. in 2017. · Consequences of Q1 and Q2 changes in product responsibilities between segments are described in detail in Financial highlights, page 4 in the complete report. NOTES TO EDITORS You find the complete report with tables in the attached PDF or by following this link https://www.ericsson.com/assets/local/investors/documents/financial-reports-and-filings/interim-reports-archive/2018/3month18-en.pdf or on www.ericsson.com/investors The company will hold two identical conference calls for journalists, financial analysts and investors. President and CEO Börje Ekholm and CFO Carl Mellander will comment on the report and take questions. The first conference call will begin at 09:00 CEST (08:00 BST in London, 03:00 EDT in New York and 16:00 JST in Tokyo), and the second at 14:00 CEST (13:00 BST in London, 08:00 EDT in New York and 21:00 JST in Tokyo). To join the conference call, please phone one of the following numbers: Sweden: +46 (0) 8 5664 2651 (Toll-free Sweden: 0200 883685) International/UK: +44 3333 000 804 (Toll-free UK: 0800 358 9473) US: +1 631 913 1422 (Toll-free US: +1 8558 570 686) PIN code: For 09:00 CEST call, 55234216# and for 14:00 CEST call, 61966022# Please call in at least 15 minutes before the conference calls begin. As there are usually a large number of callers, it may take some time before you are connected. A live audio webcast of the conference call will be available at www.ericsson.com/investors and www.ericsson.com/press Replay: Replay of the conference calls will be available from about one hour after each has ended until April 27, 2018. Sweden replay number: +46 (0) 8 519 993 85 International replay number: +44 (0) 333 300 0819 For 09:00 CEST call, 301225218# and for 14:00 CEST call, 301225221# FOR FURTHER INFORMATION, PLEASE CONTACT Contact person Peter Nyquist, Head of Investor RelationsPhone: +46 10 714 64 99E-mail: peter.nyquist@ericsson.com  Additional contacts Helena Norrman, Senior Vice President, Marketing and CommunicationsPhone: +46 10 719 34 72E-mail: media.relations@ericsson.com Investors Åsa Konnbjer, Director, Investor RelationsPhone: +46 10 713 39 28E-mail: asa.konnbjer@ericsson.com Stefan Jelvin, Director, Investor RelationsPhone: +46 10 714 20 39E-mail: stefan.jelvin@ericsson.com  Rikard Tunedal, Director, Investor RelationsPhone: +46 10 714 54 00E-mail: rikard.tunedal@ericsson.com Media Ola Rembe, Vice President, Head of External CommunicationsPhone: +46 10 719 97 27E-mail: media.relations@ericsson.com  Corporate CommunicationsPhone: +46 10 719 69 92E-mail: media.relations@ericsson.com This information is information that Telefonaktiebolaget LM Ericsson is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 07:30 CEST on April 20, 2018.

Report for the first quarter 2018: Continued improvement in earnings, despite temporary headwinds in operations

Comments by the CEO SSAB’s operating profit for Q1 2018 was SEK 916 million, up SEK 214 million compared with Q1 2017. Earnings were also up compared with the prior quarter, however earnings were negatively affected by some operational issues. There was a two weeks production disruption in the blast furnace in Oxelösund that affected SSAB Special Steels. During the quarter, we also had capacity problems in rail transport of slabs which resulted in both output and shipment losses in SSAB Europe. Both issues were resolved by the end of the quarter. Demand is still good in our markets and SSAB’s growth initiatives developed well during the quarter. Customer needs for increasingly lighter and stronger products continue to drive structural growth in SSAB Special Steels, while demand is also supported by cyclical recovery in several segments. SSAB Special Steels’ shipments were 346 thousand tonnes, up 25% compared with Q1 2017 and operating profit increased by SEK 191 million to SEK 434 million. The result was negatively affected by the blast furnace production disruption mentioned above. SSAB Europe's operating profit was SEK 657 million, somewhat lower than in Q1 2017. Demand continued to be at a good level, but SSAB’s shipments were down 4%. This was primarily due to the capacity problems in rail transport mentioned above. Shipments of high-strength steel in the Automotive segment were 11% higher than in Q1 2017. SSAB Americas’ Q1 operating profit rose with SEK 286 million to SEK 129 million. Heavy plate spot prices in North America have risen sharply since November last year. However, contract prices and longer lead times mean a certain delay before these higher prices are reflected in SSAB’s earnings and margins only began to improve towards the end of Q1. The steel tariffs introduced during Q1 have so far had limited impact. During Q1 we presented our conclusions from the pre-feasibility study for the fossil-free steel initiative, HYBRIT, and we are now planning a globally-unique pilot plant for fossil-free steel production in northern Sweden, with the first ground to be taken during the summer. The outlook remains good for 2018. SSAB has strong market positions in our home markets and in our global niches. All in all, we have good opportunities for continued profitable growth and to generate strong cash flow. We have strengthened the balance sheet significantly and the AGM held in April resolved to pay a dividend of SEK 1.00 per share.  Invitation to SSAB’s first quarter 2018 results briefing SSAB invites you to a presentation of the quarterly report at 9.30am CEST on Friday April 20, 2018. The press conference will be held in English and live webcast on SSAB’s website www.ssab.com. It is also possible to participate in the briefing via telephone. Venue and time of briefing: World Trade Center (WTC) Stockholm, Kungsbron 1, Conference room Manhattan, 09.30am CEST. Telephone numbers:+46 8 505 564 74 (Sweden),+44 203 364 5374 (UK),+1 855 753 2230 (USA). Link to webcast: Go to webcast   For further information, please contact:Investor Relations: Per Hillström, Head of IR,per.hillstrom@ssab.com, +46 70 2952 912  Media: Viktoria Karsberg, Head of Corporate Communications,viktoria.karsberg@ssab.com, +46 8 454 5734 This information is inside information that SSAB AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 7.30am CEST on April 20, 2018.

Tele2 – Sweden’s most energy efficient operator

Mobile networks are currently experiencing an exponential growth in traffic volumes in connection to increased use of data and the launch of new solutions. While technical services create opportunities for reducing carbon dioxide emissions in the world, they also contribute to increased pressure on networks and, thereby, larger energy use. Tele2 sees it as its responsibility to continuously find ways to make its operations more energy efficient. In the beginning of 2017, Tele2 initiated a solution together with Telenor in its shared 4G-network where the base station power amplifier was turned off when the customers did not use it. One year later, the initiative has saved about 2,3 million kWh which corresponds to the electricity use a BMW i3 would need to drive around the world 380 times. Tele2 is now continuing to assess if smaller changes in the networks can contribute to large energy savings for a greener world.  Sweden’s most energy efficient networkWith information from annual reports and key figures from Post- och Telestyrelsen (the National Post and Telecom Agency) Tele2 can conclude that it has Sweden's most energy-efficient network. The biggest contributing factor is that Tele2 share all its network infrastructure with other operators. Tele2 is also, as the only operator in the countries it operates in, a part of the international initiative SooGreen, which is supported by Vinnova and aims to create a greener telecom industry. “If you compare the energy use per customer, Tele2 is well ahead of its competitors and is thereby the most energy efficient operator in Sweden. Our shared networks allow both expansion and operation to be more cost effective and resource efficient, which benefit both consumers and the environment. But we do not stop there and constantly try to find new initiatives to make the environment a friendly place for the next generations. These initiatives are great examples of that”, says Samuel Skott, CEO of Tele2 Sweden. See previous press release here. Read more about Tele2’s efforts for the environment here.  For more information, please contact:Angelica Gustafsson, Head of Public Relations, Tele2 AB, Phone: +46 704 26 41 42Louise Ekman, Head of Press Relations, Tele2 Sweden, tel: +46 705 22 21 17Erik Strandin Pers, Head of Investor Relations, Tele2 AB, Phone: +46 733 41 41 88 TELE2’S MISSION IS TO FEARLESSLY LIBERATE PEOPLE TO LIVE A MORE CONNECTED LIFE. We believe the connected life is a better life, and so our aim is to make connectivity increasingly accessible to our customers, no matter where or when they need it. Ever since Jan Stenbeck founded the company in 1993, it has been a tough challenger to the former government monopolies and other established providers. Tele2 offers mobile services, fixed broadband and telephony, data network services, content services and global IoT solutions. Every day our 17 million customers across 8 countries enjoy a fast and wireless experience through our award winning networks. Tele2 has been listed on the NASDAQ OMX Stockholm since 1996. In 2017, Tele2 had net sales of SEK 25 billion and reported an EBITDA of SEK 6.4 billion. For definitions of measures, please see the last pages of the Annual Report 2017. Follow @Tele2group on Twitter for the latest updates

Interim report for 1 January – 31 March 2018

FIRST QUARTER[1] · Net sales increased by 2 percent to SEK 716.1 (705.3) million  · Gross profit amounted to SEK 135.3 (140.1) million  · Operating income before depreciation, amortization and impairment was SEK -42.7 (-2.7) million  · Operating income amounted to SEK -58.8 (-19.4) million  · Profit after tax including discontinued operations amounted to SEK 91.0 (-22.9) million  · Basic earnings per share including discontinued operations amounted to SEK 0.61 (-0.15)  · Diluted earnings per share including discontinued operations amounted to SEK 0.60 (-0.15)   · Cash and cash equivalents increased to SEK 601.9 (156.9) million at the end of the quarter +---------------------------------------------------------+--------+--------+|SEK million  | 2018| 2017|| |Jan-Mar |Jan-Mar |+---------------------------------------------------------+--------+--------+|Net sales  | 716.1| 705.3|+---------------------------------------------------------+--------+--------+|Gross profit  | 135.3| 140.1|+---------------------------------------------------------+--------+--------+|Gross margin  | 18.9%| 19.9%|+---------------------------------------------------------+--------+--------+|Operating income before depreciation and amortization  | -42.7| -2.7|+---------------------------------------------------------+--------+--------+|Operating margin before depreciation and amortization, % | -6.0%| -0.4%|+---------------------------------------------------------+--------+--------+|Operating income   | -58.8| -19.4|+---------------------------------------------------------+--------+--------+|Operating margin  | -8.2%| -2.8%|+---------------------------------------------------------+--------+--------+|Cash flow from operations  | -374.6| -194.3|+---------------------------------------------------------+--------+--------+ [1]Lekmer and HSNG are recognized as discontinued operations in the consolidated accounts.  Qliro Group’s net sales increased 2 percent, and the gross margin was 18.9 percent for the quarter. Operating result before depreciation, amortization and impairment decreased to SEK -43 million. The operating result included initiatives that increased marketing spend with SEK 9 million and personnel costs with SEK 14 million. As previously communicated, the result was also affected by a reorganization in CDON Marketplace with SEK 7 million and by increased returns in Nelly with SEK 16 million. The sale of HSNG resulted in earnings including discontinued operations of SEK 0.60 per share (fully diluted) for the quarter. We are pleased with the development in Qliro Financial Services and with the transformation of CDON Marketplace, but Nelly’s results are below our expectations.   Qliro Financial Services increased profitabilityQliro Financial Services increased its operating income by 38 percent, while growth in total operating expenses was limited to 29 percent. This shows the scalability of the business. Operating income before depreciation, amortization and impairment improved by 79 percent. At the end of the quarter, lending to the public was SEK 1,019 million. Personal loans in Sweden grew the fastest and conditions are ripe for continuing to grow this business. Qliro Financial Services’ organization has a sufficient scale to handle a considerable increase in the loan book with current offers without significantly increasing the number of employees. CDON Marketplace reorganizedCDON Marketplace has achieved a strong position as the leading Nordic digital marketplace. Although Easter took place in the end of the quarter, external merchants increased their sales by 13 percent. As part of its transformation into the marketplace model, CDON was reorganized, which affected about ten administrative positions. This affected earnings by about SEK 7 million in the quarter but will help lower costs in the long-term. We continue to invest in technology, logistics and branding. CDON also launched a new site tailored to corporate customers. Nelly reported a weak quarterNelly accelerated its marketing, which contributed to an increased total order value of 15 percent in the first quarter. However, revenue growth was limited to 3 percent due to delayed deliveries around Easter, unexpectedly high utilization of extended returns from campaigns in the fourth quarter 2017 and increased returns in the first quarter. Orders for approximately SEK 13 million were delayed by Easter and were delivered in the second quarter. Compared to the same period last year, earnings were adversely affected by approximately SEK 16 million due to the increased returns. Half of this amount was a one-off effect from extended returns from campaigns in the fourth quarter 2017, and the rest was due to generally higher return rate during the quarter. In addition, Nelly increased its marketing initiatives by SEK 8 million. Operating loss before depreciation, amortization and impairment was SEK 15 million for the quarter. This was below our expectations and we are intensifying our efforts for profitable growth. On April 17, Anna Ullman Sersé was appointed Interim Head of Nelly. Anna has led the strategy development for Nelly as Head of Business Development and is a member of Qliro Group’s management team since 2016. She replaced Jan Wallsin who left the group. Financial flexibilityCDON Marketplace and Nelly have strong positions in dynamic segments of e-commerce. Their growth drives increasing volumes to Qliro Financial Services that extend our relationship with consumers, enabling the offer to be expanded with low customer acquisition costs.  The group’s cash position amounted to SEK 602 million and the net cash position in our e-commerce business to SEK 324 million. This provides us with good opportunities to invest in our business areas and grow the loan book in Qliro Financial Services.   Stockholm, April 2018Marcus Lindqvist, President and CEO FINANCIAL TARGETSQliro Group’s long-term financial targets are: CDON Marketplace  · Attain a level of organic growth in gross merchandise value of an average of 10 per cent per year · Generate operating income before depreciation, amortization and impairment of 1-2 per cent of gross merchandise value Nelly (including NLYMan)  · Attain a level of organic growth of an average of 8 per cent per year · Generate an operating margin before depreciation, amortization and impairment of at least 6 percent Qliro Financial Services  · Reach operating income before depreciation, amortization and impairment of at least SEK 150 million in 2019 SIGNIFICANT EVENTS DURING AND AFTER THE FIRST QUARTER OF 2018 Changed accounting policies for Qliro Financial ServicesOn January 1, new rules for the reporting of financial instruments, IFRS 9, were introduced. They primarily affect Qliro Group through Qliro Financial Services’ credit loss reserves. According to IFRS 9, reserves for credit losses shall be made directly when a credit is issued, instead of as previously when there is an indication of increased credit risk. This results in earlier and higher recognition of the reserves for credit losses than before, but it will not affect cash flow or underlying credit risk. In the opening balance of 2018, the reserves increased by SEK 24 million due to the transition to IFRS 9. These provisions affect the balance sheet items equity and lending to the public but do not affect the income statement. From January 1, 2018, provisions for projected credit losses will be made directly at the time of lending with the effect recognized in earnings. Sale of Health and Sports Nutrition Group HSNG ABOn January 30, the sale of Health and Sports Nutrition Group to Orkla was completed. HSNG remains a partner with Qliro Financial Services and CDON Marketplace after the transaction. HSNG is recognized as a discontinued operation. The capital gain from the divestment excluding transaction costs amounted to SEK 140 million and was recognized as profit from discontinued operations in the first quarter. CDON Marketplace launched a corporate offeringOn March 20, CDON.COM launched a new B2B site targeted to small and medium-sized companies in Sweden. The product range consists initially of IT equipment and office supplies. The ambition going forward is to offer a broad and attractive range of products to corporate customers across the Nordic region.   Qliro Group commented on Nelly and CDON MarketplaceOn April 5, Qliro Group published a press release announcing that Nelly’s order intake increased during the first quarter, but that sales growth was limited due to delayed deliveries and increased returns, and that earnings were affected by increased investments in marketing and organization. It was also announced that CDON Marketplace adjusted the organization as part of its transformation to a marketplace. Anna Ullman Sersé appointed Interim Head of NellyOn April 17, Qliro Group announced that Anna Ullman Sersé had been appointed Interim Head of Nelly. Anna has been Head of Business Development and a member of Qliro Group’s management team since 2016. She replaced Jan Wallsin who left the group. A search process for Jan´s successor will be undertaken. Conference callAnalysts, investors and the media are invited to a conference call today at 10 a.m. To participate in the conference call, please dial:Sweden +46 (0)8 5033 6574UK +44 330 336 9105US +1 646 828 8156PIN code to participate: 3160593  The presentation material and webcast will be published at www.qlirogroup.com. For additional information, please visit www.qlirogroup.com or contact:Marcus Lindqvist, President and CEOMathias Pedersen, CFOTelephone: +46 (0)10 703 20 00 Niclas Lilja, Head of Investor Relations Telephone: +46 (0)736 511 363ir@qlirogroup.com  About Qliro GroupQliro Group is a leading Nordic e-commerce group in consumer goods and related financial services. Qliro Group operates the leading Nordic online marketplace CDON.COM, the fashion brand Nelly, and Qliro Financial Services, offering financial services to merchants and consumers. In 2017 the Group had sales of SEK 3.4 billion. Qliro Group’s shares are listed on the Nasdaq Stockholm MidCap segment under the ticker symbol QLRO.  This information is information that Qliro Group AB is required to disclose under the EU Market Abuse Regulation. The information was released for publication through the agency of the above-mentioned contacts at 8:00 a.m. CET on Friday, April 20, 2018. 

Interim Management Statement January-March 2018

Highlights during the first quarter · Adjusted net asset value*, based on estimated market values for the major wholly-owned subsidiaries and partner-owned investments within Patricia Industries, amounted to SEK 383,027 m. (SEK 501 per share) on March 31, 2018, a decrease of SEK 1,720 m., or 0 percent, during the quarter. · Reported net asset value1)* amounted to SEK 342,575 m. (SEK 448 per share) on March 31, 2018, an increase of SEK 6,312 m., or 2 percent, during the quarter. · Listed Core Investments generated a total return* of 1 percent. · Within Listed Core Investments, shares in Ericsson were purchased for SEK 1,002 m., strengthening our ownership to 7.2 and 22.5 percent of the capital and votes respectively. · Within Patricia Industries, organic sales growth for the major wholly-owned subsidiaries amounted to 4 percent in constant currency. Mölnlycke grew 2 percent organically in constant currency, with improved profitability. · Patricia Industries agreed to acquire Sarnova, a leading U.S. healthcare products specialty distributor. Upon closing on April 4, 2018, Patricia Industries paid USD 513 m. for 86 percent ownership. · The value of Investor’s investments in EQT increased by 3 percent in constant currency. Net cash flow to Investor amounted to SEK 514 m. EQT closed EQT VIII, its largest fund to date, at EUR 10.75 bn. Investor has committed SEK 5.7 bn. to the fund. Financial information, first quarter 2018 · Adjusted net asset value growth and reported net asset value growth, including dividend added back, amounted to 0 percent and 2 percent respectively. · Contribution to reported net asset value amounted to SEK 6,312 m. (30,120), of which: Listed Core Investments SEK 3,872 m. (29,840), Patricia Industries SEK 2,362 m. (16) and EQT SEK 1,143 m. (663). · Leverage* (net debt/reported total assets) was 3.6 percent on March 31, 2018 (3.5). · Consolidated net sales for the period was SEK 8,605 m. (8,407). Consolidated profit/loss for the period was SEK 4,403 m. (SEK 5.77 basic earnings per share), compared to SEK 30,404 m. (SEK 39.78 basic earnings per share) for the same period 2017.

ExpreS2ion’s U.S. partner Integrated BioTherapeutics launches first ExpreS2-based research product

ExpreS2ion stated in July 2017 that the Company will receive a two-digit percentage royalty based on net sales of ExpreS2-based products that IBT will develop and sell to its clients. It was also stated that IBT is planning to launch approximately five products for research purposes annually, and that the collaboration is expected to generate annual revenues of up to 1 MSEK to ExpreS2ion, when fully implemented. The launch of this first product is in line with these estimates. “I am very pleased that the first commercial reagent produced using ExpreS2 under the agreement with IBT is now on the market. This is the first of several planned products that will be marketed through partners, and we expect this new business area to represent both continued revenues as well as additional business opportunities”, says ExpreS2ion’s CEO Dr. Steen Klysner. The Ebola virus glycoprotein product can be ordered directly from IBT Bioservices’ website, and there is also a catalogue data sheet available. Follow the links below to reach the website or the data sheet, respectively: http://www.ibtbioservices.com/ http://www.ibtbioservices.com/IBTBioServices/assets/File/datasheets/Cat0501-025Lot1711002_100ug.pdf  About Integrated Biotherapeutics, Inc. Integrated BioTherapeutics, Inc., Rockville, Maryland, USA is a biotechnology company focused on the discovery of novel vaccines and therapeutics for emerging infectious diseases. IBT's antiviral pipeline includes unique pan-filovirus antibody candidates, vaccines and a variety of other product candidates for emerging viruses, such as zika, ebola, dengue, Marburg, and others. IBT’s service and reagent division doing business as IBT Bioservices (www.ibtbioservices.com) produces and markets high quality recombinant proteins and antibodies primarily for infectious disease research and offers in vitro and in vivo anti-microbial testing services.   Certified Adviser Sedermera Fondkommission is appointed as Certified Adviser for ExpreS2ion.

The acting CEO Mattias Carlsson is appointed as the CEO for TF bank

– Mattias Carlsson has been an important member of the working team of TF bank throughout his years of service at TF Bank. We at the Board of Directors are convinced that Mattias Carlsson is the right person for this post to lead the daily operational activities for our growth journey, says the acting Chairman of the Board of Directors of TF Bank Bertil Larsson. Mattias Carlsson has long experience in banking activities where he among other different posts worked at SEB before he became the CEO for TF Bank in year 2009. Mattias Carlsson was the CEO of the bank until year 2015 and then became the Chairman of the Board of Directors when TF Bank initiated the preparation process for listing on Nasdaq Stockholm in June 2016. Mattias has a broad experience in strategic planning, business development on product and customer level. – I am looking forward to continue managing the operational activities – along with the competent staff of the bank – at this exceptional phase of growth the bank is currently going through. We will continue strengthening our market positioning in northern Europe through expanding and diversifying our two segments of business aiming to increase the value for our shareholders, says TF bank's newly appointed CEO Mattias Carlsson. An interview with Mattias Carlsson is attached to this press release. For more information you may contact:Bertil Larsson, acting Chairman of the Board, +46 (0)70 573 13 00Mikael Meomuttel, CFO and Head of Investor Relations +46 (0)70 626 95 33 About TF BankTF Bank is an internet-based niche bank offering consumer banking services through its proprietary IT-platform with a high degree of automation. The company’s IT platform is designed for scalability and adaptation to different products, countries, currencies and digital banking solutions. TF Bank carries out deposit and lending activities with consumers in Sweden, Finland, Norway, Denmark, Poland, Germany, Estonia and Latvia through subsidiary, branch or cross-border banking. The business is divided into two segments: Consumer Lending and Ecommerce Solutions.

NeuroVive’s Board Members, Senior Executives and employees will subscribe units in the ongoing rights issue

In the current rights issue in NeuroVive, the Board, Senior Executives and employees have undertaken to subscribe for at least 191,200 units equivalent to MSEK 1.5. The subscription period in the current rights issue in NeuroVive is ongoing until April 24, 2018 and is open to both existing and new investors. Prospectus, containing full terms and conditions, as well as application forms are available on NeuroVive's website www.neurovive.com, Stockholm Corporate Finance AB's website www.stockholmcorp.se and Hagberg & Aneborn Fondkommission AB's website www.hagberganeborn.se. For more information, please contact: Daniel Schale, Director of Communications +46 (0)46 275 62 21, ir@neurovive.com NeuroVive Pharmaceutical AB (publ) Medicon Village, 223 81 Lund, Sweden Tel: +46 (0)46 275 62 20 (switchboard) info@neurovive.com, www.neurovive.com This information is information that NeuroVive Pharmaceutical AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 08:30 a.m. CEST on 20 April 2018. About NeuroVive   NeuroVive Pharmaceutical AB is a leader in mitochondrial medicine, with one project in clinical phase II development for the prevention of moderate to severe traumatic brain injury (NeuroSTAT®) and one project in clinical phase I (KL1333) for genetic mitochondrial diseases. The R&D portfolio consists of several late stage research programs in areas ranging from genetic mitochondrial disorders to cancer and metabolic diseases such as NASH. The company’s strategy is to advance drugs for rare diseases through clinical development and into the market. The strategy for projects within larger indications outside the core focus area is out-licensing in the preclinical phase. NeuroVive is listed on Nasdaq Stockholm, Sweden (ticker: NVP). The share is also traded on the OTCQX Best Market in the US (OTC: NEVPF).

Heléne Bittmann new Swedish VP Sales for the National Security focus area at Advenica

The Swedish provider of cybersecurity solutions, Advenica, has appointed Heléne Bittmann as the new VP Sales for the focus area National Security in Sweden. Heléne has extensive experience as an officer in the Swedish Air Force, where she held a number of positions at both unit and senior staff levels, including project manager for several development projects. Heléne joins Advenica from Saab, where she recently worked as Sales Director and Country Manager focusing on parts of the European market. She has previously also worked in Saab’s business area Surveillance/Electronic Warfare Systems. "The cyberthreat is distinct and has to be taken seriously. Advenica’s offer is not only of great immediate interest but also unique from a security point of view. Furthermore, there is a strong, committed and close-knit team, which is crucial for creating the long-term and reliable relationships expected by our customers. With the product portfolio, Advenica creates the best conditions for protecting our national interests. Personally, this is enormously motivating to work with. I look forward to developing the company and market together with the team", says Heléne Bittmann, new VP Sales National Security Sweden. Besides the defence industry, the National Security focus area includes secret services, counterintelligence and governmental agencies that manage information of national interest. Heléne will assume VP Sales responsibilities for National Security in Sweden late June 2018 and will be part of Advenica’s management team. "This is a strategically very important recruitment for Advenica. We are in an expansive stage with intensive sales drives both in Sweden and internationally. Heléne Bittmann’s network, leadership qualities and knowledge of military as well as political planning are major assets to our continued growth", says Einar Lindquist, CEO Advenica. For more information, please contact: Einar Lindquist, CEO Advenica AB, +46 (0)704 29 98 39, einar.lindquist@advenica.com This information is information that Advenica AB is obligated to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 08.50 a.m. CET on April 20, 2018.

Expands H2Station® product range with new compressor and increased fueling capacity

(Oslo, 20 April 2018) Nel launches new H2Station® product with increased fueling capacity of up to 100 cars or 50 buses per day per dispenser. This is made possible by use of a new hydrogen dedicated compression technology developed by Nel. The modular H2Station® design allows for fueling of various types of vehicles and is offered for both Europe and USA. The new H2Station® product builds on the previous generation introduced in 2015, but now features a new hydrogen compression technology developed by Nel. This allows for increased fueling capacity whilst maintaining the same equipment footprint, already being the world’s most compact. The new compressor has been developed specifically for hydrogen fueling with improved operations dynamics and increased efficiency, whilst ensuring a fully contamination free compression. The compressor also allows for longer service intervals as well as easy access to wear parts, which makes maintenance more efficient. The H2Station® product can be configured for fueling of multiple types of vehicles ranging from cars to heavy duty vehicles such as busses and trucks with either 70MPa or 35MPa. H2Station® is designed for use in both Europe and USA and for lean volume manufacturing at the Nel factory in Denmark – the world’s largest with a capacity up to 300 stations per year. “We see a growing demand for stations to be capable of fueling larger amounts of hydrogen, both to satisfy increased demand from passenger transport at each station, but also to fuel large quantities of hydrogen for heavy duty transport. The next generation H2Station® from Nel addresses this demand, and represents a big step forward, with regards to capacity and reliability, both key factors to accelerate the introduction of hydrogen as a zero-emission fuel across the entire transport sector,” says Jon André Løkke, CEO of Nel. ENDS For additional information, please contact: Jon André Løkke, CEO, +47 9074 4949 Bjørn Simonsen, VP Market Development & Public Relations, +47 971 79 821 About Nel Hydrogen | www.nelhydrogen.com       Nel Hydrogen is a global, dedicated hydrogen company, delivering optimal solutions to produce, store and distribute hydrogen from renewable energy. We serve industries, energy and gas companies with leading hydrogen technology. Since its foundation in 1927, Nel has a proud history of development and continual improvement of hydrogen plants. Our hydrogen solutions cover the entire value chain from hydrogen production technologies to manufacturing of hydrogen fueling stations, providing all fuel cell electric vehicles with the same fast fueling and long range as conventional vehicles today. 

RaySearch partners with Heidelberg University Hospital on RayCare OIS

Heidelberg University Hospital is a world-leader in clinical practice and advanced research in areas such as carbon ion and helium ion beam therapy and is working to establish the city of Heidelberg as a leading center for research. The innovative RayCare OIS is designed to support comprehensive cancer care. It integrates seamlessly with the RayStation® treatment planning system. But that’s just the start – RayCare will connect all the oncology disciplines, enabling users to fluidly coordinate tasks and ensure optimal use of resources. Over subsequent releases*, RayCare will evolve into a machine learning OIS with unique capabilities to coordinate oncology tasks, supporting comprehensive cancer care organized around each patient’s needs. This goal reflects the fact that many cancer patients receive a combination of treatment types, driving the need for combined workflows for radiation therapy, chemotherapy and surgery. Professor Jürgen Debus at Heidelburg University Hospital says: “We are proud to be integrated into the development process of RayCare. RayCare will improve workflow and quality in radiation oncology significantly.” Johan Löf, CEO of RaySearch, says: “The city of Heidelberg constitutes an extraordinary environment for innovation. In the field of oncology specifically, Heidelberg is home to the Heidelberg University, the University Hospital, the Ion Beam Therapy Center and even the German Cancer Research Center. Taken together, these institutions cover everything from basic research to translational research and clinical excellence. The first mission statement of RaySearch was to bring scientific advancements faster to the clinical world. We have since built a strong organization for research and development and brought two major software systems to clinics, RayStation and RayCare. The Heidelberg University Hospital and its affiliated sites are ideal partners to continue this development with, and I am proud that they have chosen to work with RaySearch to take comprehensive cancer care to the next level.” About Heidelberg University HospitalHeidelberg University is the oldest university in Germany; its first medical lectures were held here in 1388. Today, Heidelberg University Hospital is one of the largest and most prestigious medical centers in Europe, with a reputation based on excellent patient care, research and teaching. Heidelberg University Hospital offers inpatients and outpatients an innovative and effective diagnosis and therapy for all complex diseases. Modern buildings with state-of-the-art equipment delivers medical care to the highest international standards. The proximity and interlinking of the specialist departments benefit the patient, with interdisciplinary cooperation ensuring optimal treatment. About RayCareRayCare represents the future of OIS technology, developed from the ground up by RaySearch to support the complex logistical challenges of modern, large-scale radiation therapy centers. RayCare will integrate the high-performance radiation therapy algorithms available in RayStation with advanced features for clinical resource optimization, workflow automation and adaptive radiation therapy. About RaySearchRaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation® treatment planning system to clinics all over the world and distributes products through licensing agreements with leading medical technology companies. The company has now launched the next-generation oncology information system, RayCare™, which comprises a new product area for RaySearch. RaySearch’s software is used by over 2,600 clinics in more than 65 countries. The company was founded in 2000 as a spin-off from Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since November 2003. To learn more about RaySearch, go to: www.raysearchlabs.com  * Subject to regulatory clearance in some markets.   For further information, please contact:Johan Löf, President and CEO, RaySearch Laboratories AB (publ)Telephone: +46 (0)8-510 530 00johan.lof@raysearchlabs.com

Mr Green launches Express sign up, login and withdrawals

Starting today, Swedish customers can create an account with Mr Green by simply using their BankID. Existing Mr Green users are also able to use the express functions making both log-in and withdrawals . With this service Mr Green jumps on the trend with super-fast registration and withdrawals. Mr Green’s Express registration and withdrawals solution is unique in the way that it works in combination with other registration, deposit  and withdrawal methods as well as applies for customers already having an account.  With focus on player security and compliance Mr Green’s Express Registration is built to be compliant with the approaching regulation in Sweden.  Any Swedish customer signing in through BankID and deposits through bank transfer will also be able to benefit from the new Express Withdrawal feature, which will normally credit the customer’s account in less than 5 minutes.  BankID login and withdrawals is available on all Mr Green platforms including web desktop and mobile as well as iOS  and android  apps.  Jesper Kärrbrink, CEO Mr Green Ltd, commented on the new express features;  “At Mr Green, we focus on delivering a superior experience in a Green Gaming  environment and since these new features let the customers focus on enjoying our games in a safe way, we know this will contribute to a great gaming experience. This will also make the validation process of new players much easier for us, reducing the time spend approving new accounts internally leaving even more room for us to build more smart tools in the future. We are now looking at ways to roll out these features in more of our markets where BankID and similar solutions are available.” 

Nordic Nanovector appoints Tone Kvåle as Interim Chief Executive Officer

Oslo, Norway, 20 April 2018 Nordic Nanovector ASA (OSE: NANO) announces that it has appointed Tone Kvåle to the position of Interim Chief Executive Officer (CEO) in addition to her current role as Chief Financial Officer. The appointment is made to conform to Norwegian Companies Law. A search for a full-time CEO is progressing. -End- For further information, please contact: Ludvik Sandnes, Chairman Cell: +47 907 43017 Email: lsandnes@nordicnanovector.com Malene Brondberg, VP Investor Relations and Corporate Communications Cell: +44 7561 431 762 Email: ir@nordicnanovector.com Media Enquiries Mark Swallow/David Dible/Isabelle Andrews (Citigate Dewe Rogerson) Tel: +44 207 638 9571 Email: nordicnanovector@citigatedewerogerson.com About Nordic Nanovector Nordic Nanovector is committed to develop and deliver innovative therapies to patients to address major unmet medical needs and advance cancer care. The Company aspires to become a leader in the development of targeted therapies for haematological cancers. Nordic Nanovector's lead clinical-stage candidate is Betalutin®, a novel CD37-targeting Antibody-Radionuclide-Conjugates (ARC) designed to advance the treatment of non-Hodgkin's Lymphoma (NHL). NHL is an indication with substantial unmet medical need, representing a growing market forecast to be worth nearly USD 20 billion by 2024. Nordic Nanovector intends to retain marketing rights and to actively participate in the commercialisation of Betalutin® in core markets. The Company is also advancing a pipeline of ARCs and other immunotherapies for multiple cancer indications. Further information about the Company can be found at www.nordicnanovector.com

Resolutions at the annual general meeting in Evolution Gaming Group AB (publ)

Adoption of income statement and balance sheet as well as consolidated income statement and consolidated balance sheetThe annual general meeting adopted the income statement and consolidated income statement as well as the balance sheet and the consolidated balance sheet for the financial year 2017. Resolution on dividendThe annual general meeting resolved on a dividend of EUR 0.90 per share and that Tuesday 24 April 2018 shall be the record date for the dividend. Payment of the dividend is expected to be made on 2 May 2018 through Euroclear Sweden AB. Resolution on discharge from liability, re-election of board members and board feesThe annual general meeting resolved on discharge from liability for the members of the board of directors and the managing director for the financial year 2017. The annual general meeting resolved that the board of directors shall consist of six board members. Jens von Bahr, Joel Citron, Jonas Engwall, Cecilia Lager, Ian Livingstone and Fredrik Österberg were re-elected as board members and Jens von Bahr was re-elected as chairman of the board for the period until the close of the annual general meeting 2019. The annual general meeting resolved that the total fees to the board for the period until the next annual general meeting shall be increased to EUR 70,000 (EUR 60,000 the previous year), of which EUR 10,000 (unchanged) shall be paid to each of the board members elected by the annual general meeting that are not employed by the company and an additional EUR 20,000 (unchanged) shall be paid to the chairman of the board’s audit committee. The background for the increase of the total fees from EUR 60,000 to EUR 70,000 is that the re-elected board member Fredrik Österberg will end his employment with the company and he will therefore receive board fees instead of salary from the company. Amendments to the articles of associationThe annual general meeting resolved to amend § 7 of the company’s articles of association so that the company’s auditor can be elected for a term of not less than one and not more than four financial years. Further, the annual general meeting resolved to amend the object of the company set out in § 3 of the articles of association in order to make the wording of object of the company more precise so that it better corresponds with the operations that the company conducts today. In addition, the annual general meeting resolved on an editorial amendment to § 11 of the articles of association as the name of the Swedish Financial Instruments Accounts Act has been changed since the adoption of the previous articles of association. The complete new articles of association are available on the company’s website, www.evolutiongaming.com. Election of auditor and determination of fees to the auditorThe annual general meeting resolved to re-elect Öhrlings PricewaterhouseCoopers AB as auditor for the period until the close of the annual general meeting 2019 and that fees to the auditor shall be paid against approved account. Resolution on principles for appointing members of the nomination committeeThe annual general meeting resolved that the principles setting out how members of the nomination committee are appointed that were adopted at the annual general meeting 2017 shall continue to be applied during 2018. Pursuant to the principles, the nomination committee shall consist of a board member who is independent of the company and its senior management together with three additional members that shall be appointed by the three largest shareholders in terms of votes on the last business day in August 2018. Guidelines for remuneration to the senior managementThe annual general meeting resolved on guidelines for remuneration to the senior management that essentially correspond to the guidelines that were adopted at the annual general meeting 2017, however, with an addition that allows the general meeting to resolve on long-term share and share price related incentive programmes directed to senior executives, among others. Pursuant to the guidelines, remuneration to senior executives shall be based on conditions that are market competitive and at the same time aligned with shareholders’ interests. Further, the objective of the guidelines is to ensure that the company can attract, motivate and retain senior executives with the expertise and experience required to achieve the company's operating goals. Incentive programme involving directed issue and transfer of warrantsThe annual general meeting resolved to establish an incentive programme under which the company invites approximately 80–100 persons within the group to acquire warrants in the company. The right to acquire warrants is granted the managing director of the company, members of the group management, persons who report directly to the group management and other key employees. The board members of the company will not be granted warrants. The resolution includes a directed issue of not more than 617,702 warrants to a wholly-owned subsidiary with a subsequent transfer to the participants in the incentive programme. The participants can exercise the warrants for subscription of a total of not more than 617,702 shares in the company after a three-year vesting period. Minutes and complete resolutionsThe minutes from the annual general meeting, including the complete resolutions and the new articles of association, will be available on the company’s website, www.evoltiongaming.com.

Interim Report First Quarter 2018

CEO comment:”The first quarter of 2018 marks the beginning of a year of major transformation for the Tele2 Group. Our business momentum continued with growth in revenue, EBITDA and operating cash flow. Looking forward to the merger with Com Hem, we are today also announcing an updated shareholder remuneration and leverage policy, which we believe is highly attractive to all shareholders of the combined company.” Financial highlights: · Net sales growth of 5 percent, like-for-like · Mobile end-user service revenue growth of 4 percent and EBITDA growth of 6 percent, like-for-like · Adjusted for two non-cash one-off items, mobile end-user service revenue grew 5 percent and EBITDA grew 9 percent · Rolling 12 months operating cash flow growth of 26 percent · Kazakhstan reached the EBITDA margin target level of 30 percent earlier than expected · Updated financial framework for the combined company, post the proposed merger with Com Hem, aiming for:- Net debt to EBITDA target range of 2.5-3.0x- Ordinary dividend of at least 80 percent of equity free cash flow- Extraordinary dividends and/or share repurchases to maintain target leverage The report is available on www.tele2.com Presentation of the first quarter 2018 Tele2 will host a presentation with the possibility to join through a conference call, for the global financial community at 10:00 am CEST (09:00 am BST/04:00 am EDT) on Monday, April 23, 2018. The presentation will be held in English and also made available as a webcast on Tele2’s website: www.tele2.com  Dial-in information:To ensure that you are connected to the conference call, please dial in a few minutes before the start of the conference call to register your attendance. Ask for Tele2 Q1 Interim Report 2018. Dial-in numbers:SE: +46 (0)8 5065 3942UK: +44 (0)330 336 9411US: +1 646 828 8143 For more information, please contact: Angelica Gustafsson, Head of Public Relations, Tele2 AB, Phone: +46 704 26 41 42Erik Strandin Pers, Head of Investor Relations, Tele2 AB, Phone: +46 733 41 41 88 This information is information that Tele2 AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact persons set out above, at 07:00 CEST on April 23, 2018. TELE2’S MISSION IS TO FEARLESSLY LIBERATE PEOPLE TO LIVE A MORE CONNECTED LIFE. We believe the connected life is a better life, and so our aim is to make connectivity increasingly accessible to our customers, no matter where or when they need it. Ever since Jan Stenbeck founded the company in 1993, it has been a tough challenger to the former government monopolies and other established providers. Tele2 offers mobile services, fixed broadband and telephony, data network services, content services and global IoT solutions. Every day our 17 million customers across 8 countries enjoy a fast and wireless experience through our award winning networks. Tele2 has been listed on the NASDAQ OMX Stockholm since 1996. In 2017, Tele2 had net sales of SEK 25 billion and reported an EBITDA of SEK 6.4 billion. For definitions of measures, please see the last pages of the Annual Report 2017. Follow @Tele2group on Twitter for the latest updates

StarVR Corporation first day of trading on TPEx's Emerging Stocks Board

STOCKHOLM, SWEDEN (23 April, 2018) – Starbreeze joint venture StarVR Corporation's share is from today traded on TPEx's Emerging Stocks Board. The share was initially traded at prices from 69-96 TWD (Taiwanese dollars) per share. The total number of shares issued in StarVR Corporation is 48,218,000, of which 3.11 percent has been made available for trading. Starbreeze has not divested shares in connection with the listing, and the shareholding in StarVR Corporation remains at some 33 percent. StarVR Corporation has applied for and is approved for listing on the TPEx's Emerging Stocks Board with the first day of trading today, April 23, 2018 under the Chinese name Hongxing Technology Co and stock ticker 6681. Prior to listing, Acer divested 4.69 percent of its shares in StarVR Corporation.  The listing of StarVR Corporation does not affect Starbreeze accounting since the ownership in the joint venture is reported in accordance with the equity method. See previous press release from StarVR Corporation: https://news.cision.com/starvr/r/starvr-corporation-completes-application-for-public-issuance-in-taiwan--marks-first-step-for-ipo-pro,c2484279   StarVR Corporation was founded as a joint venture between Swedish entertainment content creator, publisher and innovator Starbreeze, and Acer, one of the world's top ICT companies with a presence in over 160 countries. StarVR Corporation designs, manufactures, promotes, markets and manages sales and support of StarVR solutions to the professional, enterprise, and location-based entertainment market. Headquartered in Taipei, StarVR Corporation also has presence in Los Angeles, Paris and Stockholm.

Aerial & Maritime to offer global air traffic management and ship tracking services by 2021 addressing a $1bn market

ICAO (International Civil Aviation Organization) has stated that space-based air traffic surveillance will be a cornerstone of the modernization of air traffic management. Currently, there is no way to monitor air traffic in large parts of the world, including the oceans, Africa and areas around the poles.  A&M will be using the flight-proven GomSpace nanosatellite technology. The system will enable a very price-competitive solution for global air traffic management surveillance, Global Aviation Distress Safety System (GADSS phase 1 and 2) as well as airline ADS-B tracking and maritime AIS vessel tracking. A&M will be a leader in the market to offer full surveillance (aviation) and tracking (maritime) at a much lower cost compared to traditional satellites. The satellite constellation will include interlink capability which, combined with a low latency ground infrastructure, will enable aircraft surveillance and ship tracking following stringent regulatory requirements for aviation. These features will be able to support air traffic management surveillance system requirements for air traffic control on a global scale. ICAO (International Civil Aviation Organization) has stated that space-based air traffic surveillance will be a cornerstone of the modernization of air traffic management. This will enable safe and cost-effective passenger flights whilst lowering carbon emissions at the same time. A&M will seek certification as a surveillance provider in accordance with civil aviation regulatory requirements in Europe.  As previously announced A&M will be launching 8 nanosatellites in Q1 2019 offering near real-time ADS-B and AIS data for aircraft and ship tracking in the equatorial region.  “It is a great opportunity for us to be able to offer global surveillance to customers in the aviation and maritime business by 2021. The intended upscale to a global constellation will position Aerial & Maritime as one of the dominant players in the market which will allow us to penetrate the market much more deeply. Our market pricing will reflect the low cost-base of GomSpace’s nanosatellite approach compared to much bigger and more expensive traditional satellites”, says Karsten Ingemann Pedersen, CEO of A&M. 

Ultra-low latency of 5G improves production of jet engine components

Ericsson (NASDAQ: ERIC) and the Fraunhofer Institute for Production Technology have teamed up to explore and develop industrial applications of 5G. The first use case for production of jet engine components for MTU Aero Engines is currently being evaluated and is presented this week (April 23-27) at the Hanover Fair in Germany. The components concerned, so-called blade integrated disks (blisk), are high-tech components where the disk and blades are produced as a single piece and serve the purpose of compressing the air inside jet engines. They are milled out of solid pieces of metal and have extremely high requirements towards accuracy and surface integrity. Thomas Dautl, Director of Manufacturing Technology, MTU Aero Engines, says: “A blade-integrated disk is a high-value component. The milling process takes 15-20 hours and the total lead time is around 3-4 months, including coating processes and quality checks. The new 5G-based production technology will help make our operations more efficient.” Applying 5G in the manufacturing industry has many important benefits in terms of costs, quality, and flexibility. The ultra-low latency and very high bandwidth make it possible to control machines in real-time, reducing manufacturing costs and improving quality of products. The 5G-enabled blisk case alone can save approximately EUR 27 million for one single factory, and up to EUR 360 million globally, according to the latest Ericsson Consumer and Industry Lab Business Value Report. From a sustainability perspective, CO2 emissions from both the production of blisk and their operation in jet engines can be reduced by some 16 million tons annually on a global basis. Moreover, the fact that 5G is a wireless technology also means machines can be equipped with sensors where fixed connections cannot be installed, and production lines can easily be adapted to new requirements – in a fraction of a second. The Blisk pilot shows the technical capabilities of 5G such as ultra-low latency of close to 1 millisecond, which is vital for in-process, time-critical applications. Ericsson’s 5G trial system operating on 3.5 GHz is connected to an acceleration sensor mounted directly on the blisk in the production machinery. The vibration spectrum is transmitted in real time via 5G to the evaluation system. The very low latency helps correlate the vibration to the tool’s position and enable prompt adjustment of the production process. Thomas Bergs, Managing Director at the Fraunhofer Institute for Production Technology, says: “Many of our partners are planning to implement 5G on their manufacturing sites and see a great potential in having this technology in place. It will help the companies to become more competitive and profitable.” Arun Bansal, Senior Vice President and Head of Market Area Europe and Latin America at Ericsson, says: “We are running 5G industry programs in Europe, North America and Asia. There is a strong demand from industries for 5G technology and together we can boost productivity and create new business opportunities. The Blisk project is a perfect example of what is possible in the industrial context with 5G in the future. Ultra-low latency of 5G makes this industrial use case feasible.” The Blisk 5G use case is Ericsson's first published tangible case study where the company takes a closer look at the business value of 5G-enabled production. Watch this testimonial video  to learn about the use case and business value for production of blade-integrated disks, and read about other industrial applications at the 5G for manufacturing  webpage. More information can also be found in the associated Consumer and Industry Lab Business Value  report and trial case  webpage. NOTES TO EDITORS For media kits, backgrounders and high-resolution photos, please visit www.ericsson.com/press FOLLOW US: www.twitter.com/ericssonwww.facebook.com/ericssonwww.linkedin.com/company/ericssonwww.youtube.com/ericsson Subscribe to Ericsson press releases here . MORE INFORMATION AT: News Center  media.relations@ericsson.com(+46 10 719 69 92) investor.relations@ericsson.com(+46 10 719 00 00) ABOUT ERICSSON Ericsson enables communications service providers to capture the full value of connectivity. The company’s portfolio spans Networks, Digital Services, Managed Services, and Emerging Business and is designed to help our customers go digital, increase efficiency and find new revenue streams. Ericsson’s investments in innovation have delivered the benefits of telephony and mobile broadband to billions of people around the world. The Ericsson stock is listed on Nasdaq Stockholm and on Nasdaq New York. www.ericsson.com

Exel Composites expands into the American market through the acquisition of Diversified Structural Composites

Exel Composites Plc has signed an agreement to acquire 100% of the shares in Diversified Structural Composites, Inc. (“DSC”), a composites company based in the United States of America, from Teijin Carbon America, Inc. a subsidiary of Teijin, a global carbon fiber manufacturer. DSC has one manufacturing facility using mainly pultrusion technology located in Erlanger, Kentucky. DSC has a high level of technological know-how in pultrusion related technologies, which complements well Exel Composites’ existing expertise and growth strategy. DSC’s product portfolio consists of carbon fiber and glass fiber reinforced composites that are produced particularly for the wind energy industry. DSC has about 90 employees and for the fiscal year 2017, ended in March 2018, revenue amounted to USD 19 million and operating loss close to USD one million. Restructuring initiatives since 2015 have progressively improved DSC’s profitability and breakeven profitability is expected to be reached in 2019. “We are decisively continuing the implementation of Exel Composites’ growth strategy and the DSC acquisition is a significant step in creating a true global footprint. The American market is the second largest composites market globally in terms of value and growth, right after the Asian market. With a well-established position in Europe and a strengthened presence in Asia since the Nanjing Jianhui acquisition in 2017, the Americas was the missing pillar in our pursuit for true global presence,” says Riku Kytömäki, President and CEO of Exel Composites. “DSC is a very good strategic fit for Exel Composites. It is focused on the same high growth segments, particularly wind energy and transportation, and opens up new channels to local markets enabling deliveries from the region to the region. The combined product portfolios of Exel Composites and DSC will enhance our attractiveness and provide cross-selling opportunities to existing and new customers. We appreciate DSC’s technological advantages in several key areas. We see that the technological expertise together with other complementary strengths will improve our joint competitiveness and enable synergies, among other, via technology transfers and supply chain optimization for the ultimate benefit of our customers,” he continues. The acquisition of DSC will make Exel Composites the only pultrusion company with significant presence on all three major continents. This way Exel Composites aims to improve its global supply position to the markets. Rob Klawonn, President of Teijin Carbon America, comments the acquisition and says “As DSC now becomes part of the Exel Composites Group, Exel’s enhanced global footprint and Teijin’s growth plans as an automotive composites solution provider can lead into mutual cooperation. I look forward to exploring synergies between Exel and Teijin in various areas such as the transportation sectors.” The total estimated net debt free purchase price is approximately USD 10 million, out of which USD 6 million corresponds to DSC’s business and USD 4 million to working capital. The transaction is expected to be closed during May 2018. The acquisition will be financed with a new long term loan. Vantaa, 23 April 2018                    Exel Composites Plc Riku KytömäkiPresident and CEO